Source Name	Characteristics [Age]	Characteristics [RiskStatus]	Characteristics [Sex]	Term Source REF	Term Accession Number	Characteristics [DiseaseState]	Characteristics [Organism]	Term Source REF	Term Accession Number	Characteristics [TumorSize]	Characteristics [TumorGrading]	Characteristics [BioSourceProvider]	Characteristics [SurvivalProbability]	Characteristics [Disease-Free Survival]	Characteristics [TestResult]	Characteristics [DistantMetastasis-Free Survival]	Characteristics [SurvivalTime]	Characteristics [RiskStatus]	Characteristics [RiskStatus]	Characteristics [RiskStatus]	Characteristics [OrganismPart]	Term Source REF	Term Accession Number	Protocol REF	Sample Name	Protocol REF	Extract Name	Material Type	Protocol REF	Labeled Extract Name	Label	Material Type	Protocol REF	Hybridization Name	Array Design REF	Protocol REF	Factor Value [NPI Risk Status]	Factor Value [Adjuvant online risk status]	Factor Value [MammaPrint prediction]	Factor Value [Disease-Free Survival]	Factor Value [DistantMetastasis-Free Survival]	Factor Value [St Gallen Risk Status]	Factor Value [SurvivalTime]	Factor Value [ER status]	Scan Name	Array Data File	Comment [ArrayExpress FTP file]
309210	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	88.6%	5.1 years	Estrogen Receptor Positive	5.1 years	9.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000289	P-TABM-212	4000289_e1	total_RNA	P-TABM-214	4000289_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1155.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.1 years	5.1 years	St Gallen category:high clinical risk	9.5 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_2_2_MRP_04000289_1	US22502555_251188612320_S01_2_2_MRP_04000289_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1155.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.1 years	5.1 years	St Gallen category:high clinical risk	9.5 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_2_2_MRP_04000289_1	US22502555_251188612320_S01_2_2_MRP_04000289_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2378	60 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	unknown	CRH	79.7%	2.3 years	unknown	10.6 years plus	10.6 years plus	MammaPrint result:high risk	NPI:not applicable	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000605	P-TABM-212	4000605_e1	total_RNA	P-TABM-214	4000605_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.899.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.3 years	10.6 years plus	St Gallen category:not applicable	10.6 years plus	unknown	US22502555_251188612201_S01_2_2_MRP_04000605_1	US22502555_251188612201_S01_2_2_MRP_04000605_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.899.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.3 years	10.6 years plus	St Gallen category:not applicable	10.6 years plus	unknown	US22502555_251188612201_S01_2_2_MRP_04000605_1	US22502555_251188612201_S01_2_2_MRP_04000605_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1210	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	1	JRH	96.5%	5.3 years plus	Estrogen Receptor Positive	5.3 years plus	5.3 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000717	P-TABM-212	4000717_e1	total_RNA	P-TABM-214	4000717_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2322.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	5.3 years plus	5.3 years plus	St Gallen category:low clinical risk	5.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_3_04000717_1_MRP	US22502555_251188612937_S01_1_3_04000717_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2322.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	5.3 years plus	5.3 years plus	St Gallen category:low clinical risk	5.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_3_04000717_1_MRP	US22502555_251188612937_S01_1_3_04000717_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
410j	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	JRH	67.9%	1.5 years	Estrogen Receptor Negative	10.6 years plus	10.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000694	P-TABM-212	4000694_e1	total_RNA	P-TABM-214	4000694_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2472.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_1_2_MRP_04000694_1	US22502555_251188612943_S01_1_2_MRP_04000694_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2472.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_1_2_MRP_04000694_1	US22502555_251188612943_S01_1_2_MRP_04000694_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1207	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	77.7%	2.6 years	Estrogen Receptor Positive	8.1 years plus	8.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000634	P-TABM-212	4000634_e1	total_RNA	P-TABM-214	4000634_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.813.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612198_S01_1_2_MRP_04000634_1	US22502555_251188612198_S01_1_2_MRP_04000634_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.813.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612198_S01_1_2_MRP_04000634_1	US22502555_251188612198_S01_1_2_MRP_04000634_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04073	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	GUY	87.2%	8.0 years	Estrogen Receptor Positive	8.0 years plus	8.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000514	P-TABM-212	4000514_e1	total_RNA	P-TABM-214	4000514_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1909.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.0 years	8.0 years plus	St Gallen category:high clinical risk	8.0 years	Estrogen Receptor Positive	US22502555_251188612451_S01_1_4_MRP_04000514_1	US22502555_251188612451_S01_1_4_MRP_04000514_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1909.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.0 years	8.0 years plus	St Gallen category:high clinical risk	8.0 years	Estrogen Receptor Positive	US22502555_251188612451_S01_1_4_MRP_04000514_1	US22502555_251188612451_S01_1_4_MRP_04000514_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1388.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.7 years	4.7 years plus	St Gallen category:high clinical risk	4.7 years	Estrogen Receptor Positive	US22502555_251188612377_S01_1_4_MRP_04000427_1	US22502555_251188612377_S01_1_4_MRP_04000427_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D6	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	89.2%	4.7 years	Estrogen Receptor Positive	4.7 years plus	4.7 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000427	P-TABM-212	4000427_e1	total_RNA	P-TABM-214	4000427_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1388.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.7 years	4.7 years plus	St Gallen category:high clinical risk	4.7 years	Estrogen Receptor Positive	US22502555_251188612377_S01_1_4_MRP_04000427_1	US22502555_251188612377_S01_1_4_MRP_04000427_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.316.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_2_4_MRP_04000303_1	US22502555_251188611799_S01_2_4_MRP_04000303_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246821	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	IGR	78.1%	1.5 years	Estrogen Receptor Positive	9.7 years plus	9.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000303	P-TABM-212	4000303_e1	total_RNA	P-TABM-214	4000303_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.316.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_2_4_MRP_04000303_1	US22502555_251188611799_S01_2_4_MRP_04000303_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1589.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.1 years	22.4 years plus	St Gallen category:high clinical risk	22.4 years	Estrogen Receptor Positive	US22502555_251188612420_S01_2_2_MRP_04000644_1	US22502555_251188612420_S01_2_2_MRP_04000644_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
95	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	85.7%	5.1 years	Estrogen Receptor Positive	22.4 years plus	22.4 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000644	P-TABM-212	4000644_e1	total_RNA	P-TABM-214	4000644_e1_l1.Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1589.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.1 years	22.4 years plus	St Gallen category:high clinical risk	22.4 years	Estrogen Receptor Positive	US22502555_251188612420_S01_2_2_MRP_04000644_1	US22502555_251188612420_S01_2_2_MRP_04000644_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.774.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_1_2_MRP_04000630_1	US22502555_251188612196_S01_1_2_MRP_04000630_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1481	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	2	CRH	67.1%	11.4 years plus	Estrogen Receptor Positive	11.4 years plus	11.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000630	P-TABM-212	4000630_e1	total_RNA	P-TABM-214	4000630_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.774.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_1_2_MRP_04000630_1	US22502555_251188612196_S01_1_2_MRP_04000630_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2082.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.8 years plus	17.8 years plus	St Gallen category:high clinical risk	17.8 years plus	Estrogen Receptor Positive	US22502555_251188612769_S01_2_2_MRP_04000547_1	US22502555_251188612769_S01_2_2_MRP_04000547_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04033	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	83.1%	17.8 years plus	Estrogen Receptor Positive	17.8 years plus	17.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000547	P-TABM-212	4000547_e1	total_RNA	P-TABM-214	4000547_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2082.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.8 years plus	17.8 years plus	St Gallen category:high clinical risk	17.8 years plus	Estrogen Receptor Positive	US22502555_251188612769_S01_2_2_MRP_04000547_1	US22502555_251188612769_S01_2_2_MRP_04000547_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1996	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	1	CRH	86.9%	1.7 years	Estrogen Receptor Positive	5.8 years	6.4 years	Adjuvant online:high clinical risk	St Gallen category:low clinical risk	NPI:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000612	P-TABM-212	4000612_e1	total_RNA	P-TABM-214	4000612_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1482.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.7 years	5.8 years	St Gallen category:low clinical risk	6.4 years	Estrogen Receptor Positive	US22502555_251188612389_S01_2_2_MRP_04000612_1	US22502555_251188612389_S01_2_2_MRP_04000612_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1482.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.7 years	5.8 years	St Gallen category:low clinical risk	6.4 years	Estrogen Receptor Positive	US22502555_251188612389_S01_2_2_MRP_04000612_1	US22502555_251188612389_S01_2_2_MRP_04000612_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1019.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.3 years plus	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_3_04000452_1_MRP	US22502555_251188612214_S01_1_3_04000452_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
284C63	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	KAR	88.3%	15.3 years plus	Estrogen Receptor Positive	15.3 years plus	15.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000452	P-TABM-212	4000452_e1	total_RNA	P-TABM-214	4000452_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1019.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.3 years plus	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_3_04000452_1_MRP	US22502555_251188612214_S01_1_3_04000452_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1336.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.0 years plus	19.0 years plus	St Gallen category:high clinical risk	19.0 years plus	Estrogen Receptor Negative	US22502555_251188612375_S01_1_4_MRP_04000419_1	US22502555_251188612375_S01_1_4_MRP_04000419_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16B4	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	KAR	67.3%	19.0 years plus	Estrogen Receptor Negative	19.0 years plus	19.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000419	P-TABM-212	4000419_e1	total_RNA	P-TABM-214	4000419_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1336.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.0 years plus	19.0 years plus	St Gallen category:high clinical risk	19.0 years plus	Estrogen Receptor Negative	US22502555_251188612375_S01_1_4_MRP_04000419_1	US22502555_251188612375_S01_1_4_MRP_04000419_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
57	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	83.8%	12.0 years	Estrogen Receptor Negative	12.1 years	12.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000677	P-TABM-212	4000677_e1	total_RNA	P-TABM-214	4000677_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2222.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.0 years	12.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_3_MRP_04000677_1	US22502555_251188612906_S01_2_3_MRP_04000677_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2222.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.0 years	12.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_3_MRP_04000677_1	US22502555_251188612906_S01_2_3_MRP_04000677_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2125.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.4 years	19.3 years plus	St Gallen category:high clinical risk	19.3 years plus	Estrogen Receptor Positive	US22502555_251188612772_S01_2_1_04000257_1_MRP	US22502555_251188612772_S01_2_1_04000257_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
166154	30 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	45 mm diameter	2	IGR	65.3%	15.4 years	Estrogen Receptor Positive	19.3 years plus	19.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000257	P-TABM-212	4000257_e1	total_RNA	P-TABM-214	4000257_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2125.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.4 years	19.3 years plus	St Gallen category:high clinical risk	19.3 years plus	Estrogen Receptor Positive	US22502555_251188612772_S01_2_1_04000257_1_MRP	US22502555_251188612772_S01_2_1_04000257_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04097	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	80.2%	11.6 years plus	Estrogen Receptor Positive	11.6 years plus	11.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000488	P-TABM-212	4000488_e1	total_RNA	P-TABM-214	4000488_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2029.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.6 years plus	11.6 years plus	St Gallen category:high clinical risk	11.6 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_2_4_MRP_04000488_1	US22502555_251188612458_S01_2_4_MRP_04000488_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2029.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.6 years plus	11.6 years plus	St Gallen category:high clinical risk	11.6 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_2_4_MRP_04000488_1	US22502555_251188612458_S01_2_4_MRP_04000488_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
87A79	36 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	1	KAR	95.5%	17.4 years plus	Estrogen Receptor Positive	17.4 years plus	17.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000440	P-TABM-212	4000440_e1	total_RNA	P-TABM-214	4000440_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.945.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.4 years plus	17.4 years plus	St Gallen category:low clinical risk	17.4 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_1_1_04000440_1_MRP	US22502555_251188612211_S01_1_1_04000440_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.945.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.4 years plus	17.4 years plus	St Gallen category:low clinical risk	17.4 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_1_1_04000440_1_MRP	US22502555_251188612211_S01_1_1_04000440_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.783.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years	11.9 years	St Gallen category:high clinical risk	14.9 years	Estrogen Receptor Positive	US22502555_251188612196_S01_1_4_MRP_04000631_1	US22502555_251188612196_S01_1_4_MRP_04000631_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1472	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	1	CRH	88.9%	11.9 years	Estrogen Receptor Positive	11.9 years	14.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000631	P-TABM-212	4000631_e1	total_RNA	P-TABM-214	4000631_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.783.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years	11.9 years	St Gallen category:high clinical risk	14.9 years	Estrogen Receptor Positive	US22502555_251188612196_S01_1_4_MRP_04000631_1	US22502555_251188612196_S01_1_4_MRP_04000631_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15C5	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	3	KAR	84.4%	13.6 years plus	Estrogen Receptor Negative	13.6 years plus	13.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000435	P-TABM-212	4000435_e1	total_RNA	P-TABM-214	4000435_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1415.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years plus	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Negative	US22502555_251188612378_S01_1_4_MRP_04000435_1	US22502555_251188612378_S01_1_4_MRP_04000435_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1415.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years plus	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Negative	US22502555_251188612378_S01_1_4_MRP_04000435_1	US22502555_251188612378_S01_1_4_MRP_04000435_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5224	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	86.1%	11.0 years	Estrogen Receptor Positive	19.6 years	19.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000590	P-TABM-212	4000590_e1	total_RNA	P-TABM-214	4000590_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1241.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.0 years	19.6 years	St Gallen category:high clinical risk	19.4 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_1_04000590_1_MRP	US22502555_251188612338_S01_2_1_04000590_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1241.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.0 years	19.6 years	St Gallen category:high clinical risk	19.4 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_1_04000590_1_MRP	US22502555_251188612338_S01_2_1_04000590_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2338.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_2_2_MRP_04000718_1	US22502555_251188612937_S01_2_2_MRP_04000718_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1328	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	2	JRH	88%	7.3 years plus	Estrogen Receptor Positive	7.3 years plus	7.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000718	P-TABM-212	4000718_e1	total_RNA	P-TABM-214	4000718_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2338.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_2_2_MRP_04000718_1	US22502555_251188612937_S01_2_2_MRP_04000718_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04071	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	3	GUY	80.8%	2.0 years	Estrogen Receptor Negative	14.9 years plus	14.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000516	P-TABM-212	4000516_e1	total_RNA	P-TABM-214	4000516_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1920.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_1_1_04000516_1_MRP	US22502555_251188612452_S01_1_1_04000516_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1920.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_1_1_04000516_1_MRP	US22502555_251188612452_S01_1_1_04000516_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171218	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	64.9%	14.8 years	Estrogen Receptor Negative	14.8 years	14.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000279	P-TABM-212	4000279_e1	total_RNA	P-TABM-214	4000279_e1_l4Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.694.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.8 years	14.8 years	St Gallen category:high clinical risk	14.8 years plus	Estrogen Receptor Negative	US22502555_251188611837_S01_2_4_MRP_04000279_4	US22502555_251188611837_S01_2_4_MRP_04000279_4.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.694.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.8 years	14.8 years	St Gallen category:high clinical risk	14.8 years plus	Estrogen Receptor Negative	US22502555_251188611837_S01_2_4_MRP_04000279_4	US22502555_251188611837_S01_2_4_MRP_04000279_4.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271982	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	83.2%	4.7 years	Estrogen Receptor Positive	4.7 years	5.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000330	P-TABM-212	4000330_e1	total_RNA	P-TABM-214	4000330_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.665.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.7 years	4.7 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611809_S01_2_4_MRP_04000330_1	US22502555_251188611809_S01_2_4_MRP_04000330_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.665.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.7 years	4.7 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611809_S01_2_4_MRP_04000330_1	US22502555_251188611809_S01_2_4_MRP_04000330_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
360	32 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	JRH	68.2%	12.6 years plus	Estrogen Receptor Negative	12.6 years plus	12.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000691	P-TABM-212	4000691_e1	total_RNA	P-TABM-214	4000691_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2379.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.6 years plus	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612939_S01_1_4_MRP_04000691_1	US22502555_251188612939_S01_1_4_MRP_04000691_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2379.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.6 years plus	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612939_S01_1_4_MRP_04000691_1	US22502555_251188612939_S01_1_4_MRP_04000691_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1956.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	4.8 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Negative	US22502555_251188612453_S01_2_3_04000528_1_MRP	US22502555_251188612453_S01_2_3_04000528_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04056	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	65.5%	1.5 years	Estrogen Receptor Negative	4.8 years	5.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000528	P-TABM-212	4000528_e1	total_RNA	P-TABM-214	4000528_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1956.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	4.8 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Negative	US22502555_251188612453_S01_2_3_04000528_1_MRP	US22502555_251188612453_S01_2_3_04000528_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.13.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188611675_S01_1_2_MRP_04000344_1	US22502555_251188611675_S01_1_2_MRP_04000344_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171620	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	27 mm diameter	3	IGR	64.9%	15.5 years plus	Estrogen Receptor Negative	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000344	P-TABM-212	4000344_e1	total_RNA	P-TABM-214	4000344_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.13.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188611675_S01_1_2_MRP_04000344_1	US22502555_251188611675_S01_1_2_MRP_04000344_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04022	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	GUY	80.2%	10.5 years	Estrogen Receptor Positive	10.5 years	11.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000497	P-TABM-212	4000497_e1	total_RNA	P-TABM-214	4000497_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2109.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.5 years	10.5 years	St Gallen category:high clinical risk	11.3 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_1_04000497_1_MRP	US22502555_251188612772_S01_1_1_04000497_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2109.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.5 years	10.5 years	St Gallen category:high clinical risk	11.3 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_1_04000497_1_MRP	US22502555_251188612772_S01_1_1_04000497_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.354.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years plus	4.8 years plus	St Gallen category:high clinical risk	4.8 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_2_MRP_04000309_1	US22502555_251188611801_S01_1_2_MRP_04000309_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280775	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	73.6%	4.8 years plus	Estrogen Receptor Positive	4.8 years plus	4.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000309	P-TABM-212	4000309_e1	total_RNA	P-TABM-214	4000309_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.354.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years plus	4.8 years plus	St Gallen category:high clinical risk	4.8 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_2_MRP_04000309_1	US22502555_251188611801_S01_1_2_MRP_04000309_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
217320	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	1	IGR	88.9%	3.3 years plus	Estrogen Receptor Positive	3.3 years plus	3.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000267	P-TABM-212	4000267_e1	total_RNA	P-TABM-214	4000267_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.497.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_1_04000267_1_MRP	US22502555_251188611805_S01_1_1_04000267_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.497.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_1_04000267_1_MRP	US22502555_251188611805_S01_1_1_04000267_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2889	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	KAR	89.6%	4.2 years	Estrogen Receptor Positive	14.7 years plus	14.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000566	P-TABM-212	4000566_e1	total_RNA	P-TABM-214	4000566_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1680.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.2 years	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_1_1_04000566_1_MRP	US22502555_251188612425_S01_1_1_04000566_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1680.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.2 years	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_1_1_04000566_1_MRP	US22502555_251188612425_S01_1_1_04000566_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2456.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612942_S01_1_3_04000687_1_MRP	US22502555_251188612942_S01_1_3_04000687_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
316	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	JRH	66.4%	12.8 years plus	Estrogen Receptor Negative	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000687	P-TABM-212	4000687_e1	total_RNA	P-TABM-214	4000687_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2456.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612942_S01_1_3_04000687_1_MRP	US22502555_251188612942_S01_1_3_04000687_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2280.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612909_S01_2_3_04000705_1_MRP	US22502555_251188612909_S01_2_3_04000705_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
533	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	2	JRH	77.7%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000705	P-TABM-212	4000705_e1	total_RNA	P-TABM-214	4000705_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2280.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612909_S01_2_3_04000705_1_MRP	US22502555_251188612909_S01_2_3_04000705_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256734	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	84.6%	2.2 years	Estrogen Receptor Negative	2.2 years	2.9 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000347	P-TABM-212	4000347_e1	total_RNA	P-TABM-214	4000347_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2198.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Negative	US22502555_251188612775_S01_1_4_MRP_04000347_1	US22502555_251188612775_S01_1_4_MRP_04000347_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2198.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Negative	US22502555_251188612775_S01_1_4_MRP_04000347_1	US22502555_251188612775_S01_1_4_MRP_04000347_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1503.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_4_MRP_04000615_1	US22502555_251188612392_S01_1_4_MRP_04000615_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1959	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	24 mm diameter	2	CRH	79%	13.3 years plus	Estrogen Receptor Positive	13.3 years plus	13.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000615	P-TABM-212	4000615_e1	total_RNA	P-TABM-214	4000615_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1503.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_4_MRP_04000615_1	US22502555_251188612392_S01_1_4_MRP_04000615_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2449.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612942_S01_1_1_04000686_1_MRP	US22502555_251188612942_S01_1_1_04000686_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	88.3%	12.6 years	Estrogen Receptor Positive	12.7 years plus	12.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000686	P-TABM-212	4000686_e1	total_RNA	P-TABM-214	4000686_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2449.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612942_S01_1_1_04000686_1_MRP	US22502555_251188612942_S01_1_1_04000686_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2166.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.8 years	6.5 years	St Gallen category:high clinical risk	11.1 years	Estrogen Receptor Positive	US22502555_251188612774_S01_1_1_04000307_1_MRP	US22502555_251188612774_S01_1_1_04000307_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
287508	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	2	IGR	88.3%	3.8 years	Estrogen Receptor Positive	6.5 years	11.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000307	P-TABM-212	4000307_e1	total_RNA	P-TABM-214	4000307_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2166.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.8 years	6.5 years	St Gallen category:high clinical risk	11.1 years	Estrogen Receptor Positive	US22502555_251188612774_S01_1_1_04000307_1_MRP	US22502555_251188612774_S01_1_1_04000307_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
360	32 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	JRH	68.2%	12.6 years plus	Estrogen Receptor Negative	12.6 years plus	12.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000691	P-TABM-212	4000691_e1	total_RNA	P-TABM-214	4000691_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2374.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.6 years plus	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612939_S01_1_3_04000691_1_MRP	US22502555_251188612939_S01_1_3_04000691_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2374.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.6 years plus	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612939_S01_1_3_04000691_1_MRP	US22502555_251188612939_S01_1_3_04000691_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219490	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	73.8%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000274	P-TABM-212	4000274_e1	total_RNA	P-TABM-214	4000274_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.549.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_1_04000274_1_MRP	US22502555_251188611806_S01_2_1_04000274_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.549.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_1_04000274_1_MRP	US22502555_251188611806_S01_2_1_04000274_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2319.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.4 years plus	4.4 years plus	St Gallen category:low clinical risk	4.4 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_2_MRP_04000716_1	US22502555_251188612937_S01_1_2_MRP_04000716_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1183	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	1	JRH	94.3%	4.4 years plus	Estrogen Receptor Positive	4.4 years plus	4.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000716	P-TABM-212	4000716_e1	total_RNA	P-TABM-214	4000716_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2319.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.4 years plus	4.4 years plus	St Gallen category:low clinical risk	4.4 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_2_MRP_04000716_1	US22502555_251188612937_S01_1_2_MRP_04000716_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1051.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_2_MRP_04000455_1	US22502555_251188612215_S01_1_2_MRP_04000455_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279C61	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	3	KAR	82.8%	15.5 years plus	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000455	P-TABM-212	4000455_e1	total_RNA	P-TABM-214	4000455_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1051.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_2_MRP_04000455_1	US22502555_251188612215_S01_1_2_MRP_04000455_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171897	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	89.4%	17.6 years plus	Estrogen Receptor Positive	17.6 years plus	17.6 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000351	P-TABM-212	4000351_e1	total_RNA	P-TABM-214	4000351_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2201.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.6 years plus	17.6 years plus	St Gallen category:high clinical risk	17.6 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_2_1_04000351_1_MRP	US22502555_251188612775_S01_2_1_04000351_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2201.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.6 years plus	17.6 years plus	St Gallen category:high clinical risk	17.6 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_2_1_04000351_1_MRP	US22502555_251188612775_S01_2_1_04000351_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1581.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_2_4_MRP_04000625_1	US22502555_251188612394_S01_2_4_MRP_04000625_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1549	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	CRH	84.1%	14.1 years plus	Estrogen Receptor Positive	14.1 years plus	14.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000625	P-TABM-212	4000625_e1	total_RNA	P-TABM-214	4000625_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1581.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_2_4_MRP_04000625_1	US22502555_251188612394_S01_2_4_MRP_04000625_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255926	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	IGR	81.5%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000342	P-TABM-212	4000342_e1	total_RNA	P-TABM-214	4000342_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.233.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_2_MRP_04000342_1	US22502555_251188611797_S01_2_2_MRP_04000342_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.233.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_2_MRP_04000342_1	US22502555_251188611797_S01_2_2_MRP_04000342_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255907	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	27 mm diameter	3	IGR	67.1%	13.1 years plus	Estrogen Receptor Negative	13.1 years plus	13.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000340	P-TABM-212	4000340_e1	total_RNA	P-TABM-214	4000340_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.208.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188611797_S01_1_1_04000340_1_MRP	US22502555_251188611797_S01_1_1_04000340_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.208.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188611797_S01_1_1_04000340_1_MRP	US22502555_251188611797_S01_1_1_04000340_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1923.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_1_2_MRP_04000516_1	US22502555_251188612452_S01_1_2_MRP_04000516_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04071	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	3	GUY	80.8%	2.0 years	Estrogen Receptor Negative	14.9 years plus	14.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000516	P-TABM-212	4000516_e1	total_RNA	P-TABM-214	4000516_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1923.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_1_2_MRP_04000516_1	US22502555_251188612452_S01_1_2_MRP_04000516_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2403.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Negative	US22502555_251188612940_S01_2_1_04000708_1_MRP	US22502555_251188612940_S01_2_1_04000708_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
547	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	JRH	62.9%	11.9 years plus	Estrogen Receptor Negative	11.9 years plus	11.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000708	P-TABM-212	4000708_e1	total_RNA	P-TABM-214	4000708_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2403.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Negative	US22502555_251188612940_S01_2_1_04000708_1_MRP	US22502555_251188612940_S01_2_1_04000708_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.854.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.8 years	9.1 years plus	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_1_4_MRP_04000600_1	US22502555_251188612200_S01_1_4_MRP_04000600_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3015	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	89.4%	5.8 years	Estrogen Receptor Positive	9.1 years plus	9.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000600	P-TABM-212	4000600_e1	total_RNA	P-TABM-214	4000600_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.854.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.8 years	9.1 years plus	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_1_4_MRP_04000600_1	US22502555_251188612200_S01_1_4_MRP_04000600_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1188.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.1 years plus	6.1 years plus	St Gallen category:high clinical risk	6.1 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_4_MRP_04000583_1	US22502555_251188612335_S01_2_4_MRP_04000583_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5235	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	CRH	87.6%	6.1 years plus	Estrogen Receptor Positive	6.1 years plus	6.1 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000583	P-TABM-212	4000583_e1	total_RNA	P-TABM-214	4000583_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1188.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.1 years plus	6.1 years plus	St Gallen category:high clinical risk	6.1 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_4_MRP_04000583_1	US22502555_251188612335_S01_2_4_MRP_04000583_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1605	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	JRH	95.2%	6.3 years	Estrogen Receptor Positive	7.7 years plus	7.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000721	P-TABM-212	4000721_e1	total_RNA	P-TABM-214	4000721_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2362.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	6.3 years	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188612938_S01_1_4_MRP_04000721_1	US22502555_251188612938_S01_1_4_MRP_04000721_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2362.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	6.3 years	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188612938_S01_1_4_MRP_04000721_1	US22502555_251188612938_S01_1_4_MRP_04000721_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1150.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.1 years	5.1 years	St Gallen category:high clinical risk	9.5 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_2_1_04000289_1_MRP	US22502555_251188612320_S01_2_1_04000289_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
309210	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	88.6%	5.1 years	Estrogen Receptor Positive	5.1 years	9.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000289	P-TABM-212	4000289_e1	total_RNA	P-TABM-214	4000289_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1150.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.1 years	5.1 years	St Gallen category:high clinical risk	9.5 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_2_1_04000289_1_MRP	US22502555_251188612320_S01_2_1_04000289_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5227	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	CRH	58.4%	1.5 years	Estrogen Receptor Negative	1.7 years	3.7 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000588	P-TABM-212	4000588_e1	total_RNA	P-TABM-214	4000588_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1223.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.7 years	St Gallen category:high clinical risk	3.7 years	Estrogen Receptor Negative	US22502555_251188612338_S01_1_1_04000588_1_MRP	US22502555_251188612338_S01_1_1_04000588_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1223.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.7 years	St Gallen category:high clinical risk	3.7 years	Estrogen Receptor Negative	US22502555_251188612338_S01_1_1_04000588_1_MRP	US22502555_251188612338_S01_1_1_04000588_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1818.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years	11.7 years	St Gallen category:high clinical risk	13.1 years	Estrogen Receptor Positive	US22502555_251188612447_S01_2_3_04000484_1_MRP	US22502555_251188612447_S01_2_3_04000484_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04012	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	82.8%	11.7 years	Estrogen Receptor Positive	11.7 years	13.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000484	P-TABM-212	4000484_e1	total_RNA	P-TABM-214	4000484_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1818.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years	11.7 years	St Gallen category:high clinical risk	13.1 years	Estrogen Receptor Positive	US22502555_251188612447_S01_2_3_04000484_1_MRP	US22502555_251188612447_S01_2_3_04000484_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
220	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	JRH	91.6%	10.2 years	Estrogen Receptor Negative	12.6 years plus	12.6 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000684	P-TABM-212	4000684_e1	total_RNA	P-TABM-214	4000684_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2371.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_2_4_MRP_04000684_1	US22502555_251188612938_S01_2_4_MRP_04000684_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2371.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_2_4_MRP_04000684_1	US22502555_251188612938_S01_2_4_MRP_04000684_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3642	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	42 mm diameter	3	CRH	66.6%	6.7 years	Estrogen Receptor Positive	6.7 years	14.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000599	P-TABM-212	4000599_e1	total_RNA	P-TABM-214	4000599_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.840.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	6.7 years	St Gallen category:high clinical risk	14.5 years	Estrogen Receptor Positive	US22502555_251188612200_S01_1_1_04000599_1_MRP	US22502555_251188612200_S01_1_1_04000599_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.840.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	6.7 years	St Gallen category:high clinical risk	14.5 years	Estrogen Receptor Positive	US22502555_251188612200_S01_1_1_04000599_1_MRP	US22502555_251188612200_S01_1_1_04000599_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247000	36 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	IGR	74.8%	2.3 years	Estrogen Receptor Positive	14.3 years plus	14.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000308	P-TABM-212	4000308_e1	total_RNA	P-TABM-214	4000308_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.337.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.3 years	14.3 years plus	St Gallen category:high clinical risk	14.3 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_2_3_04000308_1_MRP	US22502555_251188611800_S01_2_3_04000308_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.337.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.3 years	14.3 years plus	St Gallen category:high clinical risk	14.3 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_2_3_04000308_1_MRP	US22502555_251188611800_S01_2_3_04000308_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1935.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_2_4_MRP_04000520_1	US22502555_251188612452_S01_2_4_MRP_04000520_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04067	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	80.2%	15.8 years plus	Estrogen Receptor Negative	15.8 years plus	15.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000520	P-TABM-212	4000520_e1	total_RNA	P-TABM-214	4000520_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1935.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_2_4_MRP_04000520_1	US22502555_251188612452_S01_2_4_MRP_04000520_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1143.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612320_S01_1_3_04000277_2_MRP	US22502555_251188612320_S01_1_3_04000277_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219800	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	78.9%	15.5 years plus	Estrogen Receptor Negative	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000277	P-TABM-212	4000277_e1	total_RNA	P-TABM-214	4000277_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1143.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612320_S01_1_3_04000277_2_MRP	US22502555_251188612320_S01_1_3_04000277_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1684.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.2 years	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_1_2_MRP_04000566_1	US22502555_251188612425_S01_1_2_MRP_04000566_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2889	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	KAR	89.6%	4.2 years	Estrogen Receptor Positive	14.7 years plus	14.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000566	P-TABM-212	4000566_e1	total_RNA	P-TABM-214	4000566_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1684.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.2 years	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_1_2_MRP_04000566_1	US22502555_251188612425_S01_1_2_MRP_04000566_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1834.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.8 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612448_S01_2_3_04000500_1_MRP	US22502555_251188612448_S01_2_3_04000500_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04089	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	81%	3.8 years	Estrogen Receptor Positive	13.6 years plus	13.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000500	P-TABM-212	4000500_e1	total_RNA	P-TABM-214	4000500_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1834.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.8 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612448_S01_2_3_04000500_1_MRP	US22502555_251188612448_S01_2_3_04000500_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.223.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.8 years plus	5.8 years plus	St Gallen category:high clinical risk	5.8 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_1_4_MRP_04000341_1	US22502555_251188611797_S01_1_4_MRP_04000341_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256940	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	87.2%	5.8 years plus	Estrogen Receptor Positive	5.8 years plus	5.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000341	P-TABM-212	4000341_e1	total_RNA	P-TABM-214	4000341_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.223.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.8 years plus	5.8 years plus	St Gallen category:high clinical risk	5.8 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_1_4_MRP_04000341_1	US22502555_251188611797_S01_1_4_MRP_04000341_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04058	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	89.8%	2.6 years	Estrogen Receptor Positive	8.1 years plus	8.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000526	P-TABM-212	4000526_e1	total_RNA	P-TABM-214	4000526_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2048.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612459_S01_2_2_MRP_04000526_1	US22502555_251188612459_S01_2_2_MRP_04000526_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2048.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612459_S01_2_2_MRP_04000526_1	US22502555_251188612459_S01_2_2_MRP_04000526_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1500.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_3_04000615_1_MRP	US22502555_251188612392_S01_1_3_04000615_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1959	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	24 mm diameter	2	CRH	79%	13.3 years plus	Estrogen Receptor Positive	13.3 years plus	13.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000615	P-TABM-212	4000615_e1	total_RNA	P-TABM-214	4000615_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1500.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_3_04000615_1_MRP	US22502555_251188612392_S01_1_3_04000615_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1129.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.7 years plus	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Negative	US22502555_251188612218_S01_2_3_04000629_1_MRP	US22502555_251188612218_S01_2_3_04000629_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1496	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	CRH	61.5%	10.7 years plus	Estrogen Receptor Negative	10.7 years plus	10.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000629	P-TABM-212	4000629_e1	total_RNA	P-TABM-214	4000629_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1129.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.7 years plus	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Negative	US22502555_251188612218_S01_2_3_04000629_1_MRP	US22502555_251188612218_S01_2_3_04000629_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
27C4	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	1	KAR	93.4%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000411	P-TABM-212	4000411_e1	total_RNA	P-TABM-214	4000411_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1260.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:low clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_1_3_04000411_1_MRP	US22502555_251188612372_S01_1_3_04000411_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1260.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:low clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_1_3_04000411_1_MRP	US22502555_251188612372_S01_1_3_04000411_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.57.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611677_S01_2_4_MRP_04000285_1	US22502555_251188611677_S01_2_4_MRP_04000285_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
314827	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	IGR	80%	9.0 years plus	Estrogen Receptor Negative	9.0 years plus	9.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000285	P-TABM-212	4000285_e1	total_RNA	P-TABM-214	4000285_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.57.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611677_S01_2_4_MRP_04000285_1	US22502555_251188611677_S01_2_4_MRP_04000285_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1153	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	71.1%	14.0 years plus	Estrogen Receptor Positive	14.0 years plus	14.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000637	P-TABM-212	4000637_e1	total_RNA	P-TABM-214	4000637_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.827.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612198_S01_2_4_MRP_04000637_1	US22502555_251188612198_S01_2_4_MRP_04000637_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.827.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612198_S01_2_4_MRP_04000637_1	US22502555_251188612198_S01_2_4_MRP_04000637_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
220	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	JRH	91.6%	10.2 years	Estrogen Receptor Negative	12.6 years plus	12.6 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000684	P-TABM-212	4000684_e1	total_RNA	P-TABM-214	4000684_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2365.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_2_3_04000684_1_MRP	US22502555_251188612938_S01_2_3_04000684_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2365.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years	12.6 years plus	St Gallen category:high clinical risk	12.6 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_2_3_04000684_1_MRP	US22502555_251188612938_S01_2_3_04000684_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
272219	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	90.9%	12.9 years plus	Estrogen Receptor Positive	12.9 years plus	12.9 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000326	P-TABM-212	4000326_e1	total_RNA	P-TABM-214	4000326_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.642.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:low clinical risk	12.9 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_3_04000326_1_MRP	US22502555_251188611809_S01_1_3_04000326_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.642.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:low clinical risk	12.9 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_3_04000326_1_MRP	US22502555_251188611809_S01_1_3_04000326_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1711.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.8 years	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_1_1_04000570_1_MRP	US22502555_251188612426_S01_1_1_04000570_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2027	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	2	KAR	89%	14.8 years	Estrogen Receptor Positive	15.1 years plus	15.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000570	P-TABM-212	4000570_e1	total_RNA	P-TABM-214	4000570_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1711.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.8 years	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_1_1_04000570_1_MRP	US22502555_251188612426_S01_1_1_04000570_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.955.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	6.0 years	6.0 years	St Gallen category:high clinical risk	13.0 years	Estrogen Receptor Positive	US22502555_251188612211_S01_1_3_04000441_1_MRP	US22502555_251188612211_S01_1_3_04000441_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
74A63	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	1	KAR	83.4%	6.0 years	Estrogen Receptor Positive	6.0 years	13.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000441	P-TABM-212	4000441_e1	total_RNA	P-TABM-214	4000441_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.955.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	6.0 years	6.0 years	St Gallen category:high clinical risk	13.0 years	Estrogen Receptor Positive	US22502555_251188612211_S01_1_3_04000441_1_MRP	US22502555_251188612211_S01_1_3_04000441_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2443.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Positive	US22502555_251188612941_S01_2_3_04000715_1_MRP	US22502555_251188612941_S01_2_3_04000715_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1065	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	89.6%	2.0 years	Estrogen Receptor Positive	2.0 years	2.2 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000715	P-TABM-212	4000715_e1	total_RNA	P-TABM-214	4000715_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2443.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Positive	US22502555_251188612941_S01_2_3_04000715_1_MRP	US22502555_251188612941_S01_2_3_04000715_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246295	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	3	IGR	83.8%	10.4 years plus	Estrogen Receptor Positive	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000296	P-TABM-212	4000296_e1	total_RNA	P-TABM-214	4000296_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.253.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_2_MRP_04000296_1	US22502555_251188611798_S01_1_2_MRP_04000296_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.253.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_2_MRP_04000296_1	US22502555_251188611798_S01_1_2_MRP_04000296_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
310260	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	IGR	89.6%	1.2 years	Estrogen Receptor Positive	1.2 years	5.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000287	P-TABM-212	4000287_e1	total_RNA	P-TABM-214	4000287_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.77.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.2 years	1.2 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611678_S01_1_4_MRP_04000287_1	US22502555_251188611678_S01_1_4_MRP_04000287_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.77.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.2 years	1.2 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611678_S01_1_4_MRP_04000287_1	US22502555_251188611678_S01_1_4_MRP_04000287_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.610.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.3 years plus	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188611808_S01_1_4_MRP_04000321_1	US22502555_251188611808_S01_1_4_MRP_04000321_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171558	35 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	2	IGR	66.1%	16.3 years plus	Estrogen Receptor Negative	16.3 years plus	16.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000321	P-TABM-212	4000321_e1	total_RNA	P-TABM-214	4000321_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.610.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.3 years plus	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188611808_S01_1_4_MRP_04000321_1	US22502555_251188611808_S01_1_4_MRP_04000321_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.533.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_1_04000272_1_MRP	US22502555_251188611806_S01_1_1_04000272_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219139	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	1	IGR	84.5%	10.4 years plus	Estrogen Receptor Positive	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000272	P-TABM-212	4000272_e1	total_RNA	P-TABM-214	4000272_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.533.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_1_04000272_1_MRP	US22502555_251188611806_S01_1_1_04000272_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1078.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_2_MRP_04000459_1	US22502555_251188612217_S01_1_2_MRP_04000459_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
248C91	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	KAR	68.4%	15.8 years plus	Estrogen Receptor Positive	15.8 years plus	15.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000459	P-TABM-212	4000459_e1	total_RNA	P-TABM-214	4000459_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1078.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_2_MRP_04000459_1	US22502555_251188612217_S01_1_2_MRP_04000459_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
513	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	38 mm diameter	2	JRH	64.5%	3.1 years	Estrogen Receptor Negative	5.3 years plus	5.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000702	P-TABM-212	4000702_e1	total_RNA	P-TABM-214	4000702_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2514.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	5.3 years plus	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Negative	US22502555_251188613295_S01_2_3_04000702_1_MRP1_8	US22502555_251188613295_S01_2_3_04000702_1_MRP1_8.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2514.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	5.3 years plus	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Negative	US22502555_251188613295_S01_2_3_04000702_1_MRP1_8	US22502555_251188613295_S01_2_3_04000702_1_MRP1_8.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219468	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	IGR	74.7%	14.5 years plus	Estrogen Receptor Positive	14.5 years plus	14.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000273	P-TABM-212	4000273_e1	total_RNA	P-TABM-214	4000273_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.540.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.5 years plus	14.5 years plus	St Gallen category:high clinical risk	14.5 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_3_04000273_1_MRP	US22502555_251188611806_S01_1_3_04000273_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.540.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.5 years plus	14.5 years plus	St Gallen category:high clinical risk	14.5 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_3_04000273_1_MRP	US22502555_251188611806_S01_1_3_04000273_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246381	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	3	IGR	84.9%	7.7 years plus	Estrogen Receptor Positive	7.7 years plus	7.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000300	P-TABM-212	4000300_e1	total_RNA	P-TABM-214	4000300_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.292.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.7 years plus	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_2_MRP_04000300_1	US22502555_251188611799_S01_1_2_MRP_04000300_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.292.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.7 years plus	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_2_MRP_04000300_1	US22502555_251188611799_S01_1_2_MRP_04000300_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2210.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Positive	US22502555_251188612775_S01_2_3_04000352_1_MRP	US22502555_251188612775_S01_2_3_04000352_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
172086	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	73.2%	1.4 years	Estrogen Receptor Positive	1.4 years	16.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000352	P-TABM-212	4000352_e1	total_RNA	P-TABM-214	4000352_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2210.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Positive	US22502555_251188612775_S01_2_3_04000352_1_MRP	US22502555_251188612775_S01_2_3_04000352_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.850.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.8 years	9.1 years plus	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_1_3_04000600_1_MRP	US22502555_251188612200_S01_1_3_04000600_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3015	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	89.4%	5.8 years	Estrogen Receptor Positive	9.1 years plus	9.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000600	P-TABM-212	4000600_e1	total_RNA	P-TABM-214	4000600_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.850.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	5.8 years	9.1 years plus	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_1_3_04000600_1_MRP	US22502555_251188612200_S01_1_3_04000600_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1577.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_2_3_04000625_1_MRP	US22502555_251188612394_S01_2_3_04000625_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1549	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	CRH	84.1%	14.1 years plus	Estrogen Receptor Positive	14.1 years plus	14.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000625	P-TABM-212	4000625_e1	total_RNA	P-TABM-214	4000625_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1577.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_2_3_04000625_1_MRP	US22502555_251188612394_S01_2_3_04000625_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1539.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_2_1_04000620_1_MRP	US22502555_251188612393_S01_2_1_04000620_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1745	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	2	CRH	89.7%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000620	P-TABM-212	4000620_e1	total_RNA	P-TABM-214	4000620_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1539.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_2_1_04000620_1_MRP	US22502555_251188612393_S01_2_1_04000620_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.629.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.4 years	3.4 years	St Gallen category:high clinical risk	6.7 years	Estrogen Receptor Positive	US22502555_251188611808_S01_2_4_MRP_04000324_1	US22502555_251188611808_S01_2_4_MRP_04000324_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
272823	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	29 mm diameter	2	IGR	80.6%	3.4 years	Estrogen Receptor Positive	3.4 years	6.7 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000324	P-TABM-212	4000324_e1	total_RNA	P-TABM-214	4000324_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.629.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.4 years	3.4 years	St Gallen category:high clinical risk	6.7 years	Estrogen Receptor Positive	US22502555_251188611808_S01_2_4_MRP_04000324_1	US22502555_251188611808_S01_2_4_MRP_04000324_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2587	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	3	CRH	77.7%	7.0 years plus	Estrogen Receptor Negative	7.0 years plus	7.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000601	P-TABM-212	4000601_e1	total_RNA	P-TABM-214	4000601_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.863.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Negative	US22502555_251188612200_S01_2_2_MRP_04000601_1	US22502555_251188612200_S01_2_2_MRP_04000601_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.863.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Negative	US22502555_251188612200_S01_2_2_MRP_04000601_1	US22502555_251188612200_S01_2_2_MRP_04000601_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.888.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.1 years plus	10.1 years plus	St Gallen category:high clinical risk	10.1 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_4_MRP_04000604_1	US22502555_251188612201_S01_1_4_MRP_04000604_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2386	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	1	CRH	88.4%	10.1 years plus	Estrogen Receptor Positive	10.1 years plus	10.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000604	P-TABM-212	4000604_e1	total_RNA	P-TABM-214	4000604_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.888.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.1 years plus	10.1 years plus	St Gallen category:high clinical risk	10.1 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_4_MRP_04000604_1	US22502555_251188612201_S01_1_4_MRP_04000604_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
446	29 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	3	JRH	64.4%	0.6 years	Estrogen Receptor Negative	1.6 years plus	1.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000696	P-TABM-212	4000696_e1	total_RNA	P-TABM-214	4000696_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2475.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.6 years	1.6 years plus	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188612943_S01_2_1_04000696_1_MRP	US22502555_251188612943_S01_2_1_04000696_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2475.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.6 years	1.6 years plus	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188612943_S01_2_1_04000696_1_MRP	US22502555_251188612943_S01_2_1_04000696_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15H4	37 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	24 mm diameter	3	KAR	67.9%	12.8 years plus	Estrogen Receptor Negative	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000422	P-TABM-212	4000422_e1	total_RNA	P-TABM-214	4000422_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1353.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612376_S01_1_2_MRP_04000422_1	US22502555_251188612376_S01_1_2_MRP_04000422_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1353.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612376_S01_1_2_MRP_04000422_1	US22502555_251188612376_S01_1_2_MRP_04000422_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.214.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188611797_S01_1_2_MRP_04000340_1	US22502555_251188611797_S01_1_2_MRP_04000340_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255907	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	27 mm diameter	3	IGR	67.1%	13.1 years plus	Estrogen Receptor Negative	13.1 years plus	13.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000340	P-TABM-212	4000340_e1	total_RNA	P-TABM-214	4000340_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.214.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188611797_S01_1_2_MRP_04000340_1	US22502555_251188611797_S01_1_2_MRP_04000340_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5223	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	CRH	84.4%	14.1 years plus	Estrogen Receptor Positive	14.1 years plus	14.1 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000591	P-TABM-212	4000591_e1	total_RNA	P-TABM-214	4000591_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1251.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_3_04000591_1_MRP	US22502555_251188612338_S01_2_3_04000591_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1251.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_3_04000591_1_MRP	US22502555_251188612338_S01_2_3_04000591_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171260	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	3	IGR	63.2%	14.7 years plus	Estrogen Receptor Negative	14.7 years plus	14.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000298	P-TABM-212	4000298_e1	total_RNA	P-TABM-214	4000298_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.266.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_1_04000298_1_MRP	US22502555_251188611798_S01_2_1_04000298_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.266.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_1_04000298_1_MRP	US22502555_251188611798_S01_2_1_04000298_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.411.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.5 years plus	13.5 years plus	St Gallen category:low clinical risk	13.5 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_3_04000317_1_MRP	US22502555_251188611802_S01_2_3_04000317_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247401	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	1	IGR	92.4%	13.5 years plus	Estrogen Receptor Positive	13.5 years plus	13.5 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000317	P-TABM-212	4000317_e1	total_RNA	P-TABM-214	4000317_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.411.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.5 years plus	13.5 years plus	St Gallen category:low clinical risk	13.5 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_3_04000317_1_MRP	US22502555_251188611802_S01_2_3_04000317_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247C76	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	KAR	76.1%	15.8 years plus	Estrogen Receptor Positive	15.8 years plus	15.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000457	P-TABM-212	4000457_e1	total_RNA	P-TABM-214	4000457_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1064.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_2_MRP_04000457_1	US22502555_251188612215_S01_2_2_MRP_04000457_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1064.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_2_MRP_04000457_1	US22502555_251188612215_S01_2_2_MRP_04000457_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1526.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_1_2_MRP_04000618_1	US22502555_251188612393_S01_1_2_MRP_04000618_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1771	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	74.2%	12.5 years plus	Estrogen Receptor Positive	12.5 years plus	12.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000618	P-TABM-212	4000618_e1	total_RNA	P-TABM-214	4000618_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1526.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_1_2_MRP_04000618_1	US22502555_251188612393_S01_1_2_MRP_04000618_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04076	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	6 mm diameter	2	GUY	92.8%	15.2 years plus	Estrogen Receptor Positive	15.2 years plus	15.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000511	P-TABM-212	4000511_e1	total_RNA	P-TABM-214	4000511_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1888.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_2_MRP_04000511_1	US22502555_251188612450_S01_2_2_MRP_04000511_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1888.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_2_MRP_04000511_1	US22502555_251188612450_S01_2_2_MRP_04000511_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1061.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_1_04000457_1_MRP	US22502555_251188612215_S01_2_1_04000457_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247C76	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	KAR	76.1%	15.8 years plus	Estrogen Receptor Positive	15.8 years plus	15.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000457	P-TABM-212	4000457_e1	total_RNA	P-TABM-214	4000457_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1061.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_1_04000457_1_MRP	US22502555_251188612215_S01_2_1_04000457_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1873.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_1_2_MRP_04000507_1	US22502555_251188612450_S01_1_2_MRP_04000507_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04080	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	GUY	88.7%	3.9 years	Estrogen Receptor Positive	15.3 years plus	15.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000507	P-TABM-212	4000507_e1	total_RNA	P-TABM-214	4000507_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1873.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_1_2_MRP_04000507_1	US22502555_251188612450_S01_1_2_MRP_04000507_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1134.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.7 years plus	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Negative	US22502555_251188612218_S01_2_4_MRP_04000629_1	US22502555_251188612218_S01_2_4_MRP_04000629_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1496	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	CRH	61.5%	10.7 years plus	Estrogen Receptor Negative	10.7 years plus	10.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000629	P-TABM-212	4000629_e1	total_RNA	P-TABM-214	4000629_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1134.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.7 years plus	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Negative	US22502555_251188612218_S01_2_4_MRP_04000629_1	US22502555_251188612218_S01_2_4_MRP_04000629_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1731.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.2 years plus	11.2 years plus	St Gallen category:high clinical risk	11.2 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_2_4_MRP_04000573_1	US22502555_251188612426_S01_2_4_MRP_04000573_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1608	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	KAR	89%	11.2 years plus	Estrogen Receptor Positive	11.2 years plus	11.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000573	P-TABM-212	4000573_e1	total_RNA	P-TABM-214	4000573_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1731.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.2 years plus	11.2 years plus	St Gallen category:high clinical risk	11.2 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_2_4_MRP_04000573_1	US22502555_251188612426_S01_2_4_MRP_04000573_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1824.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years	11.7 years	St Gallen category:high clinical risk	13.1 years	Estrogen Receptor Positive	US22502555_251188612447_S01_2_4_MRP_04000484_1	US22502555_251188612447_S01_2_4_MRP_04000484_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04012	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	82.8%	11.7 years	Estrogen Receptor Positive	11.7 years	13.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000484	P-TABM-212	4000484_e1	total_RNA	P-TABM-214	4000484_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1824.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years	11.7 years	St Gallen category:high clinical risk	13.1 years	Estrogen Receptor Positive	US22502555_251188612447_S01_2_4_MRP_04000484_1	US22502555_251188612447_S01_2_4_MRP_04000484_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.420.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188611803_S01_1_1_04000258_1_MRP	US22502555_251188611803_S01_1_1_04000258_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
210322	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	62.1%	16.0 years plus	Estrogen Receptor Negative	16.0 years plus	16.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000258	P-TABM-212	4000258_e1	total_RNA	P-TABM-214	4000258_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.420.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188611803_S01_1_1_04000258_1_MRP	US22502555_251188611803_S01_1_1_04000258_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04072	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	80.2%	15.3 years	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000515	P-TABM-212	4000515_e1	total_RNA	P-TABM-214	4000515_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1912.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.3 years	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612451_S01_2_1_04000515_1_MRP	US22502555_251188612451_S01_2_1_04000515_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1912.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.3 years	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612451_S01_2_1_04000515_1_MRP	US22502555_251188612451_S01_2_1_04000515_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
125B43	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	KAR	90.4%	16.9 years plus	Estrogen Receptor Positive	16.9 years plus	16.9 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000429	P-TABM-212	4000429_e1	total_RNA	P-TABM-214	4000429_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1400.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.9 years plus	16.9 years plus	St Gallen category:high clinical risk	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_4_MRP_04000429_1	US22502555_251188612377_S01_2_4_MRP_04000429_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1400.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.9 years plus	16.9 years plus	St Gallen category:high clinical risk	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_4_MRP_04000429_1	US22502555_251188612377_S01_2_4_MRP_04000429_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1443.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	unknown	US22502555_251188612388_S01_2_1_04000594_1_MRP	US22502555_251188612388_S01_2_1_04000594_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
4181	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	87.9%	7.5 years plus	unknown	7.5 years plus	7.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000594	P-TABM-212	4000594_e1	total_RNA	P-TABM-214	4000594_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1443.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	unknown	US22502555_251188612388_S01_2_1_04000594_1_MRP	US22502555_251188612388_S01_2_1_04000594_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2332.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_2_1_04000718_1_MRP	US22502555_251188612937_S01_2_1_04000718_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1328	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	2	JRH	88%	7.3 years plus	Estrogen Receptor Positive	7.3 years plus	7.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000718	P-TABM-212	4000718_e1	total_RNA	P-TABM-214	4000718_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2332.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_2_1_04000718_1_MRP	US22502555_251188612937_S01_2_1_04000718_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
266C51	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	KAR	74.8%	15.7 years plus	Estrogen Receptor Positive	15.7 years plus	15.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000460	P-TABM-212	4000460_e1	total_RNA	P-TABM-214	4000460_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1084.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_4_MRP_04000460_1	US22502555_251188612217_S01_1_4_MRP_04000460_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1084.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_4_MRP_04000460_1	US22502555_251188612217_S01_1_4_MRP_04000460_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04098	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	79.7%	0.9 years	Estrogen Receptor Negative	2.5 years	4.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000485	P-TABM-212	4000485_e1	total_RNA	P-TABM-214	4000485_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2014.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.9 years	2.5 years	St Gallen category:high clinical risk	4.2 years	Estrogen Receptor Negative	US22502555_251188612458_S01_2_1_04000485_1_MRP	US22502555_251188612458_S01_2_1_04000485_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2014.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.9 years	2.5 years	St Gallen category:high clinical risk	4.2 years	Estrogen Receptor Negative	US22502555_251188612458_S01_2_1_04000485_1_MRP	US22502555_251188612458_S01_2_1_04000485_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1071.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_4_MRP_04000458_1	US22502555_251188612215_S01_2_4_MRP_04000458_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
268C87	32 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	KAR	87%	15.7 years plus	Estrogen Receptor Positive	15.7 years plus	15.7 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000458	P-TABM-212	4000458_e1	total_RNA	P-TABM-214	4000458_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1071.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_4_MRP_04000458_1	US22502555_251188612215_S01_2_4_MRP_04000458_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1852.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_4_MRP_04000502_1	US22502555_251188612449_S01_1_4_MRP_04000502_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04087	37 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	3	GUY	85.6%	14.7 years plus	Estrogen Receptor Positive	14.7 years plus	14.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000502	P-TABM-212	4000502_e1	total_RNA	P-TABM-214	4000502_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1852.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_4_MRP_04000502_1	US22502555_251188612449_S01_1_4_MRP_04000502_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
27D5	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	KAR	76.1%	4.8 years	Estrogen Receptor Positive	4.8 years	7.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000408	P-TABM-212	4000408_e1	total_RNA	P-TABM-214	4000408_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1164.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years	4.8 years	St Gallen category:high clinical risk	7.4 years	Estrogen Receptor Positive	US22502555_251188612322_S01_2_1_04000408_1_MRP	US22502555_251188612322_S01_2_1_04000408_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1164.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years	4.8 years	St Gallen category:high clinical risk	7.4 years	Estrogen Receptor Positive	US22502555_251188612322_S01_2_1_04000408_1_MRP	US22502555_251188612322_S01_2_1_04000408_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04105	34 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	79.9%	1.0 years	Estrogen Receptor Positive	3.3 years	3.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000467	P-TABM-212	4000467_e1	total_RNA	P-TABM-214	4000467_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1766.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	3.3 years	St Gallen category:high clinical risk	3.5 years	Estrogen Receptor Positive	US22502555_251188612446_S01_1_2_MRP_04000467_1	US22502555_251188612446_S01_1_2_MRP_04000467_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1766.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	3.3 years	St Gallen category:high clinical risk	3.5 years	Estrogen Receptor Positive	US22502555_251188612446_S01_1_2_MRP_04000467_1	US22502555_251188612446_S01_1_2_MRP_04000467_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
197B95	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	KAR	84.6%	16.2 years plus	Estrogen Receptor Positive	16.2 years plus	16.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000443	P-TABM-212	4000443_e1	total_RNA	P-TABM-214	4000443_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.976.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_2_4_MRP_04000443_1	US22502555_251188612211_S01_2_4_MRP_04000443_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.976.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_2_4_MRP_04000443_1	US22502555_251188612211_S01_2_4_MRP_04000443_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D6	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	89.2%	4.7 years	Estrogen Receptor Positive	4.7 years plus	4.7 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000427	P-TABM-212	4000427_e1	total_RNA	P-TABM-214	4000427_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1383.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.7 years	4.7 years plus	St Gallen category:high clinical risk	4.7 years	Estrogen Receptor Positive	US22502555_251188612377_S01_1_3_04000427_1_MRP	US22502555_251188612377_S01_1_3_04000427_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1383.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.7 years	4.7 years plus	St Gallen category:high clinical risk	4.7 years	Estrogen Receptor Positive	US22502555_251188612377_S01_1_3_04000427_1_MRP	US22502555_251188612377_S01_1_3_04000427_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
37	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	JRH	84.5%	8.5 years	Estrogen Receptor Negative	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000676	P-TABM-212	4000676_e1	total_RNA	P-TABM-214	4000676_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2219.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.5 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_2_MRP_04000676_1	US22502555_251188612906_S01_2_2_MRP_04000676_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2219.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.5 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_2_MRP_04000676_1	US22502555_251188612906_S01_2_2_MRP_04000676_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1610.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	18.1 years	19.7 years	St Gallen category:high clinical risk	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_3_04000641_1_MRP	US22502555_251188612421_S01_1_3_04000641_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
317	41 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	CRH	81.2%	18.1 years	Estrogen Receptor Positive	19.7 years	19.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000641	P-TABM-212	4000641_e1	total_RNA	P-TABM-214	4000641_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1610.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	18.1 years	19.7 years	St Gallen category:high clinical risk	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_3_04000641_1_MRP	US22502555_251188612421_S01_1_3_04000641_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2139.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.4 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years	Estrogen Receptor Positive	US22502555_251188612772_S01_2_4_MRP_04000281_1	US22502555_251188612772_S01_2_4_MRP_04000281_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219916	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	1	IGR	87.9%	8.4 years	Estrogen Receptor Positive	9.7 years plus	9.7 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000281	P-TABM-212	4000281_e1	total_RNA	P-TABM-214	4000281_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2139.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.4 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years	Estrogen Receptor Positive	US22502555_251188612772_S01_2_4_MRP_04000281_1	US22502555_251188612772_S01_2_4_MRP_04000281_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.803.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612196_S01_2_4_MRP_04000633_1	US22502555_251188612196_S01_2_4_MRP_04000633_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1246c	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	CRH	63.3%	17.1 years plus	Estrogen Receptor Negative	17.1 years plus	17.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000633	P-TABM-212	4000633_e1	total_RNA	P-TABM-214	4000633_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.803.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612196_S01_2_4_MRP_04000633_1	US22502555_251188612196_S01_2_4_MRP_04000633_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1786.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.6 years plus	19.6 years plus	St Gallen category:not applicable	19.6 years plus	Estrogen Receptor Positive	US22502555_251188612446_S01_2_3_04000477_1_MRP	US22502555_251188612446_S01_2_3_04000477_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04006	51 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	unknown	GUY	87.2%	19.6 years plus	Estrogen Receptor Positive	19.6 years plus	19.6 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000477	P-TABM-212	4000477_e1	total_RNA	P-TABM-214	4000477_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1786.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.6 years plus	19.6 years plus	St Gallen category:not applicable	19.6 years plus	Estrogen Receptor Positive	US22502555_251188612446_S01_2_3_04000477_1_MRP	US22502555_251188612446_S01_2_3_04000477_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.639.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_2_MRP_04000325_1	US22502555_251188611809_S01_1_2_MRP_04000325_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254031	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	IGR	74.5%	10.6 years	Estrogen Receptor Positive	13.7 years plus	13.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000325	P-TABM-212	4000325_e1	total_RNA	P-TABM-214	4000325_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.639.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_2_MRP_04000325_1	US22502555_251188611809_S01_1_2_MRP_04000325_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D9	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	KAR	84.3%	2.4 years	Estrogen Receptor Positive	2.4 years	5.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000414	P-TABM-212	4000414_e1	total_RNA	P-TABM-214	4000414_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1284.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.4 years	2.4 years	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_1_04000414_1_MRP	US22502555_251188612373_S01_1_1_04000414_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1284.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.4 years	2.4 years	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_1_04000414_1_MRP	US22502555_251188612373_S01_1_1_04000414_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
278C80	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	KAR	79.8%	15.5 years plus	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000456	P-TABM-212	4000456_e1	total_RNA	P-TABM-214	4000456_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1054.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_3_04000456_1_MRP	US22502555_251188612215_S01_1_3_04000456_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1054.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_3_04000456_1_MRP	US22502555_251188612215_S01_1_3_04000456_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.117.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_4_MRP_04000295_1	US22502555_251188611679_S01_2_4_MRP_04000295_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307506	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	1	IGR	88.2%	10.2 years plus	Estrogen Receptor Positive	10.2 years plus	10.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000295	P-TABM-212	4000295_e1	total_RNA	P-TABM-214	4000295_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.117.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_4_MRP_04000295_1	US22502555_251188611679_S01_2_4_MRP_04000295_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1740.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_1_3_04000575_1_MRP	US22502555_251188612427_S01_1_3_04000575_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
386	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	2	KAR	87.2%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000575	P-TABM-212	4000575_e1	total_RNA	P-TABM-214	4000575_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1740.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_1_3_04000575_1_MRP	US22502555_251188612427_S01_1_3_04000575_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1812.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612447_S01_2_1_04000483_1_MRP	US22502555_251188612447_S01_2_1_04000483_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04011	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	66.2%	1.4 years	Estrogen Receptor Negative	1.4 years	2.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000483	P-TABM-212	4000483_e1	total_RNA	P-TABM-214	4000483_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1812.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612447_S01_2_1_04000483_1_MRP	US22502555_251188612447_S01_2_1_04000483_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
272219	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	90.9%	12.9 years plus	Estrogen Receptor Positive	12.9 years plus	12.9 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000326	P-TABM-212	4000326_e1	total_RNA	P-TABM-214	4000326_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.646.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:low clinical risk	12.9 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_4_MRP_04000326_1	US22502555_251188611809_S01_1_4_MRP_04000326_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.646.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:low clinical risk	12.9 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_4_MRP_04000326_1	US22502555_251188611809_S01_1_4_MRP_04000326_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1805.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.0 years	Estrogen Receptor Negative	US22502555_251188612447_S01_1_3_04000482_1_MRP	US22502555_251188612447_S01_1_3_04000482_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04010	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	61.5%	1.5 years	Estrogen Receptor Negative	1.5 years	2.0 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000482	P-TABM-212	4000482_e1	total_RNA	P-TABM-214	4000482_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1805.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.0 years	Estrogen Receptor Negative	US22502555_251188612447_S01_1_3_04000482_1_MRP	US22502555_251188612447_S01_1_3_04000482_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.344.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.3 years	14.3 years plus	St Gallen category:high clinical risk	14.3 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_2_4_MRP_04000308_1	US22502555_251188611800_S01_2_4_MRP_04000308_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247000	36 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	IGR	74.8%	2.3 years	Estrogen Receptor Positive	14.3 years plus	14.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000308	P-TABM-212	4000308_e1	total_RNA	P-TABM-214	4000308_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.344.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.3 years	14.3 years plus	St Gallen category:high clinical risk	14.3 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_2_4_MRP_04000308_1	US22502555_251188611800_S01_2_4_MRP_04000308_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
194	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	3	JRH	66.6%	4.6 years	Estrogen Receptor Negative	4.6 years	8.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000683	P-TABM-212	4000683_e1	total_RNA	P-TABM-214	4000683_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2265.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.6 years	4.6 years	St Gallen category:high clinical risk	8.2 years	Estrogen Receptor Negative	US22502555_251188612908_S01_1_4_MRP_04000683_1	US22502555_251188612908_S01_1_4_MRP_04000683_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2265.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.6 years	4.6 years	St Gallen category:high clinical risk	8.2 years	Estrogen Receptor Negative	US22502555_251188612908_S01_1_4_MRP_04000683_1	US22502555_251188612908_S01_1_4_MRP_04000683_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246166	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	88.6%	14.0 years plus	Estrogen Receptor Positive	14.0 years plus	14.0 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000294	P-TABM-212	4000294_e1	total_RNA	P-TABM-214	4000294_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.100.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_1_04000294_1_MRP	US22502555_251188611679_S01_2_1_04000294_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.100.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_1_04000294_1_MRP	US22502555_251188611679_S01_2_1_04000294_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1970.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	2.7 years	St Gallen category:high clinical risk	10.5 years	Estrogen Receptor Positive	US22502555_251188612455_S01_1_3_04000532_1_MRP	US22502555_251188612455_S01_1_3_04000532_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04052	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	84.9%	2.7 years	Estrogen Receptor Positive	2.7 years	10.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000532	P-TABM-212	4000532_e1	total_RNA	P-TABM-214	4000532_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1970.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	2.7 years	St Gallen category:high clinical risk	10.5 years	Estrogen Receptor Positive	US22502555_251188612455_S01_1_3_04000532_1_MRP	US22502555_251188612455_S01_1_3_04000532_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04052	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	84.9%	2.7 years	Estrogen Receptor Positive	2.7 years	10.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000532	P-TABM-212	4000532_e1	total_RNA	P-TABM-214	4000532_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1975.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	2.7 years	St Gallen category:high clinical risk	10.5 years	Estrogen Receptor Positive	US22502555_251188612455_S01_1_4_MRP_04000532_1	US22502555_251188612455_S01_1_4_MRP_04000532_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1975.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	2.7 years	St Gallen category:high clinical risk	10.5 years	Estrogen Receptor Positive	US22502555_251188612455_S01_1_4_MRP_04000532_1	US22502555_251188612455_S01_1_4_MRP_04000532_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1869.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_1_1_04000507_1_MRP	US22502555_251188612450_S01_1_1_04000507_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04080	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	GUY	88.7%	3.9 years	Estrogen Receptor Positive	15.3 years plus	15.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000507	P-TABM-212	4000507_e1	total_RNA	P-TABM-214	4000507_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1869.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_1_1_04000507_1_MRP	US22502555_251188612450_S01_1_1_04000507_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
302	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	2	CRH	89.4%	2.0 years	Estrogen Receptor Positive	17.2 years plus	17.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000642	P-TABM-212	4000642_e1	total_RNA	P-TABM-214	4000642_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1602.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_1_04000642_1_MRP	US22502555_251188612421_S01_1_1_04000642_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1602.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_1_04000642_1_MRP	US22502555_251188612421_S01_1_1_04000642_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1831.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	17.1 years plus	St Gallen category:high clinical risk	17.1 years	Estrogen Receptor Positive	US22502555_251188612448_S01_1_2_MRP_04000487_1	US22502555_251188612448_S01_1_2_MRP_04000487_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04014	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	3	GUY	84.9%	6.0 years	Estrogen Receptor Positive	17.1 years plus	17.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000487	P-TABM-212	4000487_e1	total_RNA	P-TABM-214	4000487_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1831.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	17.1 years plus	St Gallen category:high clinical risk	17.1 years	Estrogen Receptor Positive	US22502555_251188612448_S01_1_2_MRP_04000487_1	US22502555_251188612448_S01_1_2_MRP_04000487_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256296	37 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	95.4%	4.9 years	Estrogen Receptor Positive	4.9 years	5.1 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000349	P-TABM-212	4000349_e1	total_RNA	P-TABM-214	4000349_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.120.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.9 years	4.9 years	St Gallen category:low clinical risk	5.1 years plus	Estrogen Receptor Positive	US22502555_251188611681_S01_1_3_04000349_1_MRP	US22502555_251188611681_S01_1_3_04000349_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.120.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.9 years	4.9 years	St Gallen category:low clinical risk	5.1 years plus	Estrogen Receptor Positive	US22502555_251188611681_S01_1_3_04000349_1_MRP	US22502555_251188611681_S01_1_3_04000349_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
324524	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	1	IGR	94.3%	7.4 years plus	Estrogen Receptor Positive	7.4 years plus	7.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000283	P-TABM-212	4000283_e1	total_RNA	P-TABM-214	4000283_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.37.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.4 years plus	7.4 years plus	St Gallen category:low clinical risk	7.4 years plus	Estrogen Receptor Positive	US22502555_251188611677_S01_1_4_MRP_04000283_1	US22502555_251188611677_S01_1_4_MRP_04000283_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.37.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.4 years plus	7.4 years plus	St Gallen category:low clinical risk	7.4 years plus	Estrogen Receptor Positive	US22502555_251188611677_S01_1_4_MRP_04000283_1	US22502555_251188611677_S01_1_4_MRP_04000283_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2377	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	CRH	93.7%	10.0 years	Estrogen Receptor Positive	10.6 years plus	10.6 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000606	P-TABM-212	4000606_e1	total_RNA	P-TABM-214	4000606_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.902.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.0 years	10.6 years plus	St Gallen category:low clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_2_3_04000606_1_MRP	US22502555_251188612201_S01_2_3_04000606_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.902.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.0 years	10.6 years plus	St Gallen category:low clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_2_3_04000606_1_MRP	US22502555_251188612201_S01_2_3_04000606_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
547	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	JRH	62.9%	11.9 years plus	Estrogen Receptor Negative	11.9 years plus	11.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000708	P-TABM-212	4000708_e1	total_RNA	P-TABM-214	4000708_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2407.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Negative	US22502555_251188612940_S01_2_2_MRP_04000708_1	US22502555_251188612940_S01_2_2_MRP_04000708_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2407.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Negative	US22502555_251188612940_S01_2_2_MRP_04000708_1	US22502555_251188612940_S01_2_2_MRP_04000708_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1584.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.1 years	22.4 years plus	St Gallen category:high clinical risk	22.4 years	Estrogen Receptor Positive	US22502555_251188612420_S01_2_1_04000644_1_MRP	US22502555_251188612420_S01_2_1_04000644_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
95	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	85.7%	5.1 years	Estrogen Receptor Positive	22.4 years plus	22.4 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000644	P-TABM-212	4000644_e1	total_RNA	P-TABM-214	4000644_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1584.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.1 years	22.4 years plus	St Gallen category:high clinical risk	22.4 years	Estrogen Receptor Positive	US22502555_251188612420_S01_2_1_04000644_1_MRP	US22502555_251188612420_S01_2_1_04000644_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2183.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.4 years plus	13.4 years plus	St Gallen category:low clinical risk	13.4 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_2_1_04000319_1_MRP	US22502555_251188612774_S01_2_1_04000319_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247845	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	90.9%	13.4 years plus	Estrogen Receptor Positive	13.4 years plus	13.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000319	P-TABM-212	4000319_e1	total_RNA	P-TABM-214	4000319_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2183.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.4 years plus	13.4 years plus	St Gallen category:low clinical risk	13.4 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_2_1_04000319_1_MRP	US22502555_251188612774_S01_2_1_04000319_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.556.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_2_MRP_04000274_1	US22502555_251188611806_S01_2_2_MRP_04000274_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219490	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	73.8%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000274	P-TABM-212	4000274_e1	total_RNA	P-TABM-214	4000274_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.556.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_2_MRP_04000274_1	US22502555_251188611806_S01_2_2_MRP_04000274_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15C10	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	3	KAR	84.8%	22.3 years plus	Estrogen Receptor Positive	22.3 years plus	22.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000433	P-TABM-212	4000433_e1	total_RNA	P-TABM-214	4000433_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1318.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	22.3 years plus	22.3 years plus	St Gallen category:high clinical risk	22.3 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_4_MRP_04000433_1	US22502555_251188612374_S01_2_4_MRP_04000433_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1318.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	22.3 years plus	22.3 years plus	St Gallen category:high clinical risk	22.3 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_4_MRP_04000433_1	US22502555_251188612374_S01_2_4_MRP_04000433_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.576.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.3 years	15.4 years plus	St Gallen category:high clinical risk	15.4 years plus	Estrogen Receptor Positive	US22502555_251188611807_S01_2_1_04000278_1_MRP	US22502555_251188611807_S01_2_1_04000278_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219863	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	87.2%	2.3 years	Estrogen Receptor Positive	15.4 years plus	15.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000278	P-TABM-212	4000278_e1	total_RNA	P-TABM-214	4000278_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.576.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.3 years	15.4 years plus	St Gallen category:high clinical risk	15.4 years plus	Estrogen Receptor Positive	US22502555_251188611807_S01_2_1_04000278_1_MRP	US22502555_251188611807_S01_2_1_04000278_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1783.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188612446_S01_2_2_MRP_04000475_1	US22502555_251188612446_S01_2_2_MRP_04000475_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04005	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	GUY	64.3%	1.4 years	Estrogen Receptor Positive	1.4 years	9.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000475	P-TABM-212	4000475_e1	total_RNA	P-TABM-214	4000475_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1783.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188612446_S01_2_2_MRP_04000475_1	US22502555_251188612446_S01_2_2_MRP_04000475_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219C42	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	KAR	81.4%	6.0 years	Estrogen Receptor Negative	6.0 years plus	6.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000449	P-TABM-212	4000449_e1	total_RNA	P-TABM-214	4000449_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.992.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	6.0 years plus	St Gallen category:high clinical risk	6.0 years	Estrogen Receptor Negative	US22502555_251188612213_S01_1_3_04000449_1_MRP	US22502555_251188612213_S01_1_3_04000449_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.992.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	6.0 years plus	St Gallen category:high clinical risk	6.0 years	Estrogen Receptor Negative	US22502555_251188612213_S01_1_3_04000449_1_MRP	US22502555_251188612213_S01_1_3_04000449_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
138	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	JRH	70.1%	14.9 years plus	Estrogen Receptor Positive	14.9 years plus	14.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000680	P-TABM-212	4000680_e1	total_RNA	P-TABM-214	4000680_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2239.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.9 years plus	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188612907_S01_2_1_04000680_1_MRP	US22502555_251188612907_S01_2_1_04000680_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2239.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.9 years plus	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188612907_S01_2_1_04000680_1_MRP	US22502555_251188612907_S01_2_1_04000680_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.879.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.6 years plus	9.6 years plus	St Gallen category:low clinical risk	9.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_2_MRP_04000603_1	US22502555_251188612201_S01_1_2_MRP_04000603_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2393	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	CRH	94%	9.6 years plus	Estrogen Receptor Positive	9.6 years plus	9.6 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000603	P-TABM-212	4000603_e1	total_RNA	P-TABM-214	4000603_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.879.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.6 years plus	9.6 years plus	St Gallen category:low clinical risk	9.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_2_MRP_04000603_1	US22502555_251188612201_S01_1_2_MRP_04000603_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256939	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	IGR	81.9%	9.3 years plus	Estrogen Receptor Positive	9.3 years plus	9.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000343	P-TABM-212	4000343_e1	total_RNA	P-TABM-214	4000343_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.243.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.3 years plus	9.3 years plus	St Gallen category:high clinical risk	9.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_4_MRP_04000343_1	US22502555_251188611797_S01_2_4_MRP_04000343_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.243.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.3 years plus	9.3 years plus	St Gallen category:high clinical risk	9.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_4_MRP_04000343_1	US22502555_251188611797_S01_2_4_MRP_04000343_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
410c	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	CRH	74.2%	9.1 years	Estrogen Receptor Positive	9.1 years	12.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000639	P-TABM-212	4000639_e1	total_RNA	P-TABM-214	4000639_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.942.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.1 years	9.1 years	St Gallen category:high clinical risk	12.6 years	Estrogen Receptor Positive	US22502555_251188612202_S01_2_4_MRP_04000639_1	US22502555_251188612202_S01_2_4_MRP_04000639_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.942.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.1 years	9.1 years	St Gallen category:high clinical risk	12.6 years	Estrogen Receptor Positive	US22502555_251188612202_S01_2_4_MRP_04000639_1	US22502555_251188612202_S01_2_4_MRP_04000639_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1210	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	1	JRH	96.5%	5.3 years plus	Estrogen Receptor Positive	5.3 years plus	5.3 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000717	P-TABM-212	4000717_e1	total_RNA	P-TABM-214	4000717_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2329.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	5.3 years plus	5.3 years plus	St Gallen category:low clinical risk	5.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_4_MRP_04000717_1	US22502555_251188612937_S01_1_4_MRP_04000717_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2329.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	5.3 years plus	5.3 years plus	St Gallen category:low clinical risk	5.3 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_4_MRP_04000717_1	US22502555_251188612937_S01_1_4_MRP_04000717_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.390.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.0 years	14.6 years plus	St Gallen category:high clinical risk	14.6 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_2_MRP_04000314_1	US22502555_251188611802_S01_1_2_MRP_04000314_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247243	45 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	80.4%	5.0 years	Estrogen Receptor Positive	14.6 years plus	14.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000314	P-TABM-212	4000314_e1	total_RNA	P-TABM-214	4000314_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.390.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.0 years	14.6 years plus	St Gallen category:high clinical risk	14.6 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_2_MRP_04000314_1	US22502555_251188611802_S01_1_2_MRP_04000314_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.937.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.1 years	9.1 years	St Gallen category:high clinical risk	12.6 years	Estrogen Receptor Positive	US22502555_251188612202_S01_2_3_04000639_1_MRP	US22502555_251188612202_S01_2_3_04000639_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
410c	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	CRH	74.2%	9.1 years	Estrogen Receptor Positive	9.1 years	12.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000639	P-TABM-212	4000639_e1	total_RNA	P-TABM-214	4000639_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.937.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.1 years	9.1 years	St Gallen category:high clinical risk	12.6 years	Estrogen Receptor Positive	US22502555_251188612202_S01_2_3_04000639_1_MRP	US22502555_251188612202_S01_2_3_04000639_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D3	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	unknown	KAR	88.9%	19.9 years plus	Estrogen Receptor Positive	19.9 years plus	19.9 years plus	St Gallen category:not applicable	NPI:not applicable	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000432	P-TABM-212	4000432_e1	total_RNA	P-TABM-214	4000432_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1309.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:low risk	19.9 years plus	19.9 years plus	St Gallen category:not applicable	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_2_MRP_04000432_1	US22502555_251188612374_S01_2_2_MRP_04000432_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1309.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:low risk	19.9 years plus	19.9 years plus	St Gallen category:not applicable	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_2_MRP_04000432_1	US22502555_251188612374_S01_2_2_MRP_04000432_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1917.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.3 years	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612451_S01_2_2_MRP_04000515_1	US22502555_251188612451_S01_2_2_MRP_04000515_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04072	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	80.2%	15.3 years	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000515	P-TABM-212	4000515_e1	total_RNA	P-TABM-214	4000515_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1917.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.3 years	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612451_S01_2_2_MRP_04000515_1	US22502555_251188612451_S01_2_2_MRP_04000515_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1349.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612376_S01_1_1_04000422_1_MRP	US22502555_251188612376_S01_1_1_04000422_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15H4	37 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	24 mm diameter	3	KAR	67.9%	12.8 years plus	Estrogen Receptor Negative	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000422	P-TABM-212	4000422_e1	total_RNA	P-TABM-214	4000422_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1349.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612376_S01_1_1_04000422_1_MRP	US22502555_251188612376_S01_1_1_04000422_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256975	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	81.3%	1.5 years	Estrogen Receptor Negative	1.5 years	2.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000339	P-TABM-212	4000339_e1	total_RNA	P-TABM-214	4000339_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.198.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188611796_S01_2_3_04000339_1_MRP	US22502555_251188611796_S01_2_3_04000339_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.198.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188611796_S01_2_3_04000339_1_MRP	US22502555_251188611796_S01_2_3_04000339_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245596	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	67.1%	12.9 years plus	Estrogen Receptor Negative	12.9 years plus	12.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000286	P-TABM-212	4000286_e1	total_RNA	P-TABM-214	4000286_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.60.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188611678_S01_1_1_04000286_1_MRP	US22502555_251188611678_S01_1_1_04000286_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.60.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188611678_S01_1_1_04000286_1_MRP	US22502555_251188611678_S01_1_1_04000286_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1721	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	77.1%	4.4 years	Estrogen Receptor Positive	4.4 years	5.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000621	P-TABM-212	4000621_e1	total_RNA	P-TABM-214	4000621_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1546.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	4.4 years	St Gallen category:high clinical risk	5.1 years	Estrogen Receptor Positive	US22502555_251188612393_S01_2_3_04000621_1_MRP	US22502555_251188612393_S01_2_3_04000621_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1546.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	4.4 years	St Gallen category:high clinical risk	5.1 years	Estrogen Receptor Positive	US22502555_251188612393_S01_2_3_04000621_1_MRP	US22502555_251188612393_S01_2_3_04000621_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
138	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	JRH	70.1%	14.9 years plus	Estrogen Receptor Positive	14.9 years plus	14.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000680	P-TABM-212	4000680_e1	total_RNA	P-TABM-214	4000680_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2243.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.9 years plus	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188612907_S01_2_2_MRP_04000680_1	US22502555_251188612907_S01_2_2_MRP_04000680_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2243.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.9 years plus	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188612907_S01_2_2_MRP_04000680_1	US22502555_251188612907_S01_2_2_MRP_04000680_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.632.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_1_04000325_1_MRP	US22502555_251188611809_S01_1_1_04000325_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254031	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	IGR	74.5%	10.6 years	Estrogen Receptor Positive	13.7 years plus	13.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000325	P-TABM-212	4000325_e1	total_RNA	P-TABM-214	4000325_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.632.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_1_1_04000325_1_MRP	US22502555_251188611809_S01_1_1_04000325_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1293.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_3_04000415_1_MRP	US22502555_251188612373_S01_1_3_04000415_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16G1	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	89.6%	2.2 years	Estrogen Receptor Positive	2.2 years	4.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000415	P-TABM-212	4000415_e1	total_RNA	P-TABM-214	4000415_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1293.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_3_04000415_1_MRP	US22502555_251188612373_S01_1_3_04000415_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
476	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	unknown	JRH	72.1%	3.5 years	unknown	3.5 years	4.5 years	NPI:not applicable	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000700	P-TABM-212	4000700_e1	total_RNA	P-TABM-214	4000700_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2502.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.5 years	3.5 years	St Gallen category:high clinical risk	4.5 years	unknown	US22502555_251188612944_S01_2_2_MRP_04000700_1	US22502555_251188612944_S01_2_2_MRP_04000700_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2502.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.5 years	3.5 years	St Gallen category:high clinical risk	4.5 years	unknown	US22502555_251188612944_S01_2_2_MRP_04000700_1	US22502555_251188612944_S01_2_2_MRP_04000700_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.195.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_2_2_MRP_04000337_1	US22502555_251188611796_S01_2_2_MRP_04000337_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271316	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	88%	11.9 years plus	Estrogen Receptor Positive	11.9 years plus	11.9 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000337	P-TABM-212	4000337_e1	total_RNA	P-TABM-214	4000337_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.195.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_2_2_MRP_04000337_1	US22502555_251188611796_S01_2_2_MRP_04000337_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.714.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.7 years	12.4 years plus	St Gallen category:high clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_1_3_04000322_2_MRP	US22502555_251188611855_S01_1_3_04000322_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279276	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	86.7%	7.7 years	Estrogen Receptor Positive	12.4 years plus	12.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000322	P-TABM-212	4000322_e1	total_RNA	P-TABM-214	4000322_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.714.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.7 years	12.4 years plus	St Gallen category:high clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_1_3_04000322_2_MRP	US22502555_251188611855_S01_1_3_04000322_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171150	35 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	IGR	81.8%	2.6 years plus	Estrogen Receptor Positive	2.6 years plus	2.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000268	P-TABM-212	4000268_e1	total_RNA	P-TABM-214	4000268_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.504.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years plus	2.6 years plus	St Gallen category:high clinical risk	2.6 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_3_04000268_1_MRP	US22502555_251188611805_S01_1_3_04000268_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.504.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years plus	2.6 years plus	St Gallen category:high clinical risk	2.6 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_3_04000268_1_MRP	US22502555_251188611805_S01_1_3_04000268_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2011.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_1_4_MRP_04000478_1	US22502555_251188612458_S01_1_4_MRP_04000478_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04099	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	2	GUY	83.1%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000478	P-TABM-212	4000478_e1	total_RNA	P-TABM-214	4000478_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2011.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_1_4_MRP_04000478_1	US22502555_251188612458_S01_1_4_MRP_04000478_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5235	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	CRH	87.6%	6.1 years plus	Estrogen Receptor Positive	6.1 years plus	6.1 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000583	P-TABM-212	4000583_e1	total_RNA	P-TABM-214	4000583_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1182.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.1 years plus	6.1 years plus	St Gallen category:high clinical risk	6.1 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_3_04000583_1_MRP	US22502555_251188612335_S01_2_3_04000583_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1182.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.1 years plus	6.1 years plus	St Gallen category:high clinical risk	6.1 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_3_04000583_1_MRP	US22502555_251188612335_S01_2_3_04000583_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.816.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188612198_S01_2_1_04000636_1_MRP	US22502555_251188612198_S01_2_1_04000636_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1158	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	CRH	73.4%	16.0 years plus	Estrogen Receptor Negative	16.0 years plus	16.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000636	P-TABM-212	4000636_e1	total_RNA	P-TABM-214	4000636_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.816.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188612198_S01_2_1_04000636_1_MRP	US22502555_251188612198_S01_2_1_04000636_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1608	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	KAR	89%	11.2 years plus	Estrogen Receptor Positive	11.2 years plus	11.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000573	P-TABM-212	4000573_e1	total_RNA	P-TABM-214	4000573_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1725.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.2 years plus	11.2 years plus	St Gallen category:high clinical risk	11.2 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_2_3_04000573_1_MRP	US22502555_251188612426_S01_2_3_04000573_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1725.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.2 years plus	11.2 years plus	St Gallen category:high clinical risk	11.2 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_2_3_04000573_1_MRP	US22502555_251188612426_S01_2_3_04000573_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1950.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_2_1_04000523_1_MRP	US22502555_251188612453_S01_2_1_04000523_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04062	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	87.6%	16.0 years plus	Estrogen Receptor Positive	16.0 years plus	16.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000523	P-TABM-212	4000523_e1	total_RNA	P-TABM-214	4000523_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1950.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_2_1_04000523_1_MRP	US22502555_251188612453_S01_2_1_04000523_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1103.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	unknown	US22502555_251188612218_S01_1_1_04000626_1_MRP	US22502555_251188612218_S01_1_1_04000626_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1544	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	CRH	85.7%	13.7 years plus	unknown	13.7 years plus	13.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000626	P-TABM-212	4000626_e1	total_RNA	P-TABM-214	4000626_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1103.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	unknown	US22502555_251188612218_S01_1_1_04000626_1_MRP	US22502555_251188612218_S01_1_1_04000626_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1415	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	2	JRH	91.6%	3.5 years plus	Estrogen Receptor Negative	3.5 years plus	3.5 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000720	P-TABM-212	4000720_e1	total_RNA	P-TABM-214	4000720_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2348.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.5 years plus	3.5 years plus	St Gallen category:high clinical risk	3.5 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_1_1_04000720_1_MRP	US22502555_251188612938_S01_1_1_04000720_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2348.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.5 years plus	3.5 years plus	St Gallen category:high clinical risk	3.5 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_1_1_04000720_1_MRP	US22502555_251188612938_S01_1_1_04000720_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.559.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_3_04000275_1_MRP	US22502555_251188611806_S01_2_3_04000275_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219507	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	88.6%	15.2 years plus	Estrogen Receptor Positive	15.2 years plus	15.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000275	P-TABM-212	4000275_e1	total_RNA	P-TABM-214	4000275_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.559.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_3_04000275_1_MRP	US22502555_251188611806_S01_2_3_04000275_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2248	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	79.3%	7.0 years	Estrogen Receptor Positive	11.1 years plus	11.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000610	P-TABM-212	4000610_e1	total_RNA	P-TABM-214	4000610_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1466.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.0 years	11.1 years plus	St Gallen category:high clinical risk	11.1 years plus	Estrogen Receptor Positive	US22502555_251188612389_S01_1_2_MRP_04000610_1	US22502555_251188612389_S01_1_2_MRP_04000610_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1466.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.0 years	11.1 years plus	St Gallen category:high clinical risk	11.1 years plus	Estrogen Receptor Positive	US22502555_251188612389_S01_1_2_MRP_04000610_1	US22502555_251188612389_S01_1_2_MRP_04000610_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1207	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	77.7%	2.6 years	Estrogen Receptor Positive	8.1 years plus	8.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000634	P-TABM-212	4000634_e1	total_RNA	P-TABM-214	4000634_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.806.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612198_S01_1_1_04000634_1_MRP	US22502555_251188612198_S01_1_1_04000634_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.806.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612198_S01_1_1_04000634_1_MRP	US22502555_251188612198_S01_1_1_04000634_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171558	35 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	2	IGR	66.1%	16.3 years plus	Estrogen Receptor Negative	16.3 years plus	16.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000321	P-TABM-212	4000321_e1	total_RNA	P-TABM-214	4000321_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.603.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.3 years plus	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188611808_S01_1_3_04000321_1_MRP	US22502555_251188611808_S01_1_3_04000321_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.603.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.3 years plus	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188611808_S01_1_3_04000321_1_MRP	US22502555_251188611808_S01_1_3_04000321_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
282C51	55 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	1	KAR	91.5%	2.4 years	Estrogen Receptor Positive	9.9 years plus	9.9 years	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000453	P-TABM-212	4000453_e1	total_RNA	P-TABM-214	4000453_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1029.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.4 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_1_04000453_1_MRP	US22502555_251188612214_S01_2_1_04000453_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1029.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.4 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_1_04000453_1_MRP	US22502555_251188612214_S01_2_1_04000453_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2416.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.1 years plus	12.1 years plus	St Gallen category:high clinical risk	12.1 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_2_4_MRP_04000709_1	US22502555_251188612940_S01_2_4_MRP_04000709_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
554	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	1	JRH	88.7%	12.1 years plus	Estrogen Receptor Positive	12.1 years plus	12.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000709	P-TABM-212	4000709_e1	total_RNA	P-TABM-214	4000709_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2416.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.1 years plus	12.1 years plus	St Gallen category:high clinical risk	12.1 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_2_4_MRP_04000709_1	US22502555_251188612940_S01_2_4_MRP_04000709_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1300.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.8 years plus	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612373_S01_2_4_MRP_04000417_1	US22502555_251188612373_S01_2_4_MRP_04000417_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16C8	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	KAR	83.8%	16.8 years plus	Estrogen Receptor Positive	16.8 years plus	16.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000417	P-TABM-212	4000417_e1	total_RNA	P-TABM-214	4000417_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1300.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.8 years plus	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612373_S01_2_4_MRP_04000417_1	US22502555_251188612373_S01_2_4_MRP_04000417_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
554	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	1	JRH	88.7%	12.1 years plus	Estrogen Receptor Positive	12.1 years plus	12.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000709	P-TABM-212	4000709_e1	total_RNA	P-TABM-214	4000709_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2410.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.1 years plus	12.1 years plus	St Gallen category:high clinical risk	12.1 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_2_3_04000709_1_MRP	US22502555_251188612940_S01_2_3_04000709_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2410.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.1 years plus	12.1 years plus	St Gallen category:high clinical risk	12.1 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_2_3_04000709_1_MRP	US22502555_251188612940_S01_2_3_04000709_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1579	28 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	CRH	65.4%	14.2 years plus	Estrogen Receptor Positive	14.2 years plus	14.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000623	P-TABM-212	4000623_e1	total_RNA	P-TABM-214	4000623_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1567.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_1_4_MRP_04000623_1	US22502555_251188612394_S01_1_4_MRP_04000623_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1567.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_1_4_MRP_04000623_1	US22502555_251188612394_S01_1_4_MRP_04000623_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
231C80	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	KAR	76.1%	6.4 years	Estrogen Receptor Positive	6.4 years	10.0 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000454	P-TABM-212	4000454_e1	total_RNA	P-TABM-214	4000454_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1044.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.4 years	6.4 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_4_MRP_04000454_1	US22502555_251188612214_S01_2_4_MRP_04000454_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1044.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.4 years	6.4 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_4_MRP_04000454_1	US22502555_251188612214_S01_2_4_MRP_04000454_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04034	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	80.6%	1.9 years	Estrogen Receptor Negative	16.3 years plus	16.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000546	P-TABM-212	4000546_e1	total_RNA	P-TABM-214	4000546_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2073.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188612769_S01_1_4_MRP_04000546_1	US22502555_251188612769_S01_1_4_MRP_04000546_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2073.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188612769_S01_1_4_MRP_04000546_1	US22502555_251188612769_S01_1_4_MRP_04000546_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1734.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Negative	US22502555_251188612427_S01_1_1_04000574_1_MRP	US22502555_251188612427_S01_1_1_04000574_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1469	35 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	KAR	81.8%	10.9 years	Estrogen Receptor Negative	15.3 years plus	15.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000574	P-TABM-212	4000574_e1	total_RNA	P-TABM-214	4000574_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1734.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Negative	US22502555_251188612427_S01_1_1_04000574_1_MRP	US22502555_251188612427_S01_1_1_04000574_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271448	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	94.3%	13.2 years plus	Estrogen Receptor Positive	13.2 years plus	13.2 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000335	P-TABM-212	4000335_e1	total_RNA	P-TABM-214	4000335_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.169.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.2 years plus	13.2 years plus	St Gallen category:low clinical risk	13.2 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_1_04000335_1_MRP	US22502555_251188611796_S01_1_1_04000335_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.169.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.2 years plus	13.2 years plus	St Gallen category:low clinical risk	13.2 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_1_04000335_1_MRP	US22502555_251188611796_S01_1_1_04000335_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.363.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.0 years plus	6.0 years plus	St Gallen category:low clinical risk	6.0 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_4_MRP_04000311_1	US22502555_251188611801_S01_1_4_MRP_04000311_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280527	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	92.8%	6.0 years plus	Estrogen Receptor Positive	6.0 years plus	6.0 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000311	P-TABM-212	4000311_e1	total_RNA	P-TABM-214	4000311_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.363.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.0 years plus	6.0 years plus	St Gallen category:low clinical risk	6.0 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_4_MRP_04000311_1	US22502555_251188611801_S01_1_4_MRP_04000311_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.514.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188611805_S01_2_1_04000269_1_MRP	US22502555_251188611805_S01_2_1_04000269_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
217743	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	63.2%	15.1 years plus	Estrogen Receptor Negative	15.1 years plus	15.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000269	P-TABM-212	4000269_e1	total_RNA	P-TABM-214	4000269_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.514.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188611805_S01_2_1_04000269_1_MRP	US22502555_251188611805_S01_2_1_04000269_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1281.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	0.3 years	St Gallen category:high clinical risk	0.4 years	Estrogen Receptor Negative	US22502555_251188612372_S01_2_4_MRP_04000413_1	US22502555_251188612372_S01_2_4_MRP_04000413_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
27B8	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	3	KAR	79.3%	0.3 years	Estrogen Receptor Negative	0.3 years	0.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000413	P-TABM-212	4000413_e1	total_RNA	P-TABM-214	4000413_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1281.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	0.3 years	St Gallen category:high clinical risk	0.4 years	Estrogen Receptor Negative	US22502555_251188612372_S01_2_4_MRP_04000413_1	US22502555_251188612372_S01_2_4_MRP_04000413_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2036.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_2_MRP_04000492_1	US22502555_251188612459_S01_1_2_MRP_04000492_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04096	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	2	GUY	88.6%	4.6 years	Estrogen Receptor Positive	12.7 years plus	12.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000492	P-TABM-212	4000492_e1	total_RNA	P-TABM-214	4000492_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2036.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_2_MRP_04000492_1	US22502555_251188612459_S01_1_2_MRP_04000492_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
317	41 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	CRH	81.2%	18.1 years	Estrogen Receptor Positive	19.7 years	19.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000641	P-TABM-212	4000641_e1	total_RNA	P-TABM-214	4000641_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1616.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	18.1 years	19.7 years	St Gallen category:high clinical risk	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_4_MRP_04000641_1	US22502555_251188612421_S01_1_4_MRP_04000641_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1616.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	18.1 years	19.7 years	St Gallen category:high clinical risk	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_4_MRP_04000641_1	US22502555_251188612421_S01_1_4_MRP_04000641_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
440	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	2	KAR	92.4%	4.0 years	Estrogen Receptor Positive	7.1 years	8.8 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000578	P-TABM-212	4000578_e1	total_RNA	P-TABM-214	4000578_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1653.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.0 years	7.1 years	St Gallen category:high clinical risk	8.8 years	Estrogen Receptor Positive	US22502555_251188612422_S01_2_4_MRP_04000578_1	US22502555_251188612422_S01_2_4_MRP_04000578_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1653.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.0 years	7.1 years	St Gallen category:high clinical risk	8.8 years	Estrogen Receptor Positive	US22502555_251188612422_S01_2_4_MRP_04000578_1	US22502555_251188612422_S01_2_4_MRP_04000578_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1274.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	0.3 years	St Gallen category:high clinical risk	0.4 years	Estrogen Receptor Negative	US22502555_251188612372_S01_2_3_04000413_1_MRP	US22502555_251188612372_S01_2_3_04000413_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
27B8	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	3	KAR	79.3%	0.3 years	Estrogen Receptor Negative	0.3 years	0.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000413	P-TABM-212	4000413_e1	total_RNA	P-TABM-214	4000413_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1274.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	0.3 years	St Gallen category:high clinical risk	0.4 years	Estrogen Receptor Negative	US22502555_251188612372_S01_2_3_04000413_1_MRP	US22502555_251188612372_S01_2_3_04000413_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1409.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years plus	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Negative	US22502555_251188612378_S01_1_3_04000435_1_MRP	US22502555_251188612378_S01_1_3_04000435_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15C5	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	3	KAR	84.4%	13.6 years plus	Estrogen Receptor Negative	13.6 years plus	13.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000435	P-TABM-212	4000435_e1	total_RNA	P-TABM-214	4000435_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1409.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years plus	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Negative	US22502555_251188612378_S01_1_3_04000435_1_MRP	US22502555_251188612378_S01_1_3_04000435_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
93	58 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	unknown	JRH	87.6%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000678	P-TABM-212	4000678_e1	total_RNA	P-TABM-214	4000678_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2304.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:not applicable	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_2_MRP_04000678_1	US22502555_251188612911_S01_2_2_MRP_04000678_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2304.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:not applicable	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_2_MRP_04000678_1	US22502555_251188612911_S01_2_2_MRP_04000678_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1897.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	3.2 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188612451_S01_1_1_04000513_1_MRP	US22502555_251188612451_S01_1_1_04000513_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04074	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	62.1%	0.3 years	Estrogen Receptor Negative	3.2 years	4.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000513	P-TABM-212	4000513_e1	total_RNA	P-TABM-214	4000513_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1897.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	3.2 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188612451_S01_1_1_04000513_1_MRP	US22502555_251188612451_S01_1_1_04000513_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
662	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	JRH	74%	5.7 years	Estrogen Receptor Positive	11.5 years plus	11.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000711	P-TABM-212	4000711_e1	total_RNA	P-TABM-214	4000711_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2419.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.7 years	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_1_04000711_1_MRP	US22502555_251188612941_S01_1_1_04000711_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2419.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.7 years	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_1_04000711_1_MRP	US22502555_251188612941_S01_1_1_04000711_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5229	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	64.1%	13.5 years plus	Estrogen Receptor Negative	13.5 years plus	13.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000586	P-TABM-212	4000586_e1	total_RNA	P-TABM-214	4000586_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1209.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years plus	13.5 years plus	St Gallen category:high clinical risk	13.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_1_04000586_1_MRP	US22502555_251188612337_S01_2_1_04000586_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1209.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years plus	13.5 years plus	St Gallen category:high clinical risk	13.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_1_04000586_1_MRP	US22502555_251188612337_S01_2_1_04000586_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.573.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	1.2 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Negative	US22502555_251188611807_S01_1_2_MRP_04000276_1	US22502555_251188611807_S01_1_2_MRP_04000276_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219587	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	31 mm diameter	3	IGR	63.9%	1.2 years	Estrogen Receptor Negative	1.2 years	2.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000276	P-TABM-212	4000276_e1	total_RNA	P-TABM-214	4000276_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.573.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	1.2 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Negative	US22502555_251188611807_S01_1_2_MRP_04000276_1	US22502555_251188611807_S01_1_2_MRP_04000276_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1644.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.4 years plus	12.4 years plus	St Gallen category:low clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_2_2_MRP_04000579_1	US22502555_251188612422_S01_2_2_MRP_04000579_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
205	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	1	KAR	91.5%	12.4 years plus	Estrogen Receptor Positive	12.4 years plus	12.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000579	P-TABM-212	4000579_e1	total_RNA	P-TABM-214	4000579_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1644.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.4 years plus	12.4 years plus	St Gallen category:low clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_2_2_MRP_04000579_1	US22502555_251188612422_S01_2_2_MRP_04000579_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
157	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	89.8%	13.5 years	Estrogen Receptor Positive	13.6 years plus	13.6 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000682	P-TABM-212	4000682_e1	total_RNA	P-TABM-214	4000682_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2253.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.5 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612908_S01_1_1_04000682_1_MRP	US22502555_251188612908_S01_1_1_04000682_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2253.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.5 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612908_S01_1_1_04000682_1_MRP	US22502555_251188612908_S01_1_1_04000682_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1126.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_2_2_MRP_04000628_1	US22502555_251188612218_S01_2_2_MRP_04000628_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1522	31 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	3	CRH	80.1%	14.2 years plus	Estrogen Receptor Positive	14.2 years plus	14.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000628	P-TABM-212	4000628_e1	total_RNA	P-TABM-214	4000628_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1126.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_2_2_MRP_04000628_1	US22502555_251188612218_S01_2_2_MRP_04000628_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.312.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_2_3_04000303_1_MRP	US22502555_251188611799_S01_2_3_04000303_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246821	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	IGR	78.1%	1.5 years	Estrogen Receptor Positive	9.7 years plus	9.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000303	P-TABM-212	4000303_e1	total_RNA	P-TABM-214	4000303_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.312.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_2_3_04000303_1_MRP	US22502555_251188611799_S01_2_3_04000303_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
144B49	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	2	KAR	81.4%	11.5 years	Estrogen Receptor Positive	11.5 years	14.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000437	P-TABM-212	4000437_e1	total_RNA	P-TABM-214	4000437_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1424.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.5 years	11.5 years	St Gallen category:high clinical risk	14.6 years	Estrogen Receptor Positive	US22502555_251188612379_S01_1_4_MRP_04000437_1	US22502555_251188612379_S01_1_4_MRP_04000437_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1424.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.5 years	11.5 years	St Gallen category:high clinical risk	14.6 years	Estrogen Receptor Positive	US22502555_251188612379_S01_1_4_MRP_04000437_1	US22502555_251188612379_S01_1_4_MRP_04000437_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1359.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_1_04000424_1_MRP	US22502555_251188612376_S01_2_1_04000424_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E8	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	KAR	85.5%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000424	P-TABM-212	4000424_e1	total_RNA	P-TABM-214	4000424_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1359.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_1_04000424_1_MRP	US22502555_251188612376_S01_2_1_04000424_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
272015	40 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	IGR	89.2%	2.5 years	Estrogen Receptor Positive	13.0 years plus	13.0 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000328	P-TABM-212	4000328_e1	total_RNA	P-TABM-214	4000328_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.733.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.5 years	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_1_1_04000328_1_MRP	US22502555_251188611856_S01_1_1_04000328_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.733.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.5 years	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_1_1_04000328_1_MRP	US22502555_251188611856_S01_1_1_04000328_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271509	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	89.4%	0.2 years plus	Estrogen Receptor Positive	0.2 years plus	0.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000334	P-TABM-212	4000334_e1	total_RNA	P-TABM-214	4000334_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.166.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	0.2 years plus	0.2 years plus	St Gallen category:high clinical risk	0.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_2_4_MRP_04000334_1	US22502555_251188611795_S01_2_4_MRP_04000334_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.166.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	0.2 years plus	0.2 years plus	St Gallen category:high clinical risk	0.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_2_4_MRP_04000334_1	US22502555_251188611795_S01_2_4_MRP_04000334_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1116.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years plus	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_1_4_MRP_04000627_1	US22502555_251188612218_S01_1_4_MRP_04000627_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1526	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	3	CRH	59.9%	10.6 years plus	Estrogen Receptor Positive	10.6 years plus	10.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000627	P-TABM-212	4000627_e1	total_RNA	P-TABM-214	4000627_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1116.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years plus	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_1_4_MRP_04000627_1	US22502555_251188612218_S01_1_4_MRP_04000627_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.749.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.5 years plus	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_2_4_MRP_04000338_3	US22502555_251188611856_S01_2_4_MRP_04000338_3.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255778	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	1	IGR	78.8%	11.5 years plus	Estrogen Receptor Positive	11.5 years plus	11.5 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000338	P-TABM-212	4000338_e1	total_RNA	P-TABM-214	4000338_e1_l3Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.749.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.5 years plus	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_2_4_MRP_04000338_3	US22502555_251188611856_S01_2_4_MRP_04000338_3.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	CRH	79.9%	21.7 years plus	unknown	21.7 years plus	21.7 years plus	NPI:high clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000643	P-TABM-212	4000643_e1	total_RNA	P-TABM-214	4000643_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1599.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	21.7 years plus	21.7 years plus	St Gallen category:high clinical risk	21.7 years plus	unknown	US22502555_251188612420_S01_2_4_MRP_04000643_1	US22502555_251188612420_S01_2_4_MRP_04000643_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1599.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	21.7 years plus	21.7 years plus	St Gallen category:high clinical risk	21.7 years plus	unknown	US22502555_251188612420_S01_2_4_MRP_04000643_1	US22502555_251188612420_S01_2_4_MRP_04000643_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2480.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.6 years	1.6 years plus	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188612943_S01_2_2_MRP_04000696_1	US22502555_251188612943_S01_2_2_MRP_04000696_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
446	29 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	3	JRH	64.4%	0.6 years	Estrogen Receptor Negative	1.6 years plus	1.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000696	P-TABM-212	4000696_e1	total_RNA	P-TABM-214	4000696_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2480.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.6 years	1.6 years plus	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188612943_S01_2_2_MRP_04000696_1	US22502555_251188612943_S01_2_2_MRP_04000696_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D7	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	88.9%	13.7 years plus	Estrogen Receptor Positive	13.7 years plus	13.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000428	P-TABM-212	4000428_e1	total_RNA	P-TABM-214	4000428_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1391.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_1_04000428_1_MRP	US22502555_251188612377_S01_2_1_04000428_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1391.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_1_04000428_1_MRP	US22502555_251188612377_S01_2_1_04000428_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219468	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	IGR	74.7%	14.5 years plus	Estrogen Receptor Positive	14.5 years plus	14.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000273	P-TABM-212	4000273_e1	total_RNA	P-TABM-214	4000273_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.546.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.5 years plus	14.5 years plus	St Gallen category:high clinical risk	14.5 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_4_MRP_04000273_1	US22502555_251188611806_S01_1_4_MRP_04000273_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.546.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.5 years plus	14.5 years plus	St Gallen category:high clinical risk	14.5 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_4_MRP_04000273_1	US22502555_251188611806_S01_1_4_MRP_04000273_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1406.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.4 years	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612378_S01_1_2_MRP_04000434_1	US22502555_251188612378_S01_1_2_MRP_04000434_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
136B04	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	2	KAR	85.7%	2.4 years	Estrogen Receptor Positive	16.8 years plus	16.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000434	P-TABM-212	4000434_e1	total_RNA	P-TABM-214	4000434_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1406.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.4 years	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612378_S01_1_2_MRP_04000434_1	US22502555_251188612378_S01_1_2_MRP_04000434_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
324524	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	1	IGR	94.3%	7.4 years plus	Estrogen Receptor Positive	7.4 years plus	7.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000283	P-TABM-212	4000283_e1	total_RNA	P-TABM-214	4000283_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.30.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.4 years plus	7.4 years plus	St Gallen category:low clinical risk	7.4 years plus	Estrogen Receptor Positive	US22502555_251188611677_S01_1_3_04000283_1_MRP	US22502555_251188611677_S01_1_3_04000283_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.30.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	7.4 years plus	7.4 years plus	St Gallen category:low clinical risk	7.4 years plus	Estrogen Receptor Positive	US22502555_251188611677_S01_1_3_04000283_1_MRP	US22502555_251188611677_S01_1_3_04000283_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
74A63	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	1	KAR	83.4%	6.0 years	Estrogen Receptor Positive	6.0 years	13.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000441	P-TABM-212	4000441_e1	total_RNA	P-TABM-214	4000441_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1094.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	6.0 years	6.0 years	St Gallen category:high clinical risk	13.0 years	Estrogen Receptor Positive	US22502555_251188612217_S01_2_2_MRP_04000441_1	US22502555_251188612217_S01_2_2_MRP_04000441_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1094.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	6.0 years	6.0 years	St Gallen category:high clinical risk	13.0 years	Estrogen Receptor Positive	US22502555_251188612217_S01_2_2_MRP_04000441_1	US22502555_251188612217_S01_2_2_MRP_04000441_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1838.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.8 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612448_S01_2_4_MRP_04000500_1	US22502555_251188612448_S01_2_4_MRP_04000500_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04089	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	81%	3.8 years	Estrogen Receptor Positive	13.6 years plus	13.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000500	P-TABM-212	4000500_e1	total_RNA	P-TABM-214	4000500_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1838.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.8 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612448_S01_2_4_MRP_04000500_1	US22502555_251188612448_S01_2_4_MRP_04000500_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.568.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	1.2 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Negative	US22502555_251188611807_S01_1_1_04000276_1_MRP	US22502555_251188611807_S01_1_1_04000276_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219587	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	31 mm diameter	3	IGR	63.9%	1.2 years	Estrogen Receptor Negative	1.2 years	2.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000276	P-TABM-212	4000276_e1	total_RNA	P-TABM-214	4000276_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.568.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	1.2 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Negative	US22502555_251188611807_S01_1_1_04000276_1_MRP	US22502555_251188611807_S01_1_1_04000276_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
218444	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	79.7%	1.9 years	Estrogen Receptor Negative	1.9 years	4.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000271	P-TABM-212	4000271_e1	total_RNA	P-TABM-214	4000271_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.523.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188611805_S01_2_3_04000271_1_MRP	US22502555_251188611805_S01_2_3_04000271_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.523.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188611805_S01_2_3_04000271_1_MRP	US22502555_251188611805_S01_2_3_04000271_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1111.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years plus	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_1_3_04000627_1_MRP	US22502555_251188612218_S01_1_3_04000627_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1526	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	3	CRH	59.9%	10.6 years plus	Estrogen Receptor Positive	10.6 years plus	10.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000627	P-TABM-212	4000627_e1	total_RNA	P-TABM-214	4000627_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1111.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.6 years plus	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_1_3_04000627_1_MRP	US22502555_251188612218_S01_1_3_04000627_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1720	24 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	1	CRH	79.5%	2.2 years	Estrogen Receptor Positive	2.2 years	3.6 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000622	P-TABM-212	4000622_e1	total_RNA	P-TABM-214	4000622_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1555.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	3.6 years	Estrogen Receptor Positive	US22502555_251188612394_S01_1_1_04000622_1_MRP	US22502555_251188612394_S01_1_1_04000622_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1555.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	3.6 years	Estrogen Receptor Positive	US22502555_251188612394_S01_1_1_04000622_1_MRP	US22502555_251188612394_S01_1_1_04000622_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04011	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	66.2%	1.4 years	Estrogen Receptor Negative	1.4 years	2.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000483	P-TABM-212	4000483_e1	total_RNA	P-TABM-214	4000483_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1815.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612447_S01_2_2_MRP_04000483_1	US22502555_251188612447_S01_2_2_MRP_04000483_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1815.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612447_S01_2_2_MRP_04000483_1	US22502555_251188612447_S01_2_2_MRP_04000483_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1485.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.4 years plus	8.4 years plus	St Gallen category:high clinical risk	8.4 years plus	Estrogen Receptor Negative	US22502555_251188612389_S01_2_3_04000613_1_MRP	US22502555_251188612389_S01_2_3_04000613_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1974	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	CRH	74.8%	8.4 years plus	Estrogen Receptor Negative	8.4 years plus	8.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000613	P-TABM-212	4000613_e1	total_RNA	P-TABM-214	4000613_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1485.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.4 years plus	8.4 years plus	St Gallen category:high clinical risk	8.4 years plus	Estrogen Receptor Negative	US22502555_251188612389_S01_2_3_04000613_1_MRP	US22502555_251188612389_S01_2_3_04000613_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
306818	39 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	90.3%	6.9 years	Estrogen Receptor Positive	10.7 years plus	10.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000301	P-TABM-212	4000301_e1	total_RNA	P-TABM-214	4000301_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.302.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.9 years	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_4_MRP_04000301_1	US22502555_251188611799_S01_1_4_MRP_04000301_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.302.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.9 years	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_4_MRP_04000301_1	US22502555_251188611799_S01_1_4_MRP_04000301_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
449	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	JRH	69%	12.5 years plus	Estrogen Receptor Positive	12.5 years plus	12.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000698	P-TABM-212	4000698_e1	total_RNA	P-TABM-214	4000698_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2489.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612944_S01_1_1_04000698_1_MRP	US22502555_251188612944_S01_1_1_04000698_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2489.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612944_S01_1_1_04000698_1_MRP	US22502555_251188612944_S01_1_1_04000698_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
447	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	JRH	90.9%	8.7 years plus	Estrogen Receptor Negative	8.7 years plus	8.7 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000697	P-TABM-212	4000697_e1	total_RNA	P-TABM-214	4000697_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2483.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.7 years plus	8.7 years plus	St Gallen category:high clinical risk	8.7 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_2_3_04000697_1_MRP	US22502555_251188612943_S01_2_3_04000697_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2483.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.7 years plus	8.7 years plus	St Gallen category:high clinical risk	8.7 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_2_3_04000697_1_MRP	US22502555_251188612943_S01_2_3_04000697_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
308963	45 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	89.2%	2.7 years	Estrogen Receptor Positive	9.7 years plus	9.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000291	P-TABM-212	4000291_e1	total_RNA	P-TABM-214	4000291_e1_l4Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.702.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.7 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611838_S01_2_4_MRP_04000291_4	US22502555_251188611838_S01_2_4_MRP_04000291_4.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.702.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.7 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611838_S01_2_4_MRP_04000291_4	US22502555_251188611838_S01_2_4_MRP_04000291_4.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.678.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.3 years	5.3 years	St Gallen category:high clinical risk	8.6 years	Estrogen Receptor Negative	US22502555_251188611837_S01_1_1_04000270_1_MRP	US22502555_251188611837_S01_1_1_04000270_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
218086	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	1	IGR	90.6%	5.3 years	Estrogen Receptor Negative	5.3 years	8.6 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000270	P-TABM-212	4000270_e1	total_RNA	P-TABM-214	4000270_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.678.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.3 years	5.3 years	St Gallen category:high clinical risk	8.6 years	Estrogen Receptor Negative	US22502555_251188611837_S01_1_1_04000270_1_MRP	US22502555_251188611837_S01_1_1_04000270_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04034	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	80.6%	1.9 years	Estrogen Receptor Negative	16.3 years plus	16.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000546	P-TABM-212	4000546_e1	total_RNA	P-TABM-214	4000546_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2070.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188612769_S01_1_3_04000546_1_MRP	US22502555_251188612769_S01_1_3_04000546_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2070.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	16.3 years plus	St Gallen category:high clinical risk	16.3 years plus	Estrogen Receptor Negative	US22502555_251188612769_S01_1_3_04000546_1_MRP	US22502555_251188612769_S01_1_3_04000546_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04067	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	80.2%	15.8 years plus	Estrogen Receptor Negative	15.8 years plus	15.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000520	P-TABM-212	4000520_e1	total_RNA	P-TABM-214	4000520_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1932.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_2_3_04000520_1_MRP	US22502555_251188612452_S01_2_3_04000520_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1932.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Negative	US22502555_251188612452_S01_2_3_04000520_1_MRP	US22502555_251188612452_S01_2_3_04000520_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04086	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	GUY	89%	8.5 years	Estrogen Receptor Positive	8.5 years	9.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000503	P-TABM-212	4000503_e1	total_RNA	P-TABM-214	4000503_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1860.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	8.5 years	8.5 years	St Gallen category:high clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612449_S01_2_2_MRP_04000503_1	US22502555_251188612449_S01_2_2_MRP_04000503_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1860.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	8.5 years	8.5 years	St Gallen category:high clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612449_S01_2_2_MRP_04000503_1	US22502555_251188612449_S01_2_2_MRP_04000503_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280352	57 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	75.5%	9.1 years	Estrogen Receptor Positive	11.1 years	12.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000315	P-TABM-212	4000315_e1	total_RNA	P-TABM-214	4000315_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.393.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.1 years	11.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_3_04000315_1_MRP	US22502555_251188611802_S01_1_3_04000315_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.393.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.1 years	11.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_3_04000315_1_MRP	US22502555_251188611802_S01_1_3_04000315_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04098	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	79.7%	0.9 years	Estrogen Receptor Negative	2.5 years	4.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000485	P-TABM-212	4000485_e1	total_RNA	P-TABM-214	4000485_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2020.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.9 years	2.5 years	St Gallen category:high clinical risk	4.2 years	Estrogen Receptor Negative	US22502555_251188612458_S01_2_2_MRP_04000485_1	US22502555_251188612458_S01_2_2_MRP_04000485_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2020.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.9 years	2.5 years	St Gallen category:high clinical risk	4.2 years	Estrogen Receptor Negative	US22502555_251188612458_S01_2_2_MRP_04000485_1	US22502555_251188612458_S01_2_2_MRP_04000485_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219507	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	88.6%	15.2 years plus	Estrogen Receptor Positive	15.2 years plus	15.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000275	P-TABM-212	4000275_e1	total_RNA	P-TABM-214	4000275_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.565.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_4_MRP_04000275_1	US22502555_251188611806_S01_2_4_MRP_04000275_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.565.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_2_4_MRP_04000275_1	US22502555_251188611806_S01_2_4_MRP_04000275_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.217.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.8 years plus	5.8 years plus	St Gallen category:high clinical risk	5.8 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_1_3_04000341_1_MRP	US22502555_251188611797_S01_1_3_04000341_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256940	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	87.2%	5.8 years plus	Estrogen Receptor Positive	5.8 years plus	5.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000341	P-TABM-212	4000341_e1	total_RNA	P-TABM-214	4000341_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.217.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.8 years plus	5.8 years plus	St Gallen category:high clinical risk	5.8 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_1_3_04000341_1_MRP	US22502555_251188611797_S01_1_3_04000341_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256734	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	84.6%	2.2 years	Estrogen Receptor Negative	2.2 years	2.9 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000347	P-TABM-212	4000347_e1	total_RNA	P-TABM-214	4000347_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2195.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Negative	US22502555_251188612775_S01_1_3_04000347_1_MRP	US22502555_251188612775_S01_1_3_04000347_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2195.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Negative	US22502555_251188612775_S01_1_3_04000347_1_MRP	US22502555_251188612775_S01_1_3_04000347_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1919	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	64.5%	11.8 years plus	Estrogen Receptor Negative	11.8 years plus	11.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000616	P-TABM-212	4000616_e1	total_RNA	P-TABM-214	4000616_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1510.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.8 years plus	11.8 years plus	St Gallen category:high clinical risk	11.8 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_2_MRP_04000616_1	US22502555_251188612392_S01_2_2_MRP_04000616_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1510.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.8 years plus	11.8 years plus	St Gallen category:high clinical risk	11.8 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_2_MRP_04000616_1	US22502555_251188612392_S01_2_2_MRP_04000616_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1894.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_4_MRP_04000512_1	US22502555_251188612450_S01_2_4_MRP_04000512_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04075	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	1	GUY	81.4%	14.0 years plus	Estrogen Receptor Positive	14.0 years plus	14.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000512	P-TABM-212	4000512_e1	total_RNA	P-TABM-214	4000512_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1894.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_4_MRP_04000512_1	US22502555_251188612450_S01_2_4_MRP_04000512_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.97.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.9 years plus	9.9 years plus	St Gallen category:high clinical risk	9.9 years plus	Estrogen Receptor Negative	US22502555_251188611679_S01_1_2_MRP_04000292_1	US22502555_251188611679_S01_1_2_MRP_04000292_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246114	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	65.3%	9.9 years plus	Estrogen Receptor Negative	9.9 years plus	9.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000292	P-TABM-212	4000292_e1	total_RNA	P-TABM-214	4000292_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.97.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.9 years plus	9.9 years plus	St Gallen category:high clinical risk	9.9 years plus	Estrogen Receptor Negative	US22502555_251188611679_S01_1_2_MRP_04000292_1	US22502555_251188611679_S01_1_2_MRP_04000292_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.989.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_1_2_MRP_04000448_1	US22502555_251188612213_S01_1_2_MRP_04000448_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
292C66	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	87.2%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000448	P-TABM-212	4000448_e1	total_RNA	P-TABM-214	4000448_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.989.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_1_2_MRP_04000448_1	US22502555_251188612213_S01_1_2_MRP_04000448_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1745	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	2	CRH	89.7%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000620	P-TABM-212	4000620_e1	total_RNA	P-TABM-214	4000620_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1543.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_2_2_MRP_04000620_1	US22502555_251188612393_S01_2_2_MRP_04000620_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1543.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_2_2_MRP_04000620_1	US22502555_251188612393_S01_2_2_MRP_04000620_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246560	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	IGR	84.4%	9.0 years plus	Estrogen Receptor Negative	9.0 years plus	9.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000302	P-TABM-212	4000302_e1	total_RNA	P-TABM-214	4000302_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.309.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611799_S01_2_2_MRP_04000302_1	US22502555_251188611799_S01_2_2_MRP_04000302_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.309.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611799_S01_2_2_MRP_04000302_1	US22502555_251188611799_S01_2_2_MRP_04000302_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256209	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	92.8%	4.9 years	Estrogen Receptor Positive	5.0 years	9.2 years	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000346	P-TABM-212	4000346_e1	total_RNA	P-TABM-214	4000346_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.27.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.9 years	5.0 years	St Gallen category:low clinical risk	9.2 years	Estrogen Receptor Positive	US22502555_251188611675_S01_2_2_MRP_04000346_1	US22502555_251188611675_S01_2_2_MRP_04000346_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.27.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.9 years	5.0 years	St Gallen category:low clinical risk	9.2 years	Estrogen Receptor Positive	US22502555_251188611675_S01_2_2_MRP_04000346_1	US22502555_251188611675_S01_2_2_MRP_04000346_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1494.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_1_04000614_1_MRP	US22502555_251188612392_S01_1_1_04000614_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1970	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	73.8%	11.4 years plus	Estrogen Receptor Positive	11.4 years plus	11.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000614	P-TABM-212	4000614_e1	total_RNA	P-TABM-214	4000614_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1494.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_1_04000614_1_MRP	US22502555_251188612392_S01_1_1_04000614_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1200.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.2 years plus	7.2 years plus	St Gallen category:high clinical risk	7.2 years plus	Estrogen Receptor Positive	US22502555_251188612337_S01_1_3_04000585_1_MRP	US22502555_251188612337_S01_1_3_04000585_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5230	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	71.1%	7.2 years plus	Estrogen Receptor Positive	7.2 years plus	7.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000585	P-TABM-212	4000585_e1	total_RNA	P-TABM-214	4000585_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1200.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.2 years plus	7.2 years plus	St Gallen category:high clinical risk	7.2 years plus	Estrogen Receptor Positive	US22502555_251188612337_S01_1_3_04000585_1_MRP	US22502555_251188612337_S01_1_3_04000585_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1917	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	66.4%	12.3 years plus	Estrogen Receptor Negative	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000617	P-TABM-212	4000617_e1	total_RNA	P-TABM-214	4000617_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1513.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_3_04000617_1_MRP	US22502555_251188612392_S01_2_3_04000617_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1513.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_3_04000617_1_MRP	US22502555_251188612392_S01_2_3_04000617_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.600.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_1_2_MRP_04000320_1	US22502555_251188611808_S01_1_2_MRP_04000320_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279847	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	72.6%	9.4 years plus	Estrogen Receptor Positive	9.4 years plus	9.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000320	P-TABM-212	4000320_e1	total_RNA	P-TABM-214	4000320_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.600.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_1_2_MRP_04000320_1	US22502555_251188611808_S01_1_2_MRP_04000320_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
93	58 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	unknown	JRH	87.6%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000678	P-TABM-212	4000678_e1	total_RNA	P-TABM-214	4000678_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2301.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:not applicable	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_1_04000678_1_MRP	US22502555_251188612911_S01_2_1_04000678_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2301.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:not applicable	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_1_04000678_1_MRP	US22502555_251188612911_S01_2_1_04000678_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2271.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Negative	US22502555_251188612908_S01_2_4_MRP_04000685_1	US22502555_251188612908_S01_2_4_MRP_04000685_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	3	JRH	85.7%	13.3 years plus	Estrogen Receptor Negative	13.3 years plus	13.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000685	P-TABM-212	4000685_e1	total_RNA	P-TABM-214	4000685_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2271.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Negative	US22502555_251188612908_S01_2_4_MRP_04000685_1	US22502555_251188612908_S01_2_4_MRP_04000685_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.983.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612212_S01_1_4_MRP_04000445_1	US22502555_251188612212_S01_1_4_MRP_04000445_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
199B55	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	2	KAR	77.1%	16.2 years plus	Estrogen Receptor Positive	16.2 years plus	16.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000445	P-TABM-212	4000445_e1	total_RNA	P-TABM-214	4000445_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.983.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612212_S01_1_4_MRP_04000445_1	US22502555_251188612212_S01_1_4_MRP_04000445_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
216939	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	79%	13.1 years plus	Estrogen Receptor Positive	13.1 years plus	13.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000265	P-TABM-212	4000265_e1	total_RNA	P-TABM-214	4000265_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.484.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_2_2_MRP_04000265_1	US22502555_251188611804_S01_2_2_MRP_04000265_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.484.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_2_2_MRP_04000265_1	US22502555_251188611804_S01_2_2_MRP_04000265_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.40.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188611677_S01_2_1_04000284_1_MRP	US22502555_251188611677_S01_2_1_04000284_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245471	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	IGR	67.6%	0.7 years	Estrogen Receptor Negative	0.7 years	1.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000284	P-TABM-212	4000284_e1	total_RNA	P-TABM-214	4000284_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.40.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188611677_S01_2_1_04000284_1_MRP	US22502555_251188611677_S01_2_1_04000284_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2171.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.8 years	6.5 years	St Gallen category:high clinical risk	11.1 years	Estrogen Receptor Positive	US22502555_251188612774_S01_1_2_MRP_04000307_1	US22502555_251188612774_S01_1_2_MRP_04000307_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
287508	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	2	IGR	88.3%	3.8 years	Estrogen Receptor Positive	6.5 years	11.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000307	P-TABM-212	4000307_e1	total_RNA	P-TABM-214	4000307_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2171.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.8 years	6.5 years	St Gallen category:high clinical risk	11.1 years	Estrogen Receptor Positive	US22502555_251188612774_S01_1_2_MRP_04000307_1	US22502555_251188612774_S01_1_2_MRP_04000307_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
87A79	36 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	1	KAR	95.5%	17.4 years plus	Estrogen Receptor Positive	17.4 years plus	17.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000440	P-TABM-212	4000440_e1	total_RNA	P-TABM-214	4000440_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.952.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.4 years plus	17.4 years plus	St Gallen category:low clinical risk	17.4 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_1_2_MRP_04000440_1	US22502555_251188612211_S01_1_2_MRP_04000440_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.952.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.4 years plus	17.4 years plus	St Gallen category:low clinical risk	17.4 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_1_2_MRP_04000440_1	US22502555_251188612211_S01_1_2_MRP_04000440_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1315	33 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	CRH	86.9%	5.1 years	Estrogen Receptor Positive	25.0 years plus	25.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000632	P-TABM-212	4000632_e1	total_RNA	P-TABM-214	4000632_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.793.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.1 years	25.0 years plus	St Gallen category:high clinical risk	25.0 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_2_2_MRP_04000632_1	US22502555_251188612196_S01_2_2_MRP_04000632_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.793.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.1 years	25.0 years plus	St Gallen category:high clinical risk	25.0 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_2_2_MRP_04000632_1	US22502555_251188612196_S01_2_2_MRP_04000632_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2236.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.8 years	1.8 years	St Gallen category:high clinical risk	2.8 years	Estrogen Receptor Positive	US22502555_251188612907_S01_1_4_MRP_04000679_1	US22502555_251188612907_S01_1_4_MRP_04000679_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
104	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	31 mm diameter	3	JRH	59.9%	1.8 years	Estrogen Receptor Positive	1.8 years	2.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000679	P-TABM-212	4000679_e1	total_RNA	P-TABM-214	4000679_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2236.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.8 years	1.8 years	St Gallen category:high clinical risk	2.8 years	Estrogen Receptor Positive	US22502555_251188612907_S01_1_4_MRP_04000679_1	US22502555_251188612907_S01_1_4_MRP_04000679_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1696.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	14.8 years plus	14.8 years plus	St Gallen category:low clinical risk	14.8 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_1_04000568_1_MRP	US22502555_251188612425_S01_2_1_04000568_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2656	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	1	KAR	92.2%	14.8 years plus	Estrogen Receptor Positive	14.8 years plus	14.8 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000568	P-TABM-212	4000568_e1	total_RNA	P-TABM-214	4000568_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1696.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	14.8 years plus	14.8 years plus	St Gallen category:low clinical risk	14.8 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_1_04000568_1_MRP	US22502555_251188612425_S01_2_1_04000568_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.739.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.5 years	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_1_2_MRP_04000328_1	US22502555_251188611856_S01_1_2_MRP_04000328_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
272015	40 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	IGR	89.2%	2.5 years	Estrogen Receptor Positive	13.0 years plus	13.0 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000328	P-TABM-212	4000328_e1	total_RNA	P-TABM-214	4000328_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.739.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.5 years	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_1_2_MRP_04000328_1	US22502555_251188611856_S01_1_2_MRP_04000328_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
869	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	1	JRH	95.1%	8.7 years plus	Estrogen Receptor Positive	8.7 years plus	8.7 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000712	P-TABM-212	4000712_e1	total_RNA	P-TABM-214	4000712_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2427.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.7 years plus	8.7 years plus	St Gallen category:low clinical risk	8.7 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_3_04000712_1_MRP	US22502555_251188612941_S01_1_3_04000712_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2427.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.7 years plus	8.7 years plus	St Gallen category:low clinical risk	8.7 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_3_04000712_1_MRP	US22502555_251188612941_S01_1_3_04000712_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04008	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	69%	0.5 years	Estrogen Receptor Positive	18.1 years plus	18.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000480	P-TABM-212	4000480_e1	total_RNA	P-TABM-214	4000480_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1795.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.5 years	18.1 years plus	St Gallen category:high clinical risk	18.1 years plus	Estrogen Receptor Positive	US22502555_251188612447_S01_1_1_04000480_1_MRP	US22502555_251188612447_S01_1_1_04000480_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1795.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.5 years	18.1 years plus	St Gallen category:high clinical risk	18.1 years plus	Estrogen Receptor Positive	US22502555_251188612447_S01_1_1_04000480_1_MRP	US22502555_251188612447_S01_1_1_04000480_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.437.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	5.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188611803_S01_1_4_MRP_04000259_1	US22502555_251188611803_S01_1_4_MRP_04000259_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
211068	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	74.7%	1.0 years	Estrogen Receptor Positive	5.8 years	9.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000259	P-TABM-212	4000259_e1	total_RNA	P-TABM-214	4000259_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.437.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	5.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188611803_S01_1_4_MRP_04000259_1	US22502555_251188611803_S01_1_4_MRP_04000259_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.373.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.9 years plus	13.9 years plus	St Gallen category:high clinical risk	13.9 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_2_MRP_04000312_1	US22502555_251188611801_S01_2_2_MRP_04000312_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247188	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	84.8%	13.9 years plus	Estrogen Receptor Positive	13.9 years plus	13.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000312	P-TABM-212	4000312_e1	total_RNA	P-TABM-214	4000312_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.373.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.9 years plus	13.9 years plus	St Gallen category:high clinical risk	13.9 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_2_MRP_04000312_1	US22502555_251188611801_S01_2_2_MRP_04000312_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2076.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.8 years plus	17.8 years plus	St Gallen category:high clinical risk	17.8 years plus	Estrogen Receptor Positive	US22502555_251188612769_S01_2_1_04000547_1_MRP	US22502555_251188612769_S01_2_1_04000547_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04033	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	83.1%	17.8 years plus	Estrogen Receptor Positive	17.8 years plus	17.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000547	P-TABM-212	4000547_e1	total_RNA	P-TABM-214	4000547_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2076.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.8 years plus	17.8 years plus	St Gallen category:high clinical risk	17.8 years plus	Estrogen Receptor Positive	US22502555_251188612769_S01_2_1_04000547_1_MRP	US22502555_251188612769_S01_2_1_04000547_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04010	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	61.5%	1.5 years	Estrogen Receptor Negative	1.5 years	2.0 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000482	P-TABM-212	4000482_e1	total_RNA	P-TABM-214	4000482_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1809.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.0 years	Estrogen Receptor Negative	US22502555_251188612447_S01_1_4_MRP_04000482_1	US22502555_251188612447_S01_1_4_MRP_04000482_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1809.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.0 years	Estrogen Receptor Negative	US22502555_251188612447_S01_1_4_MRP_04000482_1	US22502555_251188612447_S01_1_4_MRP_04000482_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255160	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	1	IGR	92.4%	9.1 years plus	Estrogen Receptor Positive	9.1 years plus	9.1 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000331	P-TABM-212	4000331_e1	total_RNA	P-TABM-214	4000331_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.129.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.1 years plus	9.1 years plus	St Gallen category:low clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_1_04000331_1_MRP	US22502555_251188611795_S01_1_1_04000331_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.129.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.1 years plus	9.1 years plus	St Gallen category:low clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_1_04000331_1_MRP	US22502555_251188611795_S01_1_1_04000331_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04043	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	77.8%	3.1 years	Estrogen Receptor Positive	3.1 years	5.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000541	P-TABM-212	4000541_e1	total_RNA	P-TABM-214	4000541_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2005.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	3.1 years	St Gallen category:high clinical risk	5.2 years	Estrogen Receptor Positive	US22502555_251188612457_S01_2_2_MRP_04000541_1	US22502555_251188612457_S01_2_2_MRP_04000541_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2005.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	3.1 years	St Gallen category:high clinical risk	5.2 years	Estrogen Receptor Positive	US22502555_251188612457_S01_2_2_MRP_04000541_1	US22502555_251188612457_S01_2_2_MRP_04000541_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
4188	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	3	CRH	62.3%	7.9 years plus	Estrogen Receptor Negative	7.9 years plus	7.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000592	P-TABM-212	4000592_e1	total_RNA	P-TABM-214	4000592_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1440.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years plus	7.9 years plus	St Gallen category:high clinical risk	7.9 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_1_2_MRP_04000592_1	US22502555_251188612388_S01_1_2_MRP_04000592_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1440.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years plus	7.9 years plus	St Gallen category:high clinical risk	7.9 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_1_2_MRP_04000592_1	US22502555_251188612388_S01_1_2_MRP_04000592_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.907.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.0 years	10.6 years plus	St Gallen category:low clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_2_4_MRP_04000606_1	US22502555_251188612201_S01_2_4_MRP_04000606_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2377	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	CRH	93.7%	10.0 years	Estrogen Receptor Positive	10.6 years plus	10.6 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000606	P-TABM-212	4000606_e1	total_RNA	P-TABM-214	4000606_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.907.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.0 years	10.6 years plus	St Gallen category:low clinical risk	10.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_2_4_MRP_04000606_1	US22502555_251188612201_S01_2_4_MRP_04000606_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1579	28 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	CRH	65.4%	14.2 years plus	Estrogen Receptor Positive	14.2 years plus	14.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000623	P-TABM-212	4000623_e1	total_RNA	P-TABM-214	4000623_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1563.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_1_3_04000623_1_MRP	US22502555_251188612394_S01_1_3_04000623_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1563.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612394_S01_1_3_04000623_1_MRP	US22502555_251188612394_S01_1_3_04000623_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.175.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.2 years plus	13.2 years plus	St Gallen category:low clinical risk	13.2 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_2_MRP_04000335_1	US22502555_251188611796_S01_1_2_MRP_04000335_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271448	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	94.3%	13.2 years plus	Estrogen Receptor Positive	13.2 years plus	13.2 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000335	P-TABM-212	4000335_e1	total_RNA	P-TABM-214	4000335_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.175.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.2 years plus	13.2 years plus	St Gallen category:low clinical risk	13.2 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_2_MRP_04000335_1	US22502555_251188611796_S01_1_2_MRP_04000335_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280328	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	2	IGR	79.6%	10.9 years	Estrogen Receptor Positive	10.9 years	12.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000316	P-TABM-212	4000316_e1	total_RNA	P-TABM-214	4000316_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.408.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.9 years	10.9 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_2_MRP_04000316_1	US22502555_251188611802_S01_2_2_MRP_04000316_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.408.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.9 years	10.9 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_2_MRP_04000316_1	US22502555_251188611802_S01_2_2_MRP_04000316_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1108.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	unknown	US22502555_251188612218_S01_1_2_MRP_04000626_1	US22502555_251188612218_S01_1_2_MRP_04000626_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1544	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	CRH	85.7%	13.7 years plus	unknown	13.7 years plus	13.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000626	P-TABM-212	4000626_e1	total_RNA	P-TABM-214	4000626_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1108.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	unknown	US22502555_251188612218_S01_1_2_MRP_04000626_1	US22502555_251188612218_S01_1_2_MRP_04000626_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
309C49	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	KAR	84.6%	15.2 years plus	Estrogen Receptor Positive	15.2 years plus	15.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000438	P-TABM-212	4000438_e1	total_RNA	P-TABM-214	4000438_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1427.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612379_S01_2_1_04000438_1_MRP	US22502555_251188612379_S01_2_1_04000438_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1427.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612379_S01_2_1_04000438_1_MRP	US22502555_251188612379_S01_2_1_04000438_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254485	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	1	IGR	88.4%	12.7 years plus	Estrogen Receptor Positive	12.7 years plus	12.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000329	P-TABM-212	4000329_e1	total_RNA	P-TABM-214	4000329_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.656.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.7 years plus	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_2_2_MRP_04000329_1	US22502555_251188611809_S01_2_2_MRP_04000329_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.656.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.7 years plus	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_2_2_MRP_04000329_1	US22502555_251188611809_S01_2_2_MRP_04000329_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
533	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	2	JRH	77.7%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000705	P-TABM-212	4000705_e1	total_RNA	P-TABM-214	4000705_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2283.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612909_S01_2_4_MRP_04000705_1	US22502555_251188612909_S01_2_4_MRP_04000705_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2283.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612909_S01_2_4_MRP_04000705_1	US22502555_251188612909_S01_2_4_MRP_04000705_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1257.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_4_MRP_04000591_1	US22502555_251188612338_S01_2_4_MRP_04000591_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5223	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	CRH	84.4%	14.1 years plus	Estrogen Receptor Positive	14.1 years plus	14.1 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000591	P-TABM-212	4000591_e1	total_RNA	P-TABM-214	4000591_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1257.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.1 years plus	14.1 years plus	St Gallen category:high clinical risk	14.1 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_4_MRP_04000591_1	US22502555_251188612338_S01_2_4_MRP_04000591_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2320	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	CRH	80.8%	3.9 years	Estrogen Receptor Positive	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000609	P-TABM-212	4000609_e1	total_RNA	P-TABM-214	4000609_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.934.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.9 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_2_2_MRP_04000609_1	US22502555_251188612202_S01_2_2_MRP_04000609_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.934.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.9 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_2_2_MRP_04000609_1	US22502555_251188612202_S01_2_2_MRP_04000609_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307251	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	67.6%	4.3 years plus	Estrogen Receptor Negative	4.3 years plus	4.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000299	P-TABM-212	4000299_e1	total_RNA	P-TABM-214	4000299_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.282.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.3 years plus	4.3 years plus	St Gallen category:high clinical risk	4.3 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_4_MRP_04000299_1	US22502555_251188611798_S01_2_4_MRP_04000299_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.282.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.3 years plus	4.3 years plus	St Gallen category:high clinical risk	4.3 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_4_MRP_04000299_1	US22502555_251188611798_S01_2_4_MRP_04000299_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04086	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	GUY	89%	8.5 years	Estrogen Receptor Positive	8.5 years	9.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000503	P-TABM-212	4000503_e1	total_RNA	P-TABM-214	4000503_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1855.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	8.5 years	8.5 years	St Gallen category:high clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612449_S01_2_1_04000503_1_MRP	US22502555_251188612449_S01_2_1_04000503_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1855.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	8.5 years	8.5 years	St Gallen category:high clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612449_S01_2_1_04000503_1_MRP	US22502555_251188612449_S01_2_1_04000503_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.16.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.9 years	5.0 years	St Gallen category:low clinical risk	9.2 years	Estrogen Receptor Positive	US22502555_251188611675_S01_2_1_04000346_1_MRP	US22502555_251188611675_S01_2_1_04000346_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256209	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	92.8%	4.9 years	Estrogen Receptor Positive	5.0 years	9.2 years	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000346	P-TABM-212	4000346_e1	total_RNA	P-TABM-214	4000346_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.16.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.9 years	5.0 years	St Gallen category:low clinical risk	9.2 years	Estrogen Receptor Positive	US22502555_251188611675_S01_2_1_04000346_1_MRP	US22502555_251188611675_S01_2_1_04000346_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
4181	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	87.9%	7.5 years plus	unknown	7.5 years plus	7.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000594	P-TABM-212	4000594_e1	total_RNA	P-TABM-214	4000594_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1447.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	unknown	US22502555_251188612388_S01_2_2_MRP_04000594_1	US22502555_251188612388_S01_2_2_MRP_04000594_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1447.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	unknown	US22502555_251188612388_S01_2_2_MRP_04000594_1	US22502555_251188612388_S01_2_2_MRP_04000594_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1312.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	22.3 years plus	22.3 years plus	St Gallen category:high clinical risk	22.3 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_3_04000433_1_MRP	US22502555_251188612374_S01_2_3_04000433_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15C10	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	3	KAR	84.8%	22.3 years plus	Estrogen Receptor Positive	22.3 years plus	22.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000433	P-TABM-212	4000433_e1	total_RNA	P-TABM-214	4000433_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1312.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	22.3 years plus	22.3 years plus	St Gallen category:high clinical risk	22.3 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_3_04000433_1_MRP	US22502555_251188612374_S01_2_3_04000433_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2495.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.5 years	3.5 years	St Gallen category:high clinical risk	4.5 years	unknown	US22502555_251188612944_S01_2_1_04000700_1_MRP	US22502555_251188612944_S01_2_1_04000700_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
476	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	unknown	JRH	72.1%	3.5 years	unknown	3.5 years	4.5 years	NPI:not applicable	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000700	P-TABM-212	4000700_e1	total_RNA	P-TABM-214	4000700_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2495.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	3.5 years	3.5 years	St Gallen category:high clinical risk	4.5 years	unknown	US22502555_251188612944_S01_2_1_04000700_1_MRP	US22502555_251188612944_S01_2_1_04000700_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247188	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	84.8%	13.9 years plus	Estrogen Receptor Positive	13.9 years plus	13.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000312	P-TABM-212	4000312_e1	total_RNA	P-TABM-214	4000312_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.366.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.9 years plus	13.9 years plus	St Gallen category:high clinical risk	13.9 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_1_04000312_1_MRP	US22502555_251188611801_S01_2_1_04000312_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.366.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.9 years plus	13.9 years plus	St Gallen category:high clinical risk	13.9 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_1_04000312_1_MRP	US22502555_251188611801_S01_2_1_04000312_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246114	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	65.3%	9.9 years plus	Estrogen Receptor Negative	9.9 years plus	9.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000292	P-TABM-212	4000292_e1	total_RNA	P-TABM-214	4000292_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.90.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.9 years plus	9.9 years plus	St Gallen category:high clinical risk	9.9 years plus	Estrogen Receptor Negative	US22502555_251188611679_S01_1_1_04000292_1_MRP	US22502555_251188611679_S01_1_1_04000292_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.90.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.9 years plus	9.9 years plus	St Gallen category:high clinical risk	9.9 years plus	Estrogen Receptor Negative	US22502555_251188611679_S01_1_1_04000292_1_MRP	US22502555_251188611679_S01_1_1_04000292_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04046	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	78.3%	7.8 years	Estrogen Receptor Negative	11.1 years	12.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000538	P-TABM-212	4000538_e1	total_RNA	P-TABM-214	4000538_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2100.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.8 years	11.1 years	St Gallen category:high clinical risk	12.0 years	Estrogen Receptor Negative	US22502555_251188612770_S01_2_1_04000538_1_MRP	US22502555_251188612770_S01_2_1_04000538_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2100.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.8 years	11.1 years	St Gallen category:high clinical risk	12.0 years	Estrogen Receptor Negative	US22502555_251188612770_S01_2_1_04000538_1_MRP	US22502555_251188612770_S01_2_1_04000538_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2039	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	CRH	90.3%	7.3 years	Estrogen Receptor Negative	12.7 years	16.5 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000611	P-TABM-212	4000611_e1	total_RNA	P-TABM-214	4000611_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1475.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years	12.7 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Negative	US22502555_251188612389_S01_1_4_MRP_04000611_1	US22502555_251188612389_S01_1_4_MRP_04000611_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1475.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years	12.7 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Negative	US22502555_251188612389_S01_1_4_MRP_04000611_1	US22502555_251188612389_S01_1_4_MRP_04000611_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307506	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	1	IGR	88.2%	10.2 years plus	Estrogen Receptor Positive	10.2 years plus	10.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000295	P-TABM-212	4000295_e1	total_RNA	P-TABM-214	4000295_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.110.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_3_04000295_1_MRP	US22502555_251188611679_S01_2_3_04000295_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.110.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_3_04000295_1_MRP	US22502555_251188611679_S01_2_3_04000295_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1978.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.7 years	8.7 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612455_S01_2_1_04000537_1_MRP	US22502555_251188612455_S01_2_1_04000537_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04047	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	87.2%	8.7 years	Estrogen Receptor Positive	8.7 years	10.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000537	P-TABM-212	4000537_e1	total_RNA	P-TABM-214	4000537_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1978.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.7 years	8.7 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612455_S01_2_1_04000537_1_MRP	US22502555_251188612455_S01_2_1_04000537_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1216.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_3_04000587_1_MRP	US22502555_251188612337_S01_2_3_04000587_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5228	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	67.7%	15.5 years plus	Estrogen Receptor Negative	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000587	P-TABM-212	4000587_e1	total_RNA	P-TABM-214	4000587_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1216.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_3_04000587_1_MRP	US22502555_251188612337_S01_2_3_04000587_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.159.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	0.2 years plus	0.2 years plus	St Gallen category:high clinical risk	0.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_2_3_04000334_1_MRP	US22502555_251188611795_S01_2_3_04000334_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271509	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	89.4%	0.2 years plus	Estrogen Receptor Positive	0.2 years plus	0.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000334	P-TABM-212	4000334_e1	total_RNA	P-TABM-214	4000334_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.159.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	0.2 years plus	0.2 years plus	St Gallen category:high clinical risk	0.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_2_3_04000334_1_MRP	US22502555_251188611795_S01_2_3_04000334_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2459.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612942_S01_1_4_MRP_04000687_1	US22502555_251188612942_S01_1_4_MRP_04000687_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
316	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	JRH	66.4%	12.8 years plus	Estrogen Receptor Negative	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000687	P-TABM-212	4000687_e1	total_RNA	P-TABM-214	4000687_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2459.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Negative	US22502555_251188612942_S01_1_4_MRP_04000687_1	US22502555_251188612942_S01_1_4_MRP_04000687_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D9	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	KAR	84.3%	2.4 years	Estrogen Receptor Positive	2.4 years	5.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000414	P-TABM-212	4000414_e1	total_RNA	P-TABM-214	4000414_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1290.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.4 years	2.4 years	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_2_MRP_04000414_1	US22502555_251188612373_S01_1_2_MRP_04000414_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1290.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.4 years	2.4 years	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_2_MRP_04000414_1	US22502555_251188612373_S01_1_2_MRP_04000414_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.67.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188611678_S01_1_2_MRP_04000286_1	US22502555_251188611678_S01_1_2_MRP_04000286_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245596	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	67.1%	12.9 years plus	Estrogen Receptor Negative	12.9 years plus	12.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000286	P-TABM-212	4000286_e1	total_RNA	P-TABM-214	4000286_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.67.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188611678_S01_1_2_MRP_04000286_1	US22502555_251188611678_S01_1_2_MRP_04000286_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1179.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_2_MRP_04000582_1	US22502555_251188612335_S01_2_2_MRP_04000582_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5236	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	CRH	89.6%	7.5 years plus	Estrogen Receptor Positive	7.5 years plus	7.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000582	P-TABM-212	4000582_e1	total_RNA	P-TABM-214	4000582_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1179.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_2_MRP_04000582_1	US22502555_251188612335_S01_2_2_MRP_04000582_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.705.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.8 years plus	11.8 years plus	St Gallen category:low clinical risk	11.8 years plus	Estrogen Receptor Positive	US22502555_251188611840_S01_1_3_04000318_2_MRP	US22502555_251188611840_S01_1_3_04000318_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279941	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	92.8%	11.8 years plus	Estrogen Receptor Positive	11.8 years plus	11.8 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000318	P-TABM-212	4000318_e1	total_RNA	P-TABM-214	4000318_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.705.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.8 years plus	11.8 years plus	St Gallen category:low clinical risk	11.8 years plus	Estrogen Receptor Positive	US22502555_251188611840_S01_1_3_04000318_2_MRP	US22502555_251188611840_S01_1_3_04000318_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.711.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.8 years plus	11.8 years plus	St Gallen category:low clinical risk	11.8 years plus	Estrogen Receptor Positive	US22502555_251188611840_S01_1_4_MRP_04000318_2	US22502555_251188611840_S01_1_4_MRP_04000318_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279941	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	92.8%	11.8 years plus	Estrogen Receptor Positive	11.8 years plus	11.8 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000318	P-TABM-212	4000318_e1	total_RNA	P-TABM-214	4000318_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.711.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.8 years plus	11.8 years plus	St Gallen category:low clinical risk	11.8 years plus	Estrogen Receptor Positive	US22502555_251188611840_S01_1_4_MRP_04000318_2	US22502555_251188611840_S01_1_4_MRP_04000318_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2400.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:low clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_4_MRP_04000707_1	US22502555_251188612940_S01_1_4_MRP_04000707_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
544	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	1	JRH	90.3%	11.9 years plus	Estrogen Receptor Positive	11.9 years plus	11.9 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000707	P-TABM-212	4000707_e1	total_RNA	P-TABM-214	4000707_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2400.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:low clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_4_MRP_04000707_1	US22502555_251188612940_S01_1_4_MRP_04000707_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1919	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	64.5%	11.8 years plus	Estrogen Receptor Negative	11.8 years plus	11.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000616	P-TABM-212	4000616_e1	total_RNA	P-TABM-214	4000616_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1506.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.8 years plus	11.8 years plus	St Gallen category:high clinical risk	11.8 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_1_04000616_1_MRP	US22502555_251188612392_S01_2_1_04000616_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1506.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.8 years plus	11.8 years plus	St Gallen category:high clinical risk	11.8 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_1_04000616_1_MRP	US22502555_251188612392_S01_2_1_04000616_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2390.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_1_04000706_1_MRP	US22502555_251188612940_S01_1_1_04000706_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
535j	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	JRH	82.3%	12.2 years plus	Estrogen Receptor Positive	12.2 years plus	12.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000706	P-TABM-212	4000706_e1	total_RNA	P-TABM-214	4000706_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2390.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_1_04000706_1_MRP	US22502555_251188612940_S01_1_1_04000706_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1037.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.4 years	6.4 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_3_04000454_1_MRP	US22502555_251188612214_S01_2_3_04000454_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
231C80	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	KAR	76.1%	6.4 years	Estrogen Receptor Positive	6.4 years	10.0 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000454	P-TABM-212	4000454_e1	total_RNA	P-TABM-214	4000454_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1037.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.4 years	6.4 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_3_04000454_1_MRP	US22502555_251188612214_S01_2_3_04000454_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04002	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	62.7%	2.0 years	Estrogen Receptor Negative	2.0 years	2.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000471	P-TABM-212	4000471_e1	total_RNA	P-TABM-214	4000471_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1774.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.6 years	Estrogen Receptor Negative	US22502555_251188612446_S01_1_4_MRP_04000471_1	US22502555_251188612446_S01_1_4_MRP_04000471_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1774.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.6 years	Estrogen Receptor Negative	US22502555_251188612446_S01_1_4_MRP_04000471_1	US22502555_251188612446_S01_1_4_MRP_04000471_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.613.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_2_1_04000323_1_MRP	US22502555_251188611808_S01_2_1_04000323_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247933	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	IGR	89.4%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000323	P-TABM-212	4000323_e1	total_RNA	P-TABM-214	4000323_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.613.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_2_1_04000323_1_MRP	US22502555_251188611808_S01_2_1_04000323_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16A5	57 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	unknown	KAR	83.7%	16.9 years plus	Estrogen Receptor Positive	16.9 years plus	16.9 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000420	P-TABM-212	4000420_e1	total_RNA	P-TABM-214	4000420_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1346.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.9 years plus	16.9 years plus	St Gallen category:not applicable	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612375_S01_2_2_MRP_04000420_1	US22502555_251188612375_S01_2_2_MRP_04000420_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1346.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.9 years plus	16.9 years plus	St Gallen category:not applicable	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612375_S01_2_2_MRP_04000420_1	US22502555_251188612375_S01_2_2_MRP_04000420_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
282C51	55 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	1	KAR	91.5%	2.4 years	Estrogen Receptor Positive	9.9 years plus	9.9 years	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000453	P-TABM-212	4000453_e1	total_RNA	P-TABM-214	4000453_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1034.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.4 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_2_MRP_04000453_1	US22502555_251188612214_S01_2_2_MRP_04000453_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1034.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.4 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188612214_S01_2_2_MRP_04000453_1	US22502555_251188612214_S01_2_2_MRP_04000453_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15H3	33 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	KAR	68.1%	23.9 years plus	Estrogen Receptor Negative	23.9 years plus	23.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000423	P-TABM-212	4000423_e1	total_RNA	P-TABM-214	4000423_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1087.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	23.9 years plus	23.9 years plus	St Gallen category:high clinical risk	23.9 years plus	Estrogen Receptor Negative	US22502555_251188612217_S01_2_1_04000423_1_MRP	US22502555_251188612217_S01_2_1_04000423_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1087.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	23.9 years plus	23.9 years plus	St Gallen category:high clinical risk	23.9 years plus	Estrogen Receptor Negative	US22502555_251188612217_S01_2_1_04000423_1_MRP	US22502555_251188612217_S01_2_1_04000423_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
101B88	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	KAR	81.3%	17.1 years plus	Estrogen Receptor Negative	17.1 years plus	17.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000406	P-TABM-212	4000406_e1	total_RNA	P-TABM-214	4000406_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1161.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612322_S01_1_2_MRP_04000406_1	US22502555_251188612322_S01_1_2_MRP_04000406_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1161.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612322_S01_1_2_MRP_04000406_1	US22502555_251188612322_S01_1_2_MRP_04000406_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2320	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	CRH	80.8%	3.9 years	Estrogen Receptor Positive	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000609	P-TABM-212	4000609_e1	total_RNA	P-TABM-214	4000609_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.929.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.9 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_2_1_04000609_1_MRP	US22502555_251188612202_S01_2_1_04000609_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.929.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.9 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_2_1_04000609_1_MRP	US22502555_251188612202_S01_2_1_04000609_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.87.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.3 years	6.3 years	St Gallen category:high clinical risk	6.4 years	Estrogen Receptor Negative	US22502555_251188611678_S01_2_2_MRP_04000288_1	US22502555_251188611678_S01_2_2_MRP_04000288_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245964	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	78.6%	6.3 years	Estrogen Receptor Negative	6.3 years	6.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000288	P-TABM-212	4000288_e1	total_RNA	P-TABM-214	4000288_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.87.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.3 years	6.3 years	St Gallen category:high clinical risk	6.4 years	Estrogen Receptor Negative	US22502555_251188611678_S01_2_2_MRP_04000288_1	US22502555_251188611678_S01_2_2_MRP_04000288_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
205	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	1	KAR	91.5%	12.4 years plus	Estrogen Receptor Positive	12.4 years plus	12.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000579	P-TABM-212	4000579_e1	total_RNA	P-TABM-214	4000579_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1640.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.4 years plus	12.4 years plus	St Gallen category:low clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_2_1_04000579_1_MRP	US22502555_251188612422_S01_2_1_04000579_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1640.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.4 years plus	12.4 years plus	St Gallen category:low clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_2_1_04000579_1_MRP	US22502555_251188612422_S01_2_1_04000579_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1097.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.8 years plus	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_2_3_04000417_1_MRP	US22502555_251188612217_S01_2_3_04000417_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16C8	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	KAR	83.8%	16.8 years plus	Estrogen Receptor Positive	16.8 years plus	16.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000417	P-TABM-212	4000417_e1	total_RNA	P-TABM-214	4000417_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1097.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.8 years plus	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_2_3_04000417_1_MRP	US22502555_251188612217_S01_2_3_04000417_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.226.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_1_04000342_1_MRP	US22502555_251188611797_S01_2_1_04000342_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255926	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	IGR	81.5%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000342	P-TABM-212	4000342_e1	total_RNA	P-TABM-214	4000342_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.226.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_1_04000342_1_MRP	US22502555_251188611797_S01_2_1_04000342_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2157.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.4 years plus	1.4 years plus	St Gallen category:low clinical risk	1.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_3_04000305_1_MRP	US22502555_251188612773_S01_2_3_04000305_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
287611	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	92.8%	1.4 years plus	Estrogen Receptor Positive	1.4 years plus	1.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000305	P-TABM-212	4000305_e1	total_RNA	P-TABM-214	4000305_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2157.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.4 years plus	1.4 years plus	St Gallen category:low clinical risk	1.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_3_04000305_1_MRP	US22502555_251188612773_S01_2_3_04000305_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.979.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612212_S01_1_3_04000445_1_MRP	US22502555_251188612212_S01_1_3_04000445_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
199B55	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	2	KAR	77.1%	16.2 years plus	Estrogen Receptor Positive	16.2 years plus	16.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000445	P-TABM-212	4000445_e1	total_RNA	P-TABM-214	4000445_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.979.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612212_S01_1_3_04000445_1_MRP	US22502555_251188612212_S01_1_3_04000445_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246166	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	88.6%	14.0 years plus	Estrogen Receptor Positive	14.0 years plus	14.0 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000294	P-TABM-212	4000294_e1	total_RNA	P-TABM-214	4000294_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.107.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_2_MRP_04000294_1	US22502555_251188611679_S01_2_2_MRP_04000294_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.107.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188611679_S01_2_2_MRP_04000294_1	US22502555_251188611679_S01_2_2_MRP_04000294_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2091.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	1.3 years	1.4 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_2_MRP_04000551_1	US22502555_251188612770_S01_1_2_MRP_04000551_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04028	40 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	74.4%	1.3 years	Estrogen Receptor Positive	1.4 years	2.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000551	P-TABM-212	4000551_e1	total_RNA	P-TABM-214	4000551_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2091.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	1.3 years	1.4 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_2_MRP_04000551_1	US22502555_251188612770_S01_1_2_MRP_04000551_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04025	39 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	GUY	90.3%	4.8 years	Estrogen Receptor Positive	4.8 years	8.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000554	P-TABM-212	4000554_e1	total_RNA	P-TABM-214	4000554_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2097.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.8 years	4.8 years	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_4_MRP_04000554_1	US22502555_251188612770_S01_1_4_MRP_04000554_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2097.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.8 years	4.8 years	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_4_MRP_04000554_1	US22502555_251188612770_S01_1_4_MRP_04000554_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280775	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	73.6%	4.8 years plus	Estrogen Receptor Positive	4.8 years plus	4.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000309	P-TABM-212	4000309_e1	total_RNA	P-TABM-214	4000309_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.347.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years plus	4.8 years plus	St Gallen category:high clinical risk	4.8 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_1_04000309_1_MRP	US22502555_251188611801_S01_1_1_04000309_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.347.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years plus	4.8 years plus	St Gallen category:high clinical risk	4.8 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_1_04000309_1_MRP	US22502555_251188611801_S01_1_1_04000309_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1722.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years	7.9 years plus	St Gallen category:high clinical risk	7.9 years	Estrogen Receptor Negative	US22502555_251188612426_S01_2_2_MRP_04000572_1	US22502555_251188612426_S01_2_2_MRP_04000572_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1708	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	KAR	80.8%	7.9 years	Estrogen Receptor Negative	7.9 years plus	7.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000572	P-TABM-212	4000572_e1	total_RNA	P-TABM-214	4000572_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1722.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years	7.9 years plus	St Gallen category:high clinical risk	7.9 years	Estrogen Receptor Negative	US22502555_251188612426_S01_2_2_MRP_04000572_1	US22502555_251188612426_S01_2_2_MRP_04000572_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.969.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_2_3_04000443_1_MRP	US22502555_251188612211_S01_2_3_04000443_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
197B95	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	KAR	84.6%	16.2 years plus	Estrogen Receptor Positive	16.2 years plus	16.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000443	P-TABM-212	4000443_e1	total_RNA	P-TABM-214	4000443_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.969.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	16.2 years plus	16.2 years plus	St Gallen category:high clinical risk	16.2 years plus	Estrogen Receptor Positive	US22502555_251188612211_S01_2_3_04000443_1_MRP	US22502555_251188612211_S01_2_3_04000443_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04070	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	GUY	80.8%	1.9 years	Estrogen Receptor Negative	1.9 years	2.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000517	P-TABM-212	4000517_e1	total_RNA	P-TABM-214	4000517_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1926.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612452_S01_1_3_04000517_1_MRP	US22502555_251188612452_S01_1_3_04000517_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1926.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612452_S01_1_3_04000517_1_MRP	US22502555_251188612452_S01_1_3_04000517_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.830.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years	3.3 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612199_S01_2_3_04000598_1_MRP	US22502555_251188612199_S01_2_3_04000598_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3722	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	2	CRH	70.1%	3.3 years	Estrogen Receptor Positive	3.3 years	4.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000598	P-TABM-212	4000598_e1	total_RNA	P-TABM-214	4000598_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.830.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years	3.3 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612199_S01_2_3_04000598_1_MRP	US22502555_251188612199_S01_2_3_04000598_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5227	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	CRH	58.4%	1.5 years	Estrogen Receptor Negative	1.7 years	3.7 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000588	P-TABM-212	4000588_e1	total_RNA	P-TABM-214	4000588_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1229.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.7 years	St Gallen category:high clinical risk	3.7 years	Estrogen Receptor Negative	US22502555_251188612338_S01_1_2_MRP_04000588_1	US22502555_251188612338_S01_1_2_MRP_04000588_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1229.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.7 years	St Gallen category:high clinical risk	3.7 years	Estrogen Receptor Negative	US22502555_251188612338_S01_1_2_MRP_04000588_1	US22502555_251188612338_S01_1_2_MRP_04000588_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1497.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_2_MRP_04000614_1	US22502555_251188612392_S01_1_2_MRP_04000614_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1970	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	73.8%	11.4 years plus	Estrogen Receptor Positive	11.4 years plus	11.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000614	P-TABM-212	4000614_e1	total_RNA	P-TABM-214	4000614_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1497.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612392_S01_1_2_MRP_04000614_1	US22502555_251188612392_S01_1_2_MRP_04000614_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
320	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	50 mm diameter	3	JRH	63.7%	7.0 years	Estrogen Receptor Negative	8.1 years plus	8.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000688	P-TABM-212	4000688_e1	total_RNA	P-TABM-214	4000688_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2462.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Negative	US22502555_251188612942_S01_2_1_04000688_1_MRP	US22502555_251188612942_S01_2_1_04000688_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2462.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Negative	US22502555_251188612942_S01_2_1_04000688_1_MRP	US22502555_251188612942_S01_2_1_04000688_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219873	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	IGR	60.8%	8.6 years	Estrogen Receptor Negative	8.6 years	9.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000280	P-TABM-212	4000280_e1	total_RNA	P-TABM-214	4000280_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.584.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.6 years	8.6 years	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Negative	US22502555_251188611807_S01_2_3_04000280_1_MRP	US22502555_251188611807_S01_2_3_04000280_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.584.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.6 years	8.6 years	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Negative	US22502555_251188611807_S01_2_3_04000280_1_MRP	US22502555_251188611807_S01_2_3_04000280_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.697.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.7 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611838_S01_2_3_04000291_4_MRP	US22502555_251188611838_S01_2_3_04000291_4_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
308963	45 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	89.2%	2.7 years	Estrogen Receptor Positive	9.7 years plus	9.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000291	P-TABM-212	4000291_e1	total_RNA	P-TABM-214	4000291_e1_l4Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.697.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.7 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611838_S01_2_3_04000291_4_MRP	US22502555_251188611838_S01_2_3_04000291_4_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2085.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	1.3 years	1.4 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_1_04000551_1_MRP	US22502555_251188612770_S01_1_1_04000551_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04028	40 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	74.4%	1.3 years	Estrogen Receptor Positive	1.4 years	2.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000551	P-TABM-212	4000551_e1	total_RNA	P-TABM-214	4000551_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2085.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	1.3 years	1.4 years	St Gallen category:high clinical risk	2.9 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_1_04000551_1_MRP	US22502555_251188612770_S01_1_1_04000551_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1140.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_1_2_MRP_04000263_1	US22502555_251188612320_S01_1_2_MRP_04000263_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
214603	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	2	IGR	85.7%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000263	P-TABM-212	4000263_e1	total_RNA	P-TABM-214	4000263_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1140.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_1_2_MRP_04000263_1	US22502555_251188612320_S01_1_2_MRP_04000263_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
28C76	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	2	KAR	89%	15.8 years plus	Estrogen Receptor Positive	15.8 years plus	15.8 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000450	P-TABM-212	4000450_e1	total_RNA	P-TABM-214	4000450_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1000.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_2_1_04000450_1_MRP	US22502555_251188612213_S01_2_1_04000450_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1000.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_2_1_04000450_1_MRP	US22502555_251188612213_S01_2_1_04000450_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E8	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	KAR	85.5%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000424	P-TABM-212	4000424_e1	total_RNA	P-TABM-214	4000424_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1362.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_2_MRP_04000424_1	US22502555_251188612376_S01_2_2_MRP_04000424_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1362.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_2_MRP_04000424_1	US22502555_251188612376_S01_2_2_MRP_04000424_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
217004	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	3	IGR	63.8%	12.3 years	Estrogen Receptor Negative	15.7 years plus	15.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000266	P-TABM-212	4000266_e1	total_RNA	P-TABM-214	4000266_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.494.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Negative	US22502555_251188611804_S01_2_4_MRP_04000266_1	US22502555_251188611804_S01_2_4_MRP_04000266_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.494.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Negative	US22502555_251188611804_S01_2_4_MRP_04000266_1	US22502555_251188611804_S01_2_4_MRP_04000266_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
121	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	KAR	90.3%	12.5 years plus	Estrogen Receptor Positive	12.5 years plus	12.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000580	P-TABM-212	4000580_e1	total_RNA	P-TABM-214	4000580_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1637.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_1_4_MRP_04000580_1	US22502555_251188612422_S01_1_4_MRP_04000580_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1637.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_1_4_MRP_04000580_1	US22502555_251188612422_S01_1_4_MRP_04000580_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.755.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_1_2_MRP_04000348_2	US22502555_251188611857_S01_1_2_MRP_04000348_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256253	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	86.7%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000348	P-TABM-212	4000348_e1	total_RNA	P-TABM-214	4000348_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.755.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_1_2_MRP_04000348_2	US22502555_251188611857_S01_1_2_MRP_04000348_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
121	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	KAR	90.3%	12.5 years plus	Estrogen Receptor Positive	12.5 years plus	12.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000580	P-TABM-212	4000580_e1	total_RNA	P-TABM-214	4000580_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1634.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_1_3_04000580_1_MRP	US22502555_251188612422_S01_1_3_04000580_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1634.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612422_S01_1_3_04000580_1_MRP	US22502555_251188612422_S01_1_3_04000580_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.622.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.4 years	3.4 years	St Gallen category:high clinical risk	6.7 years	Estrogen Receptor Positive	US22502555_251188611808_S01_2_3_04000324_1_MRP	US22502555_251188611808_S01_2_3_04000324_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
272823	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	29 mm diameter	2	IGR	80.6%	3.4 years	Estrogen Receptor Positive	3.4 years	6.7 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000324	P-TABM-212	4000324_e1	total_RNA	P-TABM-214	4000324_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.622.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.4 years	3.4 years	St Gallen category:high clinical risk	6.7 years	Estrogen Receptor Positive	US22502555_251188611808_S01_2_3_04000324_1_MRP	US22502555_251188611808_S01_2_3_04000324_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2180.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.9 years plus	2.9 years plus	St Gallen category:high clinical risk	2.9 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_1_4_MRP_04000310_2	US22502555_251188612774_S01_1_4_MRP_04000310_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247141	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	IGR	88.9%	2.9 years plus	Estrogen Receptor Positive	2.9 years plus	2.9 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000310	P-TABM-212	4000310_e1	total_RNA	P-TABM-214	4000310_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2180.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.9 years plus	2.9 years plus	St Gallen category:high clinical risk	2.9 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_1_4_MRP_04000310_2	US22502555_251188612774_S01_1_4_MRP_04000310_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1671.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.9 years plus	10.9 years plus	St Gallen category:low clinical risk	10.9 years plus	Estrogen Receptor Positive	US22502555_251188612424_S01_2_3_04000565_1_MRP	US22502555_251188612424_S01_2_3_04000565_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2946	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	KAR	92.8%	10.9 years plus	Estrogen Receptor Positive	10.9 years plus	10.9 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000565	P-TABM-212	4000565_e1	total_RNA	P-TABM-214	4000565_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1671.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.9 years plus	10.9 years plus	St Gallen category:low clinical risk	10.9 years plus	Estrogen Receptor Positive	US22502555_251188612424_S01_2_3_04000565_1_MRP	US22502555_251188612424_S01_2_3_04000565_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2058.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.5 years plus	16.5 years plus	St Gallen category:high clinical risk	16.5 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_2_4_MRP_04000543_1	US22502555_251188612459_S01_2_4_MRP_04000543_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04040	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	73.2%	16.5 years plus	Estrogen Receptor Positive	16.5 years plus	16.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000543	P-TABM-212	4000543_e1	total_RNA	P-TABM-214	4000543_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2058.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.5 years plus	16.5 years plus	St Gallen category:high clinical risk	16.5 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_2_4_MRP_04000543_1	US22502555_251188612459_S01_2_4_MRP_04000543_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.593.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_1_1_04000320_1_MRP	US22502555_251188611808_S01_1_1_04000320_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279847	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	72.6%	9.4 years plus	Estrogen Receptor Positive	9.4 years plus	9.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000320	P-TABM-212	4000320_e1	total_RNA	P-TABM-214	4000320_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.593.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_1_1_04000320_1_MRP	US22502555_251188611808_S01_1_1_04000320_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1297.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_4_MRP_04000415_1	US22502555_251188612373_S01_1_4_MRP_04000415_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16G1	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	89.6%	2.2 years	Estrogen Receptor Positive	2.2 years	4.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000415	P-TABM-212	4000415_e1	total_RNA	P-TABM-214	4000415_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1297.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612373_S01_1_4_MRP_04000415_1	US22502555_251188612373_S01_1_4_MRP_04000415_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E2	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	3	KAR	85.2%	7.0 years plus	Estrogen Receptor Positive	7.0 years plus	7.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000412	P-TABM-212	4000412_e1	total_RNA	P-TABM-214	4000412_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1267.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_2_1_04000412_1_MRP	US22502555_251188612372_S01_2_1_04000412_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1267.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_2_1_04000412_1_MRP	US22502555_251188612372_S01_2_1_04000412_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1373	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	84.5%	0.7 years	Estrogen Receptor Negative	0.7 years	1.1 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000719	P-TABM-212	4000719_e1	total_RNA	P-TABM-214	4000719_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2341.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.1 years	Estrogen Receptor Negative	US22502555_251188612937_S01_2_3_04000719_1_MRP	US22502555_251188612937_S01_2_3_04000719_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2341.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.1 years	Estrogen Receptor Negative	US22502555_251188612937_S01_2_3_04000719_1_MRP	US22502555_251188612937_S01_2_3_04000719_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.869.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_2_4_MRP_04000602_1	US22502555_251188612200_S01_2_4_MRP_04000602_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2514	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	CRH	84.4%	9.4 years plus	Estrogen Receptor Positive	9.4 years plus	9.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000602	P-TABM-212	4000602_e1	total_RNA	P-TABM-214	4000602_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.869.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_2_4_MRP_04000602_1	US22502555_251188612200_S01_2_4_MRP_04000602_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256296	37 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	95.4%	4.9 years	Estrogen Receptor Positive	4.9 years	5.1 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000349	P-TABM-212	4000349_e1	total_RNA	P-TABM-214	4000349_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.126.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.9 years	4.9 years	St Gallen category:low clinical risk	5.1 years plus	Estrogen Receptor Positive	US22502555_251188611681_S01_1_4_MRP_04000349_1	US22502555_251188611681_S01_1_4_MRP_04000349_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.126.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.9 years	4.9 years	St Gallen category:low clinical risk	5.1 years plus	Estrogen Receptor Positive	US22502555_251188611681_S01_1_4_MRP_04000349_1	US22502555_251188611681_S01_1_4_MRP_04000349_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1863.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188612449_S01_2_3_04000506_1_MRP	US22502555_251188612449_S01_2_3_04000506_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04081	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	80%	15.1 years plus	Estrogen Receptor Negative	15.1 years plus	15.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000506	P-TABM-212	4000506_e1	total_RNA	P-TABM-214	4000506_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1863.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188612449_S01_2_3_04000506_1_MRP	US22502555_251188612449_S01_2_3_04000506_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1418.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.5 years	11.5 years	St Gallen category:high clinical risk	14.6 years	Estrogen Receptor Positive	US22502555_251188612379_S01_1_3_04000437_1_MRP	US22502555_251188612379_S01_1_3_04000437_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
144B49	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	2	KAR	81.4%	11.5 years	Estrogen Receptor Positive	11.5 years	14.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000437	P-TABM-212	4000437_e1	total_RNA	P-TABM-214	4000437_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1418.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.5 years	11.5 years	St Gallen category:high clinical risk	14.6 years	Estrogen Receptor Positive	US22502555_251188612379_S01_1_3_04000437_1_MRP	US22502555_251188612379_S01_1_3_04000437_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.688.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.8 years	14.8 years	St Gallen category:high clinical risk	14.8 years plus	Estrogen Receptor Negative	US22502555_251188611837_S01_2_3_04000279_4_MRP	US22502555_251188611837_S01_2_3_04000279_4_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171218	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	64.9%	14.8 years	Estrogen Receptor Negative	14.8 years	14.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000279	P-TABM-212	4000279_e1	total_RNA	P-TABM-214	4000279_e1_l4Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.688.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.8 years	14.8 years	St Gallen category:high clinical risk	14.8 years plus	Estrogen Receptor Negative	US22502555_251188611837_S01_2_3_04000279_4_MRP	US22502555_251188611837_S01_2_3_04000279_4_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2067.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.9 years	15.9 years plus	St Gallen category:high clinical risk	15.9 years	Estrogen Receptor Positive	US22502555_251188612769_S01_1_2_MRP_04000545_1	US22502555_251188612769_S01_1_2_MRP_04000545_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04036	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	GUY	82.1%	15.9 years	Estrogen Receptor Positive	15.9 years plus	15.9 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000545	P-TABM-212	4000545_e1	total_RNA	P-TABM-214	4000545_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2067.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.9 years	15.9 years plus	St Gallen category:high clinical risk	15.9 years	Estrogen Receptor Positive	US22502555_251188612769_S01_1_2_MRP_04000545_1	US22502555_251188612769_S01_1_2_MRP_04000545_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.501.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_2_MRP_04000267_1	US22502555_251188611805_S01_1_2_MRP_04000267_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
217320	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	1	IGR	88.9%	3.3 years plus	Estrogen Receptor Positive	3.3 years plus	3.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000267	P-TABM-212	4000267_e1	total_RNA	P-TABM-214	4000267_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.501.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_2_MRP_04000267_1	US22502555_251188611805_S01_1_2_MRP_04000267_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04054	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	81.5%	0.77 years	Estrogen Receptor Negative	1.19 years	1.83 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000535	P-TABM-212	4000535_e1	total_RNA	P-TABM-214	4000535_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2535.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.77 years	1.19 years	St Gallen category:high clinical risk	1.83 years	Estrogen Receptor Negative	US22502555_251188612911_S01_1_2_MRP_04000535_1	US22502555_251188612911_S01_1_2_MRP_04000535_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2535.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.77 years	1.19 years	St Gallen category:high clinical risk	1.83 years	Estrogen Receptor Negative	US22502555_251188612911_S01_1_2_MRP_04000535_1	US22502555_251188612911_S01_1_2_MRP_04000535_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
544	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	1	JRH	90.3%	11.9 years plus	Estrogen Receptor Positive	11.9 years plus	11.9 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000707	P-TABM-212	4000707_e1	total_RNA	P-TABM-214	4000707_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2397.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:low clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_3_04000707_1_MRP	US22502555_251188612940_S01_1_3_04000707_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2397.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:low clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_3_04000707_1_MRP	US22502555_251188612940_S01_1_3_04000707_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1373	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	84.5%	0.7 years	Estrogen Receptor Negative	0.7 years	1.1 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000719	P-TABM-212	4000719_e1	total_RNA	P-TABM-214	4000719_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2345.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.1 years	Estrogen Receptor Negative	US22502555_251188612937_S01_2_4_MRP_04000719_1	US22502555_251188612937_S01_2_4_MRP_04000719_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2345.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.1 years	Estrogen Receptor Negative	US22502555_251188612937_S01_2_4_MRP_04000719_1	US22502555_251188612937_S01_2_4_MRP_04000719_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.383.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.0 years	14.6 years plus	St Gallen category:high clinical risk	14.6 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_1_04000314_1_MRP	US22502555_251188611802_S01_1_1_04000314_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247243	45 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	80.4%	5.0 years	Estrogen Receptor Positive	14.6 years plus	14.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000314	P-TABM-212	4000314_e1	total_RNA	P-TABM-214	4000314_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.383.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.0 years	14.6 years plus	St Gallen category:high clinical risk	14.6 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_1_04000314_1_MRP	US22502555_251188611802_S01_1_1_04000314_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
531	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	JRH	89.8%	12.0 years plus	Estrogen Receptor Positive	12.0 years plus	12.0 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000704	P-TABM-212	4000704_e1	total_RNA	P-TABM-214	4000704_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2505.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.0 years plus	12.0 years plus	St Gallen category:high clinical risk	12.0 years plus	Estrogen Receptor Positive	US22502555_251188612946_S01_1_3_04000704_1_MRP	US22502555_251188612946_S01_1_3_04000704_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2505.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.0 years plus	12.0 years plus	St Gallen category:high clinical risk	12.0 years plus	Estrogen Receptor Positive	US22502555_251188612946_S01_1_3_04000704_1_MRP	US22502555_251188612946_S01_1_3_04000704_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.730.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.2 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_2_4_MRP_04000327_2	US22502555_251188611855_S01_2_4_MRP_04000327_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254162	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	IGR	74.2%	9.2 years	Estrogen Receptor Positive	14.4 years plus	14.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000327	P-TABM-212	4000327_e1	total_RNA	P-TABM-214	4000327_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.730.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.2 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_2_4_MRP_04000327_2	US22502555_251188611855_S01_2_4_MRP_04000327_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
211980	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	IGR	81%	1.1 years	Estrogen Receptor Negative	2.2 years	3.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000261	P-TABM-212	4000261_e1	total_RNA	P-TABM-214	4000261_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.457.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	2.2 years	St Gallen category:high clinical risk	3.9 years	Estrogen Receptor Negative	US22502555_251188611803_S01_2_4_MRP_04000261_1	US22502555_251188611803_S01_2_4_MRP_04000261_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.457.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	2.2 years	St Gallen category:high clinical risk	3.9 years	Estrogen Receptor Negative	US22502555_251188611803_S01_2_4_MRP_04000261_1	US22502555_251188611803_S01_2_4_MRP_04000261_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1047.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_1_04000455_1_MRP	US22502555_251188612215_S01_1_1_04000455_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279C61	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	3	KAR	82.8%	15.5 years plus	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000455	P-TABM-212	4000455_e1	total_RNA	P-TABM-214	4000455_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1047.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_1_04000455_1_MRP	US22502555_251188612215_S01_1_1_04000455_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1677.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.9 years plus	10.9 years plus	St Gallen category:low clinical risk	10.9 years plus	Estrogen Receptor Positive	US22502555_251188612424_S01_2_4_MRP_04000565_1	US22502555_251188612424_S01_2_4_MRP_04000565_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2946	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	KAR	92.8%	10.9 years plus	Estrogen Receptor Positive	10.9 years plus	10.9 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000565	P-TABM-212	4000565_e1	total_RNA	P-TABM-214	4000565_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1677.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	10.9 years plus	10.9 years plus	St Gallen category:low clinical risk	10.9 years plus	Estrogen Receptor Positive	US22502555_251188612424_S01_2_4_MRP_04000565_1	US22502555_251188612424_S01_2_4_MRP_04000565_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.581.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.3 years	15.4 years plus	St Gallen category:high clinical risk	15.4 years plus	Estrogen Receptor Positive	US22502555_251188611807_S01_2_2_MRP_04000278_1	US22502555_251188611807_S01_2_2_MRP_04000278_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219863	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	87.2%	2.3 years	Estrogen Receptor Positive	15.4 years plus	15.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000278	P-TABM-212	4000278_e1	total_RNA	P-TABM-214	4000278_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.581.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.3 years	15.4 years plus	St Gallen category:high clinical risk	15.4 years plus	Estrogen Receptor Positive	US22502555_251188611807_S01_2_2_MRP_04000278_1	US22502555_251188611807_S01_2_2_MRP_04000278_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2277.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	4.7 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Positive	US22502555_251188612909_S01_1_4_MRP_04000703_1	US22502555_251188612909_S01_1_4_MRP_04000703_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
530	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	JRH	85.7%	2.7 years	Estrogen Receptor Positive	4.7 years	5.8 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000703	P-TABM-212	4000703_e1	total_RNA	P-TABM-214	4000703_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2277.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	4.7 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Positive	US22502555_251188612909_S01_1_4_MRP_04000703_1	US22502555_251188612909_S01_1_4_MRP_04000703_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.986.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_1_1_04000448_1_MRP	US22502555_251188612213_S01_1_1_04000448_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
292C66	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	87.2%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000448	P-TABM-212	4000448_e1	total_RNA	P-TABM-214	4000448_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.986.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_1_1_04000448_1_MRP	US22502555_251188612213_S01_1_1_04000448_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256975	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	81.3%	1.5 years	Estrogen Receptor Negative	1.5 years	2.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000339	P-TABM-212	4000339_e1	total_RNA	P-TABM-214	4000339_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.205.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188611796_S01_2_4_MRP_04000339_1	US22502555_251188611796_S01_2_4_MRP_04000339_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.205.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	1.5 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188611796_S01_2_4_MRP_04000339_1	US22502555_251188611796_S01_2_4_MRP_04000339_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2039	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	CRH	90.3%	7.3 years	Estrogen Receptor Negative	12.7 years	16.5 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000611	P-TABM-212	4000611_e1	total_RNA	P-TABM-214	4000611_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1469.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years	12.7 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Negative	US22502555_251188612389_S01_1_3_04000611_1_MRP	US22502555_251188612389_S01_1_3_04000611_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1469.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years	12.7 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Negative	US22502555_251188612389_S01_1_3_04000611_1_MRP	US22502555_251188612389_S01_1_3_04000611_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
157	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	89.8%	13.5 years	Estrogen Receptor Positive	13.6 years plus	13.6 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000682	P-TABM-212	4000682_e1	total_RNA	P-TABM-214	4000682_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2257.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.5 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612908_S01_1_2_MRP_04000682_1	US22502555_251188612908_S01_1_2_MRP_04000682_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2257.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	13.5 years	13.6 years plus	St Gallen category:high clinical risk	13.6 years plus	Estrogen Receptor Positive	US22502555_251188612908_S01_1_2_MRP_04000682_1	US22502555_251188612908_S01_1_2_MRP_04000682_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
248C91	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	KAR	68.4%	15.8 years plus	Estrogen Receptor Positive	15.8 years plus	15.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000459	P-TABM-212	4000459_e1	total_RNA	P-TABM-214	4000459_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1074.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_1_04000459_1_MRP	US22502555_251188612217_S01_1_1_04000459_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1074.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_1_04000459_1_MRP	US22502555_251188612217_S01_1_1_04000459_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
410j	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	JRH	67.9%	1.5 years	Estrogen Receptor Negative	10.6 years plus	10.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000694	P-TABM-212	4000694_e1	total_RNA	P-TABM-214	4000694_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2469.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_1_1_04000694_1_MRP	US22502555_251188612943_S01_1_1_04000694_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2469.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	10.6 years plus	St Gallen category:high clinical risk	10.6 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_1_1_04000694_1_MRP	US22502555_251188612943_S01_1_1_04000694_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
329	60 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	73.4%	17.2 years plus	Estrogen Receptor Positive	17.2 years plus	17.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000640	P-TABM-212	4000640_e1	total_RNA	P-TABM-214	4000640_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1623.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.2 years plus	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_2_2_MRP_04000640_1	US22502555_251188612421_S01_2_2_MRP_04000640_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1623.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.2 years plus	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_2_2_MRP_04000640_1	US22502555_251188612421_S01_2_2_MRP_04000640_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
440	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	2	KAR	92.4%	4.0 years	Estrogen Receptor Positive	7.1 years	8.8 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000578	P-TABM-212	4000578_e1	total_RNA	P-TABM-214	4000578_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1647.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.0 years	7.1 years	St Gallen category:high clinical risk	8.8 years	Estrogen Receptor Positive	US22502555_251188612422_S01_2_3_04000578_1_MRP	US22502555_251188612422_S01_2_3_04000578_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1647.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.0 years	7.1 years	St Gallen category:high clinical risk	8.8 years	Estrogen Receptor Positive	US22502555_251188612422_S01_2_3_04000578_1_MRP	US22502555_251188612422_S01_2_3_04000578_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1986.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612457_S01_1_1_04000539_1_MRP	US22502555_251188612457_S01_1_1_04000539_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04045	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	45 mm diameter	3	GUY	62.7%	17.1 years plus	Estrogen Receptor Negative	17.1 years plus	17.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000539	P-TABM-212	4000539_e1	total_RNA	P-TABM-214	4000539_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1986.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612457_S01_1_1_04000539_1_MRP	US22502555_251188612457_S01_1_1_04000539_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1303.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:low risk	19.9 years plus	19.9 years plus	St Gallen category:not applicable	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_1_04000432_1_MRP	US22502555_251188612374_S01_2_1_04000432_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D3	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	unknown	KAR	88.9%	19.9 years plus	Estrogen Receptor Positive	19.9 years plus	19.9 years plus	St Gallen category:not applicable	NPI:not applicable	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000432	P-TABM-212	4000432_e1	total_RNA	P-TABM-214	4000432_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1303.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:low risk	19.9 years plus	19.9 years plus	St Gallen category:not applicable	19.9 years plus	Estrogen Receptor Positive	US22502555_251188612374_S01_2_1_04000432_1_MRP	US22502555_251188612374_S01_2_1_04000432_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.246.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_1_04000296_1_MRP	US22502555_251188611798_S01_1_1_04000296_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246295	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	3	IGR	83.8%	10.4 years plus	Estrogen Receptor Positive	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000296	P-TABM-212	4000296_e1	total_RNA	P-TABM-214	4000296_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.246.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_1_04000296_1_MRP	US22502555_251188611798_S01_1_1_04000296_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04047	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	87.2%	8.7 years	Estrogen Receptor Positive	8.7 years	10.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000537	P-TABM-212	4000537_e1	total_RNA	P-TABM-214	4000537_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1983.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.7 years	8.7 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612455_S01_2_2_MRP_04000537_1	US22502555_251188612455_S01_2_2_MRP_04000537_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1983.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.7 years	8.7 years	St Gallen category:high clinical risk	10.0 years	Estrogen Receptor Positive	US22502555_251188612455_S01_2_2_MRP_04000537_1	US22502555_251188612455_S01_2_2_MRP_04000537_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3423	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	KAR	66.6%	13.1 years plus	Estrogen Receptor Negative	13.1 years plus	13.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000562	P-TABM-212	4000562_e1	total_RNA	P-TABM-214	4000562_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1656.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188612424_S01_1_1_04000562_1_MRP	US22502555_251188612424_S01_1_1_04000562_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1656.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188612424_S01_1_1_04000562_1_MRP	US22502555_251188612424_S01_1_1_04000562_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.263.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.7 years plus	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_4_MRP_04000297_1	US22502555_251188611798_S01_1_4_MRP_04000297_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307327	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	85.5%	9.7 years plus	Estrogen Receptor Positive	9.7 years plus	9.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000297	P-TABM-212	4000297_e1	total_RNA	P-TABM-214	4000297_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.263.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.7 years plus	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_4_MRP_04000297_1	US22502555_251188611798_S01_1_4_MRP_04000297_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.997.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	6.0 years plus	St Gallen category:high clinical risk	6.0 years	Estrogen Receptor Negative	US22502555_251188612213_S01_1_4_MRP_04000449_1	US22502555_251188612213_S01_1_4_MRP_04000449_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219C42	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	KAR	81.4%	6.0 years	Estrogen Receptor Negative	6.0 years plus	6.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000449	P-TABM-212	4000449_e1	total_RNA	P-TABM-214	4000449_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.997.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	6.0 years plus	St Gallen category:high clinical risk	6.0 years	Estrogen Receptor Negative	US22502555_251188612213_S01_1_4_MRP_04000449_1	US22502555_251188612213_S01_1_4_MRP_04000449_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04008	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	69%	0.5 years	Estrogen Receptor Positive	18.1 years plus	18.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000480	P-TABM-212	4000480_e1	total_RNA	P-TABM-214	4000480_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1802.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.5 years	18.1 years plus	St Gallen category:high clinical risk	18.1 years plus	Estrogen Receptor Positive	US22502555_251188612447_S01_1_2_MRP_04000480_1	US22502555_251188612447_S01_1_2_MRP_04000480_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1802.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.5 years	18.1 years plus	St Gallen category:high clinical risk	18.1 years plus	Estrogen Receptor Positive	US22502555_251188612447_S01_1_2_MRP_04000480_1	US22502555_251188612447_S01_1_2_MRP_04000480_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1631.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.7 years	4.9 years plus	St Gallen category:high clinical risk	4.9 years plus	Estrogen Receptor Negative	US22502555_251188612422_S01_1_2_MRP_04000581_1	US22502555_251188612422_S01_1_2_MRP_04000581_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5240	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	67.7%	3.7 years	Estrogen Receptor Negative	4.9 years plus	4.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000581	P-TABM-212	4000581_e1	total_RNA	P-TABM-214	4000581_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1631.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.7 years	4.9 years plus	St Gallen category:high clinical risk	4.9 years plus	Estrogen Receptor Negative	US22502555_251188612422_S01_1_2_MRP_04000581_1	US22502555_251188612422_S01_1_2_MRP_04000581_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2230.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.8 years	1.8 years	St Gallen category:high clinical risk	2.8 years	Estrogen Receptor Positive	US22502555_251188612907_S01_1_3_04000679_1_MRP	US22502555_251188612907_S01_1_3_04000679_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
104	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	31 mm diameter	3	JRH	59.9%	1.8 years	Estrogen Receptor Positive	1.8 years	2.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000679	P-TABM-212	4000679_e1	total_RNA	P-TABM-214	4000679_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2230.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.8 years	1.8 years	St Gallen category:high clinical risk	2.8 years	Estrogen Receptor Positive	US22502555_251188612907_S01_1_3_04000679_1_MRP	US22502555_251188612907_S01_1_3_04000679_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2027	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	2	KAR	89%	14.8 years	Estrogen Receptor Positive	15.1 years plus	15.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000570	P-TABM-212	4000570_e1	total_RNA	P-TABM-214	4000570_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1714.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.8 years	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_1_2_MRP_04000570_1	US22502555_251188612426_S01_1_2_MRP_04000570_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1714.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	14.8 years	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Positive	US22502555_251188612426_S01_1_2_MRP_04000570_1	US22502555_251188612426_S01_1_2_MRP_04000570_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1517.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_4_MRP_04000617_1	US22502555_251188612392_S01_2_4_MRP_04000617_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1917	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	66.4%	12.3 years plus	Estrogen Receptor Negative	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000617	P-TABM-212	4000617_e1	total_RNA	P-TABM-214	4000617_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1517.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Negative	US22502555_251188612392_S01_2_4_MRP_04000617_1	US22502555_251188612392_S01_2_4_MRP_04000617_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16B5	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	KAR	81.5%	2.5 years	Estrogen Receptor Negative	3.6 years	4.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000418	P-TABM-212	4000418_e1	total_RNA	P-TABM-214	4000418_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1326.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.5 years	3.6 years	St Gallen category:high clinical risk	4.3 years	Estrogen Receptor Negative	US22502555_251188612375_S01_1_2_MRP_04000418_1	US22502555_251188612375_S01_1_2_MRP_04000418_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1326.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.5 years	3.6 years	St Gallen category:high clinical risk	4.3 years	Estrogen Receptor Negative	US22502555_251188612375_S01_1_2_MRP_04000418_1	US22502555_251188612375_S01_1_2_MRP_04000418_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.470.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	2.8 years	St Gallen category:high clinical risk	4.8 years	Estrogen Receptor Positive	US22502555_251188611804_S01_1_3_04000264_1_MRP	US22502555_251188611804_S01_1_3_04000264_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
216806	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	IGR	74.2%	2.8 years	Estrogen Receptor Positive	2.8 years	4.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000264	P-TABM-212	4000264_e1	total_RNA	P-TABM-214	4000264_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.470.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	2.8 years	St Gallen category:high clinical risk	4.8 years	Estrogen Receptor Positive	US22502555_251188611804_S01_1_3_04000264_1_MRP	US22502555_251188611804_S01_1_3_04000264_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1481	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	2	CRH	67.1%	11.4 years plus	Estrogen Receptor Positive	11.4 years plus	11.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000630	P-TABM-212	4000630_e1	total_RNA	P-TABM-214	4000630_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.768.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_1_1_04000630_1_MRP	US22502555_251188612196_S01_1_1_04000630_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.768.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.4 years plus	11.4 years plus	St Gallen category:high clinical risk	11.4 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_1_1_04000630_1_MRP	US22502555_251188612196_S01_1_1_04000630_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.185.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_4_MRP_04000336_1	US22502555_251188611796_S01_1_4_MRP_04000336_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255627	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	87.2%	13.3 years plus	Estrogen Receptor Positive	13.3 years plus	13.3 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000336	P-TABM-212	4000336_e1	total_RNA	P-TABM-214	4000336_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.185.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_4_MRP_04000336_1	US22502555_251188611796_S01_1_4_MRP_04000336_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1574.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.0 years plus	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Negative	US22502555_251188612394_S01_2_2_MRP_04000624_1	US22502555_251188612394_S01_2_2_MRP_04000624_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1568	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	3	CRH	61.5%	13.0 years plus	Estrogen Receptor Negative	13.0 years plus	13.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000624	P-TABM-212	4000624_e1	total_RNA	P-TABM-214	4000624_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1574.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.0 years plus	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Negative	US22502555_251188612394_S01_2_2_MRP_04000624_1	US22502555_251188612394_S01_2_2_MRP_04000624_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1371.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years	17.5 years plus	St Gallen category:high clinical risk	17.5 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_4_MRP_04000425_1	US22502555_251188612376_S01_2_4_MRP_04000425_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E7	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	unknown	KAR	78.6%	13.6 years	Estrogen Receptor Positive	17.5 years plus	17.5 years plus	Adjuvant online:high clinical risk	NPI:not applicable	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000425	P-TABM-212	4000425_e1	total_RNA	P-TABM-214	4000425_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1371.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years	17.5 years plus	St Gallen category:high clinical risk	17.5 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_4_MRP_04000425_1	US22502555_251188612376_S01_2_4_MRP_04000425_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2154.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.3 years plus	10.3 years plus	St Gallen category:high clinical risk	10.3 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_2_MRP_04000293_1	US22502555_251188612773_S01_2_2_MRP_04000293_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307829	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	2	IGR	80.8%	10.3 years plus	Estrogen Receptor Positive	10.3 years plus	10.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000293	P-TABM-212	4000293_e1	total_RNA	P-TABM-214	4000293_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2154.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.3 years plus	10.3 years plus	St Gallen category:high clinical risk	10.3 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_2_MRP_04000293_1	US22502555_251188612773_S01_2_2_MRP_04000293_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04025	39 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	GUY	90.3%	4.8 years	Estrogen Receptor Positive	4.8 years	8.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000554	P-TABM-212	4000554_e1	total_RNA	P-TABM-214	4000554_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2094.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.8 years	4.8 years	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_3_04000554_1_MRP	US22502555_251188612770_S01_1_3_04000554_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2094.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.8 years	4.8 years	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612770_S01_1_3_04000554_1_MRP	US22502555_251188612770_S01_1_3_04000554_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2260.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.6 years	4.6 years	St Gallen category:high clinical risk	8.2 years	Estrogen Receptor Negative	US22502555_251188612908_S01_1_3_04000683_1_MRP	US22502555_251188612908_S01_1_3_04000683_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
194	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	3	JRH	66.6%	4.6 years	Estrogen Receptor Negative	4.6 years	8.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000683	P-TABM-212	4000683_e1	total_RNA	P-TABM-214	4000683_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2260.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.6 years	4.6 years	St Gallen category:high clinical risk	8.2 years	Estrogen Receptor Negative	US22502555_251188612908_S01_1_3_04000683_1_MRP	US22502555_251188612908_S01_1_3_04000683_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.276.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.3 years plus	4.3 years plus	St Gallen category:high clinical risk	4.3 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_3_04000299_1_MRP	US22502555_251188611798_S01_2_3_04000299_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307251	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	67.6%	4.3 years plus	Estrogen Receptor Negative	4.3 years plus	4.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000299	P-TABM-212	4000299_e1	total_RNA	P-TABM-214	4000299_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.276.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.3 years plus	4.3 years plus	St Gallen category:high clinical risk	4.3 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_3_04000299_1_MRP	US22502555_251188611798_S01_2_3_04000299_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255627	51 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	87.2%	13.3 years plus	Estrogen Receptor Positive	13.3 years plus	13.3 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000336	P-TABM-212	4000336_e1	total_RNA	P-TABM-214	4000336_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.178.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_3_04000336_1_MRP	US22502555_251188611796_S01_1_3_04000336_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.178.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_1_3_04000336_1_MRP	US22502555_251188611796_S01_1_3_04000336_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255461	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	66.9%	3.3 years plus	Estrogen Receptor Negative	3.3 years plus	3.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000333	P-TABM-212	4000333_e1	total_RNA	P-TABM-214	4000333_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.156.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Negative	US22502555_251188611795_S01_2_2_MRP_04000333_1	US22502555_251188611795_S01_2_2_MRP_04000333_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.156.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Negative	US22502555_251188611795_S01_2_2_MRP_04000333_1	US22502555_251188611795_S01_2_2_MRP_04000333_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
447	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	JRH	90.9%	8.7 years plus	Estrogen Receptor Negative	8.7 years plus	8.7 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000697	P-TABM-212	4000697_e1	total_RNA	P-TABM-214	4000697_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2486.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.7 years plus	8.7 years plus	St Gallen category:high clinical risk	8.7 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_2_4_MRP_04000697_1	US22502555_251188612943_S01_2_4_MRP_04000697_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2486.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.7 years plus	8.7 years plus	St Gallen category:high clinical risk	8.7 years plus	Estrogen Receptor Negative	US22502555_251188612943_S01_2_4_MRP_04000697_1	US22502555_251188612943_S01_2_4_MRP_04000697_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
216806	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	IGR	74.2%	2.8 years	Estrogen Receptor Positive	2.8 years	4.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000264	P-TABM-212	4000264_e1	total_RNA	P-TABM-214	4000264_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.477.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	2.8 years	St Gallen category:high clinical risk	4.8 years	Estrogen Receptor Positive	US22502555_251188611804_S01_1_4_MRP_04000264_1	US22502555_251188611804_S01_1_4_MRP_04000264_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.477.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	2.8 years	St Gallen category:high clinical risk	4.8 years	Estrogen Receptor Positive	US22502555_251188611804_S01_1_4_MRP_04000264_1	US22502555_251188611804_S01_1_4_MRP_04000264_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2192.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_1_2_MRP_04000345_1	US22502555_251188612775_S01_1_2_MRP_04000345_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256818	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	87.2%	10.2 years plus	Estrogen Receptor Positive	10.2 years plus	10.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000345	P-TABM-212	4000345_e1	total_RNA	P-TABM-214	4000345_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2192.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_1_2_MRP_04000345_1	US22502555_251188612775_S01_1_2_MRP_04000345_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1901.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	3.2 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188612451_S01_1_2_MRP_04000513_1	US22502555_251188612451_S01_1_2_MRP_04000513_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04074	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	62.1%	0.3 years	Estrogen Receptor Negative	3.2 years	4.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000513	P-TABM-212	4000513_e1	total_RNA	P-TABM-214	4000513_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1901.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.3 years	3.2 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188612451_S01_1_2_MRP_04000513_1	US22502555_251188612451_S01_1_2_MRP_04000513_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5226	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	2	CRH	89.2%	19.1 years	Estrogen Receptor Positive	19.2 years plus	19.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000589	P-TABM-212	4000589_e1	total_RNA	P-TABM-214	4000589_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1232.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	19.1 years	19.2 years plus	St Gallen category:high clinical risk	19.2 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_1_3_04000589_1_MRP	US22502555_251188612338_S01_1_3_04000589_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1232.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	19.1 years	19.2 years plus	St Gallen category:high clinical risk	19.2 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_1_3_04000589_1_MRP	US22502555_251188612338_S01_1_3_04000589_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.139.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_3_04000332_1_MRP	US22502555_251188611795_S01_1_3_04000332_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271834	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	90.4%	12.2 years plus	Estrogen Receptor Positive	12.2 years plus	12.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000332	P-TABM-212	4000332_e1	total_RNA	P-TABM-214	4000332_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.139.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_3_04000332_1_MRP	US22502555_251188611795_S01_1_3_04000332_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04077	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	GUY	90.9%	4.3 years	Estrogen Receptor Positive	7.0 years	9.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000510	P-TABM-212	4000510_e1	total_RNA	P-TABM-214	4000510_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1876.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.3 years	7.0 years	St Gallen category:high clinical risk	9.1 years	Estrogen Receptor Positive	US22502555_251188612450_S01_1_3_04000510_1_MRP	US22502555_251188612450_S01_1_3_04000510_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1876.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.3 years	7.0 years	St Gallen category:high clinical risk	9.1 years	Estrogen Receptor Positive	US22502555_251188612450_S01_1_3_04000510_1_MRP	US22502555_251188612450_S01_1_3_04000510_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1394.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_2_MRP_04000428_1	US22502555_251188612377_S01_2_2_MRP_04000428_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15D7	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	88.9%	13.7 years plus	Estrogen Receptor Positive	13.7 years plus	13.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000428	P-TABM-212	4000428_e1	total_RNA	P-TABM-214	4000428_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1394.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.7 years plus	13.7 years plus	St Gallen category:high clinical risk	13.7 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_2_MRP_04000428_1	US22502555_251188612377_S01_2_2_MRP_04000428_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04046	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	78.3%	7.8 years	Estrogen Receptor Negative	11.1 years	12.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000538	P-TABM-212	4000538_e1	total_RNA	P-TABM-214	4000538_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2106.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.8 years	11.1 years	St Gallen category:high clinical risk	12.0 years	Estrogen Receptor Negative	US22502555_251188612770_S01_2_2_MRP_04000538_1	US22502555_251188612770_S01_2_2_MRP_04000538_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2106.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.8 years	11.1 years	St Gallen category:high clinical risk	12.0 years	Estrogen Receptor Negative	US22502555_251188612770_S01_2_2_MRP_04000538_1	US22502555_251188612770_S01_2_2_MRP_04000538_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219873	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	IGR	60.8%	8.6 years	Estrogen Receptor Negative	8.6 years	9.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000280	P-TABM-212	4000280_e1	total_RNA	P-TABM-214	4000280_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.590.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.6 years	8.6 years	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Negative	US22502555_251188611807_S01_2_4_MRP_04000280_1	US22502555_251188611807_S01_2_4_MRP_04000280_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.590.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.6 years	8.6 years	St Gallen category:high clinical risk	9.1 years plus	Estrogen Receptor Negative	US22502555_251188611807_S01_2_4_MRP_04000280_1	US22502555_251188611807_S01_2_4_MRP_04000280_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280391	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	78.1%	2.0 years	Estrogen Receptor Positive	12.2 years plus	12.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000313	P-TABM-212	4000313_e1	total_RNA	P-TABM-214	4000313_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.380.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_4_MRP_04000313_1	US22502555_251188611801_S01_2_4_MRP_04000313_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.380.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_4_MRP_04000313_1	US22502555_251188611801_S01_2_4_MRP_04000313_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.285.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.7 years plus	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_1_04000300_1_MRP	US22502555_251188611799_S01_1_1_04000300_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246381	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	3	IGR	84.9%	7.7 years plus	Estrogen Receptor Positive	7.7 years plus	7.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000300	P-TABM-212	4000300_e1	total_RNA	P-TABM-214	4000300_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.285.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.7 years plus	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_1_04000300_1_MRP	US22502555_251188611799_S01_1_1_04000300_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.668.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.0 years plus	3.0 years plus	St Gallen category:high clinical risk	3.0 years plus	Estrogen Receptor Positive	US22502555_251188611836_S01_2_3_04000282_1_MRP	US22502555_251188611836_S01_2_3_04000282_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245392	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	IGR	87%	3.0 years plus	Estrogen Receptor Positive	3.0 years plus	3.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000282	P-TABM-212	4000282_e1	total_RNA	P-TABM-214	4000282_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.668.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.0 years plus	3.0 years plus	St Gallen category:high clinical risk	3.0 years plus	Estrogen Receptor Positive	US22502555_251188611836_S01_2_3_04000282_1_MRP	US22502555_251188611836_S01_2_3_04000282_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5232	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	3	CRH	62.7%	1.1 years	Estrogen Receptor Negative	1.1 years	3.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000584	P-TABM-212	4000584_e1	total_RNA	P-TABM-214	4000584_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1197.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	3.4 years	Estrogen Receptor Negative	US22502555_251188612337_S01_1_2_MRP_04000584_1	US22502555_251188612337_S01_1_2_MRP_04000584_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1197.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	3.4 years	Estrogen Receptor Negative	US22502555_251188612337_S01_1_2_MRP_04000584_1	US22502555_251188612337_S01_1_2_MRP_04000584_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2148.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.3 years plus	10.3 years plus	St Gallen category:high clinical risk	10.3 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_1_04000293_1_MRP	US22502555_251188612773_S01_2_1_04000293_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307829	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	2	IGR	80.8%	10.3 years plus	Estrogen Receptor Positive	10.3 years plus	10.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000293	P-TABM-212	4000293_e1	total_RNA	P-TABM-214	4000293_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2148.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.3 years plus	10.3 years plus	St Gallen category:high clinical risk	10.3 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_1_04000293_1_MRP	US22502555_251188612773_S01_2_1_04000293_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.823.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612198_S01_2_3_04000637_1_MRP	US22502555_251188612198_S01_2_3_04000637_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1153	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	71.1%	14.0 years plus	Estrogen Receptor Positive	14.0 years plus	14.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000637	P-TABM-212	4000637_e1	total_RNA	P-TABM-214	4000637_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.823.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612198_S01_2_3_04000637_1_MRP	US22502555_251188612198_S01_2_3_04000637_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
37	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	JRH	84.5%	8.5 years	Estrogen Receptor Negative	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000676	P-TABM-212	4000676_e1	total_RNA	P-TABM-214	4000676_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2216.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.5 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_1_04000676_1_MRP	US22502555_251188612906_S01_2_1_04000676_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2216.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.5 years	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_1_04000676_1_MRP	US22502555_251188612906_S01_2_1_04000676_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2743	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	KAR	66.9%	11.7 years plus	Estrogen Receptor Negative	11.7 years plus	11.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000567	P-TABM-212	4000567_e1	total_RNA	P-TABM-214	4000567_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1693.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years plus	11.7 years plus	St Gallen category:high clinical risk	11.7 years plus	Estrogen Receptor Negative	US22502555_251188612425_S01_1_4_MRP_04000567_1	US22502555_251188612425_S01_1_4_MRP_04000567_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1693.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years plus	11.7 years plus	St Gallen category:high clinical risk	11.7 years plus	Estrogen Receptor Negative	US22502555_251188612425_S01_1_4_MRP_04000567_1	US22502555_251188612425_S01_1_4_MRP_04000567_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.619.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_2_2_MRP_04000323_1	US22502555_251188611808_S01_2_2_MRP_04000323_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247933	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	IGR	89.4%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000323	P-TABM-212	4000323_e1	total_RNA	P-TABM-214	4000323_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.619.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188611808_S01_2_2_MRP_04000323_1	US22502555_251188611808_S01_2_2_MRP_04000323_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1659.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188612424_S01_1_2_MRP_04000562_1	US22502555_251188612424_S01_1_2_MRP_04000562_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3423	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	KAR	66.6%	13.1 years plus	Estrogen Receptor Negative	13.1 years plus	13.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000562	P-TABM-212	4000562_e1	total_RNA	P-TABM-214	4000562_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1659.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Negative	US22502555_251188612424_S01_1_2_MRP_04000562_1	US22502555_251188612424_S01_1_2_MRP_04000562_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
278C80	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	KAR	79.8%	15.5 years plus	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000456	P-TABM-212	4000456_e1	total_RNA	P-TABM-214	4000456_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1058.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_4_MRP_04000456_1	US22502555_251188612215_S01_1_4_MRP_04000456_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1058.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_1_4_MRP_04000456_1	US22502555_251188612215_S01_1_4_MRP_04000456_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1845.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_2_MRP_04000501_1	US22502555_251188612449_S01_1_2_MRP_04000501_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04088	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	GUY	65.2%	12.8 years plus	Estrogen Receptor Positive	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000501	P-TABM-212	4000501_e1	total_RNA	P-TABM-214	4000501_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1845.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_2_MRP_04000501_1	US22502555_251188612449_S01_1_2_MRP_04000501_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04070	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	GUY	80.8%	1.9 years	Estrogen Receptor Negative	1.9 years	2.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000517	P-TABM-212	4000517_e1	total_RNA	P-TABM-214	4000517_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1929.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612452_S01_1_4_MRP_04000517_1	US22502555_251188612452_S01_1_4_MRP_04000517_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1929.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	2.5 years	Estrogen Receptor Negative	US22502555_251188612452_S01_1_4_MRP_04000517_1	US22502555_251188612452_S01_1_4_MRP_04000517_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
166154	30 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	45 mm diameter	2	IGR	65.3%	15.4 years	Estrogen Receptor Positive	19.3 years plus	19.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000257	P-TABM-212	4000257_e1	total_RNA	P-TABM-214	4000257_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2131.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.4 years	19.3 years plus	St Gallen category:high clinical risk	19.3 years plus	Estrogen Receptor Positive	US22502555_251188612772_S01_2_2_MRP_04000257_1	US22502555_251188612772_S01_2_2_MRP_04000257_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2131.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.4 years	19.3 years plus	St Gallen category:high clinical risk	19.3 years plus	Estrogen Receptor Positive	US22502555_251188612772_S01_2_2_MRP_04000257_1	US22502555_251188612772_S01_2_2_MRP_04000257_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.675.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.0 years plus	3.0 years plus	St Gallen category:high clinical risk	3.0 years plus	Estrogen Receptor Positive	US22502555_251188611836_S01_2_4_MRP_04000282_1	US22502555_251188611836_S01_2_4_MRP_04000282_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245392	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	IGR	87%	3.0 years plus	Estrogen Receptor Positive	3.0 years plus	3.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000282	P-TABM-212	4000282_e1	total_RNA	P-TABM-214	4000282_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.675.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.0 years plus	3.0 years plus	St Gallen category:high clinical risk	3.0 years plus	Estrogen Receptor Positive	US22502555_251188611836_S01_2_4_MRP_04000282_1	US22502555_251188611836_S01_2_4_MRP_04000282_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.659.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.7 years	4.7 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611809_S01_2_3_04000330_1_MRP	US22502555_251188611809_S01_2_3_04000330_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271982	49 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	83.2%	4.7 years	Estrogen Receptor Positive	4.7 years	5.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000330	P-TABM-212	4000330_e1	total_RNA	P-TABM-214	4000330_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.659.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.7 years	4.7 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611809_S01_2_3_04000330_1_MRP	US22502555_251188611809_S01_2_3_04000330_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.467.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.7 years	3.8 years plus	St Gallen category:high clinical risk	3.8 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_1_2_MRP_04000262_1	US22502555_251188611804_S01_1_2_MRP_04000262_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
214437	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	83.1%	3.7 years	Estrogen Receptor Positive	3.8 years plus	3.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000262	P-TABM-212	4000262_e1	total_RNA	P-TABM-214	4000262_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.467.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.7 years	3.8 years plus	St Gallen category:high clinical risk	3.8 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_1_2_MRP_04000262_1	US22502555_251188611804_S01_1_2_MRP_04000262_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2347	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	CRH	89.8%	3.7 years plus	Estrogen Receptor Positive	3.7 years plus	3.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000607	P-TABM-212	4000607_e1	total_RNA	P-TABM-214	4000607_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.910.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.7 years plus	3.7 years plus	St Gallen category:high clinical risk	3.7 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_1_04000607_1_MRP	US22502555_251188612202_S01_1_1_04000607_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.910.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.7 years plus	3.7 years plus	St Gallen category:high clinical risk	3.7 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_1_04000607_1_MRP	US22502555_251188612202_S01_1_1_04000607_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1755.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	1.3 years	Estrogen Receptor Negative	US22502555_251188612427_S01_2_3_04000577_1_MRP	US22502555_251188612427_S01_2_3_04000577_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1000	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	2	KAR	65.3%	1.1 years	Estrogen Receptor Negative	1.1 years	1.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000577	P-TABM-212	4000577_e1	total_RNA	P-TABM-214	4000577_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1755.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	1.3 years	Estrogen Receptor Negative	US22502555_251188612427_S01_2_3_04000577_1_MRP	US22502555_251188612427_S01_2_3_04000577_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
214437	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	83.1%	3.7 years	Estrogen Receptor Positive	3.8 years plus	3.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000262	P-TABM-212	4000262_e1	total_RNA	P-TABM-214	4000262_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.460.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.7 years	3.8 years plus	St Gallen category:high clinical risk	3.8 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_1_1_04000262_1_MRP	US22502555_251188611804_S01_1_1_04000262_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.460.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	3.7 years	3.8 years plus	St Gallen category:high clinical risk	3.8 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_1_1_04000262_1_MRP	US22502555_251188611804_S01_1_1_04000262_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1450.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.4 years plus	16.4 years plus	St Gallen category:high clinical risk	16.4 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_2_3_04000638_1_MRP	US22502555_251188612388_S01_2_3_04000638_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
535c	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	27 mm diameter	2	CRH	66.2%	16.4 years plus	Estrogen Receptor Negative	16.4 years plus	16.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000638	P-TABM-212	4000638_e1	total_RNA	P-TABM-214	4000638_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1450.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.4 years plus	16.4 years plus	St Gallen category:high clinical risk	16.4 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_2_3_04000638_1_MRP	US22502555_251188612388_S01_2_3_04000638_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.891.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.3 years	10.6 years plus	St Gallen category:not applicable	10.6 years plus	unknown	US22502555_251188612201_S01_2_1_04000605_1_MRP	US22502555_251188612201_S01_2_1_04000605_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2378	60 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	unknown	CRH	79.7%	2.3 years	unknown	10.6 years plus	10.6 years plus	MammaPrint result:high risk	NPI:not applicable	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000605	P-TABM-212	4000605_e1	total_RNA	P-TABM-214	4000605_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.891.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.3 years	10.6 years plus	St Gallen category:not applicable	10.6 years plus	unknown	US22502555_251188612201_S01_2_1_04000605_1_MRP	US22502555_251188612201_S01_2_1_04000605_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1365.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years	17.5 years plus	St Gallen category:high clinical risk	17.5 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_3_04000425_1_MRP	US22502555_251188612376_S01_2_3_04000425_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E7	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	unknown	KAR	78.6%	13.6 years	Estrogen Receptor Positive	17.5 years plus	17.5 years plus	Adjuvant online:high clinical risk	NPI:not applicable	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000425	P-TABM-212	4000425_e1	total_RNA	P-TABM-214	4000425_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1365.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.6 years	17.5 years plus	St Gallen category:high clinical risk	17.5 years plus	Estrogen Receptor Positive	US22502555_251188612376_S01_2_3_04000425_1_MRP	US22502555_251188612376_S01_2_3_04000425_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255461	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	66.9%	3.3 years plus	Estrogen Receptor Negative	3.3 years plus	3.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000333	P-TABM-212	4000333_e1	total_RNA	P-TABM-214	4000333_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.149.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Negative	US22502555_251188611795_S01_2_1_04000333_1_MRP	US22502555_251188611795_S01_2_1_04000333_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.149.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years plus	3.3 years plus	St Gallen category:high clinical risk	3.3 years plus	Estrogen Receptor Negative	US22502555_251188611795_S01_2_1_04000333_1_MRP	US22502555_251188611795_S01_2_1_04000333_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04065	36 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	74.8%	15.5 years plus	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000522	P-TABM-212	4000522_e1	total_RNA	P-TABM-214	4000522_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1944.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_3_04000522_1_MRP	US22502555_251188612453_S01_1_3_04000522_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1944.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_3_04000522_1_MRP	US22502555_251188612453_S01_1_3_04000522_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.837.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years	3.3 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612199_S01_2_4_MRP_04000598_1	US22502555_251188612199_S01_2_4_MRP_04000598_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3722	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	2	CRH	70.1%	3.3 years	Estrogen Receptor Positive	3.3 years	4.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000598	P-TABM-212	4000598_e1	total_RNA	P-TABM-214	4000598_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.837.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.3 years	3.3 years	St Gallen category:high clinical risk	4.9 years	Estrogen Receptor Positive	US22502555_251188612199_S01_2_4_MRP_04000598_1	US22502555_251188612199_S01_2_4_MRP_04000598_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1339.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.9 years plus	16.9 years plus	St Gallen category:not applicable	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612375_S01_2_1_04000420_1_MRP	US22502555_251188612375_S01_2_1_04000420_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16A5	57 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	unknown	KAR	83.7%	16.9 years plus	Estrogen Receptor Positive	16.9 years plus	16.9 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000420	P-TABM-212	4000420_e1	total_RNA	P-TABM-214	4000420_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1339.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.9 years plus	16.9 years plus	St Gallen category:not applicable	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612375_S01_2_1_04000420_1_MRP	US22502555_251188612375_S01_2_1_04000420_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.136.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.1 years plus	9.1 years plus	St Gallen category:low clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_2_MRP_04000331_1	US22502555_251188611795_S01_1_2_MRP_04000331_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255160	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	1	IGR	92.4%	9.1 years plus	Estrogen Receptor Positive	9.1 years plus	9.1 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000331	P-TABM-212	4000331_e1	total_RNA	P-TABM-214	4000331_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.136.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.1 years plus	9.1 years plus	St Gallen category:low clinical risk	9.1 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_2_MRP_04000331_1	US22502555_251188611795_S01_1_2_MRP_04000331_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171260	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	3	IGR	63.2%	14.7 years plus	Estrogen Receptor Negative	14.7 years plus	14.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000298	P-TABM-212	4000298_e1	total_RNA	P-TABM-214	4000298_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.273.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_2_MRP_04000298_1	US22502555_251188611798_S01_2_2_MRP_04000298_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.273.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Negative	US22502555_251188611798_S01_2_2_MRP_04000298_1	US22502555_251188611798_S01_2_2_MRP_04000298_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
136B04	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	2	KAR	85.7%	2.4 years	Estrogen Receptor Positive	16.8 years plus	16.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000434	P-TABM-212	4000434_e1	total_RNA	P-TABM-214	4000434_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1403.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.4 years	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612378_S01_1_1_04000434_1_MRP	US22502555_251188612378_S01_1_1_04000434_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1403.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.4 years	16.8 years plus	St Gallen category:high clinical risk	16.8 years plus	Estrogen Receptor Positive	US22502555_251188612378_S01_1_1_04000434_1_MRP	US22502555_251188612378_S01_1_1_04000434_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.796.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612196_S01_2_3_04000633_1_MRP	US22502555_251188612196_S01_2_3_04000633_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1246c	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	CRH	63.3%	17.1 years plus	Estrogen Receptor Negative	17.1 years plus	17.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000633	P-TABM-212	4000633_e1	total_RNA	P-TABM-214	4000633_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.796.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612196_S01_2_3_04000633_1_MRP	US22502555_251188612196_S01_2_3_04000633_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.305.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611799_S01_2_1_04000302_1_MRP	US22502555_251188611799_S01_2_1_04000302_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246560	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	IGR	84.4%	9.0 years plus	Estrogen Receptor Negative	9.0 years plus	9.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000302	P-TABM-212	4000302_e1	total_RNA	P-TABM-214	4000302_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.305.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611799_S01_2_1_04000302_1_MRP	US22502555_251188611799_S01_2_1_04000302_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04073	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	GUY	87.2%	8.0 years	Estrogen Receptor Positive	8.0 years plus	8.0 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000514	P-TABM-212	4000514_e1	total_RNA	P-TABM-214	4000514_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1904.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.0 years	8.0 years plus	St Gallen category:high clinical risk	8.0 years	Estrogen Receptor Positive	US22502555_251188612451_S01_1_3_04000514_1_MRP	US22502555_251188612451_S01_1_3_04000514_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1904.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.0 years	8.0 years plus	St Gallen category:high clinical risk	8.0 years	Estrogen Receptor Positive	US22502555_251188612451_S01_1_3_04000514_1_MRP	US22502555_251188612451_S01_1_3_04000514_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2227.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.0 years	12.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_4_04000677_1_MRP	US22502555_251188612906_S01_2_4_04000677_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
57	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	83.8%	12.0 years	Estrogen Receptor Negative	12.1 years	12.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000677	P-TABM-212	4000677_e1	total_RNA	P-TABM-214	4000677_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2227.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.0 years	12.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Negative	US22502555_251188612906_S01_2_4_04000677_1_MRP	US22502555_251188612906_S01_2_4_04000677_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04066	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	GUY	93.4%	15.7 years plus	Estrogen Receptor Positive	15.7 years plus	15.7 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000521	P-TABM-212	4000521_e1	total_RNA	P-TABM-214	4000521_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1938.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:low clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_1_04000521_1_MRP	US22502555_251188612453_S01_1_1_04000521_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1938.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:low clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_1_04000521_1_MRP	US22502555_251188612453_S01_1_1_04000521_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1173.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_1_04000582_1_MRP	US22502555_251188612335_S01_2_1_04000582_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5236	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	CRH	89.6%	7.5 years plus	Estrogen Receptor Positive	7.5 years plus	7.5 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000582	P-TABM-212	4000582_e1	total_RNA	P-TABM-214	4000582_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1173.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	7.5 years plus	7.5 years plus	St Gallen category:high clinical risk	7.5 years plus	Estrogen Receptor Positive	US22502555_251188612335_S01_2_1_04000582_1_MRP	US22502555_251188612335_S01_2_1_04000582_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1759.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	1.3 years	Estrogen Receptor Negative	US22502555_251188612427_S01_2_4_MRP_04000577_1	US22502555_251188612427_S01_2_4_MRP_04000577_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1000	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	2	KAR	65.3%	1.1 years	Estrogen Receptor Negative	1.1 years	1.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000577	P-TABM-212	4000577_e1	total_RNA	P-TABM-214	4000577_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1759.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	1.3 years	Estrogen Receptor Negative	US22502555_251188612427_S01_2_4_MRP_04000577_1	US22502555_251188612427_S01_2_4_MRP_04000577_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04061	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	80.2%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000524	P-TABM-212	4000524_e1	total_RNA	P-TABM-214	4000524_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2039.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_3_04000524_1_MRP	US22502555_251188612459_S01_1_3_04000524_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2039.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_3_04000524_1_MRP	US22502555_251188612459_S01_1_3_04000524_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280527	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	1	IGR	92.8%	6.0 years plus	Estrogen Receptor Positive	6.0 years plus	6.0 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000311	P-TABM-212	4000311_e1	total_RNA	P-TABM-214	4000311_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.357.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.0 years plus	6.0 years plus	St Gallen category:low clinical risk	6.0 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_3_04000311_1_MRP	US22502555_251188611801_S01_1_3_04000311_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.357.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.0 years plus	6.0 years plus	St Gallen category:low clinical risk	6.0 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_1_3_04000311_1_MRP	US22502555_251188611801_S01_1_3_04000311_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.427.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188611803_S01_1_2_MRP_04000258_1	US22502555_251188611803_S01_1_2_MRP_04000258_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
210322	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	62.1%	16.0 years plus	Estrogen Receptor Negative	16.0 years plus	16.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000258	P-TABM-212	4000258_e1	total_RNA	P-TABM-214	4000258_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.427.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188611803_S01_1_2_MRP_04000258_1	US22502555_251188611803_S01_1_2_MRP_04000258_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1246k	24 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	3	KAR	95.4%	9.6 years	Estrogen Receptor Positive	18.6 years	22.6 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000576	P-TABM-212	4000576_e1	total_RNA	P-TABM-214	4000576_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1752.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	9.6 years	18.6 years	St Gallen category:high clinical risk	22.6 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_2_2_MRP_04000576_1	US22502555_251188612427_S01_2_2_MRP_04000576_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1752.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	9.6 years	18.6 years	St Gallen category:high clinical risk	22.6 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_2_2_MRP_04000576_1	US22502555_251188612427_S01_2_2_MRP_04000576_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
210172	30 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	IGR	75.2%	12.8 years plus	Estrogen Receptor Positive	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000350	P-TABM-212	4000350_e1	total_RNA	P-TABM-214	4000350_e1_l3Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.765.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_2_4_MRP_04000350_3	US22502555_251188611857_S01_2_4_MRP_04000350_3.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.765.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_2_4_MRP_04000350_3	US22502555_251188611857_S01_2_4_MRP_04000350_3.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.721.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.7 years	12.4 years plus	St Gallen category:high clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_1_4_MRP_04000322_2	US22502555_251188611855_S01_1_4_MRP_04000322_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
279276	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	86.7%	7.7 years	Estrogen Receptor Positive	12.4 years plus	12.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000322	P-TABM-212	4000322_e1	total_RNA	P-TABM-214	4000322_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.721.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.7 years	12.4 years plus	St Gallen category:high clinical risk	12.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_1_4_MRP_04000322_2	US22502555_251188611855_S01_1_4_MRP_04000322_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04003	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	2	GUY	73.4%	13.5 years	Estrogen Receptor Positive	20.1 years plus	20.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000473	P-TABM-212	4000473_e1	total_RNA	P-TABM-214	4000473_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2291.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years	20.1 years plus	St Gallen category:high clinical risk	20.1 years plus	Estrogen Receptor Positive	US22502555_251188612910_S01_1_4_MRP_04000473_1	US22502555_251188612910_S01_1_4_MRP_04000473_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2291.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years	20.1 years plus	St Gallen category:high clinical risk	20.1 years plus	Estrogen Receptor Positive	US22502555_251188612910_S01_1_4_MRP_04000473_1	US22502555_251188612910_S01_1_4_MRP_04000473_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04041	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	81.5%	1.2 years	Estrogen Receptor Positive	3.4 years	4.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000542	P-TABM-212	4000542_e1	total_RNA	P-TABM-214	4000542_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2122.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	3.4 years	St Gallen category:high clinical risk	4.1 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_4_MRP_04000542_1	US22502555_251188612772_S01_1_4_MRP_04000542_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2122.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	3.4 years	St Gallen category:high clinical risk	4.1 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_4_MRP_04000542_1	US22502555_251188612772_S01_1_4_MRP_04000542_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1026.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.3 years plus	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_4_MRP_04000452_1	US22502555_251188612214_S01_1_4_MRP_04000452_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
284C63	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	KAR	88.3%	15.3 years plus	Estrogen Receptor Positive	15.3 years plus	15.3 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000452	P-TABM-212	4000452_e1	total_RNA	P-TABM-214	4000452_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1026.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.3 years plus	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_4_MRP_04000452_1	US22502555_251188612214_S01_1_4_MRP_04000452_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
255778	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	1	IGR	78.8%	11.5 years plus	Estrogen Receptor Positive	11.5 years plus	11.5 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000338	P-TABM-212	4000338_e1	total_RNA	P-TABM-214	4000338_e1_l3Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.742.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.5 years plus	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_2_3_04000338_3_MRP	US22502555_251188611856_S01_2_3_04000338_3_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.742.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.5 years plus	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188611856_S01_2_3_04000338_3_MRP	US22502555_251188611856_S01_2_3_04000338_3_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5240	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	67.7%	3.7 years	Estrogen Receptor Negative	4.9 years plus	4.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000581	P-TABM-212	4000581_e1	total_RNA	P-TABM-214	4000581_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1626.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.7 years	4.9 years plus	St Gallen category:high clinical risk	4.9 years plus	Estrogen Receptor Negative	US22502555_251188612422_S01_1_1_04000581_1_MRP	US22502555_251188612422_S01_1_1_04000581_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1626.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.7 years	4.9 years plus	St Gallen category:high clinical risk	4.9 years plus	Estrogen Receptor Negative	US22502555_251188612422_S01_1_1_04000581_1_MRP	US22502555_251188612422_S01_1_1_04000581_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1478.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.7 years	5.8 years	St Gallen category:low clinical risk	6.4 years	Estrogen Receptor Positive	US22502555_251188612389_S01_2_1_04000612_1_MRP	US22502555_251188612389_S01_2_1_04000612_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1996	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	1	CRH	86.9%	1.7 years	Estrogen Receptor Positive	5.8 years	6.4 years	Adjuvant online:high clinical risk	St Gallen category:low clinical risk	NPI:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000612	P-TABM-212	4000612_e1	total_RNA	P-TABM-214	4000612_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1478.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.7 years	5.8 years	St Gallen category:low clinical risk	6.4 years	Estrogen Receptor Positive	US22502555_251188612389_S01_2_1_04000612_1_MRP	US22502555_251188612389_S01_2_1_04000612_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04097	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	80.2%	11.6 years plus	Estrogen Receptor Positive	11.6 years plus	11.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000488	P-TABM-212	4000488_e1	total_RNA	P-TABM-214	4000488_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2023.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.6 years plus	11.6 years plus	St Gallen category:high clinical risk	11.6 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_2_3_04000488_1_MRP	US22502555_251188612458_S01_2_3_04000488_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2023.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.6 years plus	11.6 years plus	St Gallen category:high clinical risk	11.6 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_2_3_04000488_1_MRP	US22502555_251188612458_S01_2_3_04000488_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1213.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years plus	13.5 years plus	St Gallen category:high clinical risk	13.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_2_MRP_04000586_1	US22502555_251188612337_S01_2_2_MRP_04000586_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5229	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	64.1%	13.5 years plus	Estrogen Receptor Negative	13.5 years plus	13.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000586	P-TABM-212	4000586_e1	total_RNA	P-TABM-214	4000586_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1213.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years plus	13.5 years plus	St Gallen category:high clinical risk	13.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_2_MRP_04000586_1	US22502555_251188612337_S01_2_2_MRP_04000586_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
210172	30 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	IGR	75.2%	12.8 years plus	Estrogen Receptor Positive	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000350	P-TABM-212	4000350_e1	total_RNA	P-TABM-214	4000350_e1_l3Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.758.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_2_3_04000350_3_MRP	US22502555_251188611857_S01_2_3_04000350_3_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.758.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_2_3_04000350_3_MRP	US22502555_251188611857_S01_2_3_04000350_3_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04081	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	80%	15.1 years plus	Estrogen Receptor Negative	15.1 years plus	15.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000506	P-TABM-212	4000506_e1	total_RNA	P-TABM-214	4000506_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1866.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188612449_S01_2_4_MRP_04000506_1	US22502555_251188612449_S01_2_4_MRP_04000506_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1866.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188612449_S01_2_4_MRP_04000506_1	US22502555_251188612449_S01_2_4_MRP_04000506_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3367	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	38 mm diameter	3	KAR	60.8%	0.8 years	Estrogen Receptor Negative	0.8 years	1.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000563	P-TABM-212	4000563_e1	total_RNA	P-TABM-214	4000563_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1668.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.8 years	0.8 years	St Gallen category:high clinical risk	1.8 years	Estrogen Receptor Negative	US22502555_251188612424_S01_1_4_MRP_04000563_1	US22502555_251188612424_S01_1_4_MRP_04000563_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1668.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.8 years	0.8 years	St Gallen category:high clinical risk	1.8 years	Estrogen Receptor Negative	US22502555_251188612424_S01_1_4_MRP_04000563_1	US22502555_251188612424_S01_1_4_MRP_04000563_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.188.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_2_1_04000337_1_MRP	US22502555_251188611796_S01_2_1_04000337_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271316	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	88%	11.9 years plus	Estrogen Receptor Positive	11.9 years plus	11.9 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000337	P-TABM-212	4000337_e1	total_RNA	P-TABM-214	4000337_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.188.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years plus	11.9 years plus	St Gallen category:high clinical risk	11.9 years plus	Estrogen Receptor Positive	US22502555_251188611796_S01_2_1_04000337_1_MRP	US22502555_251188611796_S01_2_1_04000337_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2313.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.4 years plus	4.4 years plus	St Gallen category:low clinical risk	4.4 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_1_04000716_1_MRP	US22502555_251188612937_S01_1_1_04000716_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1183	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	1	JRH	94.3%	4.4 years plus	Estrogen Receptor Positive	4.4 years plus	4.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000716	P-TABM-212	4000716_e1	total_RNA	P-TABM-214	4000716_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2313.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.4 years plus	4.4 years plus	St Gallen category:low clinical risk	4.4 years plus	Estrogen Receptor Positive	US22502555_251188612937_S01_1_1_04000716_1_MRP	US22502555_251188612937_S01_1_1_04000716_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2213.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Positive	US22502555_251188612775_S01_2_4_MRP_04000352_1	US22502555_251188612775_S01_2_4_MRP_04000352_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
172086	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	IGR	73.2%	1.4 years	Estrogen Receptor Positive	1.4 years	16.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000352	P-TABM-212	4000352_e1	total_RNA	P-TABM-214	4000352_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2213.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	16.5 years	Estrogen Receptor Positive	US22502555_251188612775_S01_2_4_MRP_04000352_1	US22502555_251188612775_S01_2_4_MRP_04000352_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219916	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	1	IGR	87.9%	8.4 years	Estrogen Receptor Positive	9.7 years plus	9.7 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000281	P-TABM-212	4000281_e1	total_RNA	P-TABM-214	4000281_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2134.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.4 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years	Estrogen Receptor Positive	US22502555_251188612772_S01_2_3_04000281_1_MRP	US22502555_251188612772_S01_2_3_04000281_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2134.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.4 years	9.7 years plus	St Gallen category:high clinical risk	9.7 years	Estrogen Receptor Positive	US22502555_251188612772_S01_2_3_04000281_1_MRP	US22502555_251188612772_S01_2_3_04000281_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2453.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612942_S01_1_2_MRP_04000686_1	US22502555_251188612942_S01_1_2_MRP_04000686_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	88.3%	12.6 years	Estrogen Receptor Positive	12.7 years plus	12.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000686	P-TABM-212	4000686_e1	total_RNA	P-TABM-214	4000686_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2453.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612942_S01_1_2_MRP_04000686_1	US22502555_251188612942_S01_1_2_MRP_04000686_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1170.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years	4.8 years	St Gallen category:high clinical risk	7.4 years	Estrogen Receptor Positive	US22502555_251188612322_S01_2_2_MRP_04000408_1	US22502555_251188612322_S01_2_2_MRP_04000408_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
27D5	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	KAR	76.1%	4.8 years	Estrogen Receptor Positive	4.8 years	7.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000408	P-TABM-212	4000408_e1	total_RNA	P-TABM-214	4000408_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1170.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	4.8 years	4.8 years	St Gallen category:high clinical risk	7.4 years	Estrogen Receptor Positive	US22502555_251188612322_S01_2_2_MRP_04000408_1	US22502555_251188612322_S01_2_2_MRP_04000408_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
220C70	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	89.8%	16.1 years plus	Estrogen Receptor Positive	16.1 years plus	16.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000451	P-TABM-212	4000451_e1	total_RNA	P-TABM-214	4000451_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1010.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_1_04000451_1_MRP	US22502555_251188612214_S01_1_1_04000451_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1010.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_1_04000451_1_MRP	US22502555_251188612214_S01_1_1_04000451_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2347	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	CRH	89.8%	3.7 years plus	Estrogen Receptor Positive	3.7 years plus	3.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000607	P-TABM-212	4000607_e1	total_RNA	P-TABM-214	4000607_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.917.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.7 years plus	3.7 years plus	St Gallen category:high clinical risk	3.7 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_2_MRP_04000607_1	US22502555_251188612202_S01_1_2_MRP_04000607_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.917.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	3.7 years plus	3.7 years plus	St Gallen category:high clinical risk	3.7 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_2_MRP_04000607_1	US22502555_251188612202_S01_1_2_MRP_04000607_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1998.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	3.1 years	St Gallen category:high clinical risk	5.2 years	Estrogen Receptor Positive	US22502555_251188612457_S01_2_1_04000541_1_MRP	US22502555_251188612457_S01_2_1_04000541_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04043	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	77.8%	3.1 years	Estrogen Receptor Positive	3.1 years	5.2 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000541	P-TABM-212	4000541_e1	total_RNA	P-TABM-214	4000541_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1998.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	3.1 years	St Gallen category:high clinical risk	5.2 years	Estrogen Receptor Positive	US22502555_251188612457_S01_2_1_04000541_1_MRP	US22502555_251188612457_S01_2_1_04000541_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
535c	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	27 mm diameter	2	CRH	66.2%	16.4 years plus	Estrogen Receptor Negative	16.4 years plus	16.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000638	P-TABM-212	4000638_e1	total_RNA	P-TABM-214	4000638_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1457.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.4 years plus	16.4 years plus	St Gallen category:high clinical risk	16.4 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_2_4_MRP_04000638_1	US22502555_251188612388_S01_2_4_MRP_04000638_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1457.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.4 years plus	16.4 years plus	St Gallen category:high clinical risk	16.4 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_2_4_MRP_04000638_1	US22502555_251188612388_S01_2_4_MRP_04000638_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04066	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	GUY	93.4%	15.7 years plus	Estrogen Receptor Positive	15.7 years plus	15.7 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000521	P-TABM-212	4000521_e1	total_RNA	P-TABM-214	4000521_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1941.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:low clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_2_MRP_04000521_1	US22502555_251188612453_S01_1_2_MRP_04000521_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1941.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:low clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_2_MRP_04000521_1	US22502555_251188612453_S01_1_2_MRP_04000521_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04044	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	1	GUY	94.3%	16.4 years plus	Estrogen Receptor Positive	16.4 years plus	16.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000540	P-TABM-212	4000540_e1	total_RNA	P-TABM-214	4000540_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1995.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.4 years plus	16.4 years plus	St Gallen category:low clinical risk	16.4 years plus	Estrogen Receptor Positive	US22502555_251188612457_S01_1_4_MRP_04000540_1	US22502555_251188612457_S01_1_4_MRP_04000540_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1995.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.4 years plus	16.4 years plus	St Gallen category:low clinical risk	16.4 years plus	Estrogen Receptor Positive	US22502555_251188612457_S01_1_4_MRP_04000540_1	US22502555_251188612457_S01_1_4_MRP_04000540_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2032.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_1_04000492_1_MRP	US22502555_251188612459_S01_1_1_04000492_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04096	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	2	GUY	88.6%	4.6 years	Estrogen Receptor Positive	12.7 years plus	12.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000492	P-TABM-212	4000492_e1	total_RNA	P-TABM-214	4000492_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2032.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	4.6 years	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_1_04000492_1_MRP	US22502555_251188612459_S01_1_1_04000492_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
214603	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	2	IGR	85.7%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000263	P-TABM-212	4000263_e1	total_RNA	P-TABM-214	4000263_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1137.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_1_1_04000263_1_MRP	US22502555_251188612320_S01_1_1_04000263_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1137.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612320_S01_1_1_04000263_1_MRP	US22502555_251188612320_S01_1_1_04000263_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2386	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	1	CRH	88.4%	10.1 years plus	Estrogen Receptor Positive	10.1 years plus	10.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000604	P-TABM-212	4000604_e1	total_RNA	P-TABM-214	4000604_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.882.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.1 years plus	10.1 years plus	St Gallen category:high clinical risk	10.1 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_3_04000604_1_MRP	US22502555_251188612201_S01_1_3_04000604_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.882.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	10.1 years plus	10.1 years plus	St Gallen category:high clinical risk	10.1 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_3_04000604_1_MRP	US22502555_251188612201_S01_1_3_04000604_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2437.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_2_1_04000714_1_MRP	US22502555_251188612941_S01_2_1_04000714_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1006	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	JRH	84.8%	7.3 years plus	Estrogen Receptor Positive	7.3 years plus	7.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000714	P-TABM-212	4000714_e1	total_RNA	P-TABM-214	4000714_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2437.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_2_1_04000714_1_MRP	US22502555_251188612941_S01_2_1_04000714_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1961.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	4.8 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Negative	US22502555_251188612453_S01_2_4_MRP_04000528_1	US22502555_251188612453_S01_2_4_MRP_04000528_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04056	55 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	65.5%	1.5 years	Estrogen Receptor Negative	4.8 years	5.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000528	P-TABM-212	4000528_e1	total_RNA	P-TABM-214	4000528_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1961.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.5 years	4.8 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Negative	US22502555_251188612453_S01_2_4_MRP_04000528_1	US22502555_251188612453_S01_2_4_MRP_04000528_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.786.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.1 years	25.0 years plus	St Gallen category:high clinical risk	25.0 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_2_1_04000632_1_MRP	US22502555_251188612196_S01_2_1_04000632_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1315	33 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	CRH	86.9%	5.1 years	Estrogen Receptor Positive	25.0 years plus	25.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000632	P-TABM-212	4000632_e1	total_RNA	P-TABM-214	4000632_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.786.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.1 years	25.0 years plus	St Gallen category:high clinical risk	25.0 years plus	Estrogen Receptor Positive	US22502555_251188612196_S01_2_1_04000632_1_MRP	US22502555_251188612196_S01_2_1_04000632_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256818	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	87.2%	10.2 years plus	Estrogen Receptor Positive	10.2 years plus	10.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000345	P-TABM-212	4000345_e1	total_RNA	P-TABM-214	4000345_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2189.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_1_1_04000345_1_MRP	US22502555_251188612775_S01_1_1_04000345_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2189.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.2 years plus	10.2 years plus	St Gallen category:high clinical risk	10.2 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_1_1_04000345_1_MRP	US22502555_251188612775_S01_1_1_04000345_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.962.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	0.6 years	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Negative	US22502555_251188612211_S01_2_1_04000442_1_MRP	US22502555_251188612211_S01_2_1_04000442_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
43C47	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	KAR	83.1%	0.6 years	Estrogen Receptor Negative	15.2 years plus	15.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000442	P-TABM-212	4000442_e1	total_RNA	P-TABM-214	4000442_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.962.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	0.6 years	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Negative	US22502555_251188612211_S01_2_1_04000442_1_MRP	US22502555_251188612211_S01_2_1_04000442_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
145	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	JRH	68.8%	12.9 years plus	Estrogen Receptor Negative	12.9 years plus	12.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000681	P-TABM-212	4000681_e1	total_RNA	P-TABM-214	4000681_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2250.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188612907_S01_2_4_MRP_04000681_1	US22502555_251188612907_S01_2_4_MRP_04000681_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2250.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188612907_S01_2_4_MRP_04000681_1	US22502555_251188612907_S01_2_4_MRP_04000681_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2142.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_1_3_04000290_4_MRP	US22502555_251188612773_S01_1_3_04000290_4_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246047	39 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	IGR	81.4%	4.4 years	Estrogen Receptor Positive	14.4 years plus	14.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000290	P-TABM-212	4000290_e1	total_RNA	P-TABM-214	4000290_e1_l4Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2142.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_1_3_04000290_4_MRP	US22502555_251188612773_S01_1_3_04000290_4_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	3	JRH	85.7%	13.3 years plus	Estrogen Receptor Negative	13.3 years plus	13.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000685	P-TABM-212	4000685_e1	total_RNA	P-TABM-214	4000685_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2268.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Negative	US22502555_251188612908_S01_2_3_04000685_1_MRP	US22502555_251188612908_S01_2_3_04000685_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2268.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.3 years plus	13.3 years plus	St Gallen category:high clinical risk	13.3 years plus	Estrogen Receptor Negative	US22502555_251188612908_S01_2_3_04000685_1_MRP	US22502555_251188612908_S01_2_3_04000685_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.511.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years plus	2.6 years plus	St Gallen category:high clinical risk	2.6 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_4_MRP_04000268_1	US22502555_251188611805_S01_1_4_MRP_04000268_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171150	35 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	IGR	81.8%	2.6 years plus	Estrogen Receptor Positive	2.6 years plus	2.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000268	P-TABM-212	4000268_e1	total_RNA	P-TABM-214	4000268_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.511.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	2.6 years plus	2.6 years plus	St Gallen category:high clinical risk	2.6 years plus	Estrogen Receptor Positive	US22502555_251188611805_S01_1_4_MRP_04000268_1	US22502555_251188611805_S01_1_4_MRP_04000268_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
320	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	50 mm diameter	3	JRH	63.7%	7.0 years	Estrogen Receptor Negative	8.1 years plus	8.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000688	P-TABM-212	4000688_e1	total_RNA	P-TABM-214	4000688_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2466.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Negative	US22502555_251188612942_S01_2_2_MRP_04000688_1	US22502555_251188612942_S01_2_2_MRP_04000688_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2466.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Negative	US22502555_251188612942_S01_2_2_MRP_04000688_1	US22502555_251188612942_S01_2_2_MRP_04000688_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245964	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	78.6%	6.3 years	Estrogen Receptor Negative	6.3 years	6.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000288	P-TABM-212	4000288_e1	total_RNA	P-TABM-214	4000288_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.80.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.3 years	6.3 years	St Gallen category:high clinical risk	6.4 years	Estrogen Receptor Negative	US22502555_251188611678_S01_2_1_04000288_1_MRP	US22502555_251188611678_S01_2_1_04000288_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.80.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.3 years	6.3 years	St Gallen category:high clinical risk	6.4 years	Estrogen Receptor Negative	US22502555_251188611678_S01_2_1_04000288_1_MRP	US22502555_251188611678_S01_2_1_04000288_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1220.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_4_MRP_04000587_1	US22502555_251188612337_S01_2_4_MRP_04000587_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5228	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	67.7%	15.5 years plus	Estrogen Receptor Negative	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000587	P-TABM-212	4000587_e1	total_RNA	P-TABM-214	4000587_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1220.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612337_S01_2_4_MRP_04000587_1	US22502555_251188612337_S01_2_4_MRP_04000587_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
287897	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	94.3%	8.8 years	Estrogen Receptor Positive	9.9 years plus	9.9 years	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000304	P-TABM-212	4000304_e1	total_RNA	P-TABM-214	4000304_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.319.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.8 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188611800_S01_1_1_04000304_1_MRP	US22502555_251188611800_S01_1_1_04000304_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.319.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.8 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188611800_S01_1_1_04000304_1_MRP	US22502555_251188611800_S01_1_1_04000304_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2514	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	CRH	84.4%	9.4 years plus	Estrogen Receptor Positive	9.4 years plus	9.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000602	P-TABM-212	4000602_e1	total_RNA	P-TABM-214	4000602_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.866.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_2_3_04000602_1_MRP	US22502555_251188612200_S01_2_3_04000602_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.866.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.4 years plus	9.4 years plus	St Gallen category:high clinical risk	9.4 years plus	Estrogen Receptor Positive	US22502555_251188612200_S01_2_3_04000602_1_MRP	US22502555_251188612200_S01_2_3_04000602_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1746.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	9.6 years	18.6 years	St Gallen category:high clinical risk	22.6 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_2_1_04000576_1_MRP	US22502555_251188612427_S01_2_1_04000576_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1246k	24 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	3	KAR	95.4%	9.6 years	Estrogen Receptor Positive	18.6 years	22.6 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000576	P-TABM-212	4000576_e1	total_RNA	P-TABM-214	4000576_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1746.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	9.6 years	18.6 years	St Gallen category:high clinical risk	22.6 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_2_1_04000576_1_MRP	US22502555_251188612427_S01_2_1_04000576_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04075	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	1	GUY	81.4%	14.0 years plus	Estrogen Receptor Positive	14.0 years plus	14.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000512	P-TABM-212	4000512_e1	total_RNA	P-TABM-214	4000512_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1891.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_3_04000512_1_MRP	US22502555_251188612450_S01_2_3_04000512_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1891.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.0 years plus	14.0 years plus	St Gallen category:high clinical risk	14.0 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_3_04000512_1_MRP	US22502555_251188612450_S01_2_3_04000512_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2743	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	KAR	66.9%	11.7 years plus	Estrogen Receptor Negative	11.7 years plus	11.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000567	P-TABM-212	4000567_e1	total_RNA	P-TABM-214	4000567_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1687.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years plus	11.7 years plus	St Gallen category:high clinical risk	11.7 years plus	Estrogen Receptor Negative	US22502555_251188612425_S01_1_3_04000567_1_MRP	US22502555_251188612425_S01_1_3_04000567_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1687.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	11.7 years plus	11.7 years plus	St Gallen category:high clinical risk	11.7 years plus	Estrogen Receptor Negative	US22502555_251188612425_S01_1_3_04000567_1_MRP	US22502555_251188612425_S01_1_3_04000567_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
366	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	JRH	62.7%	2.8 years	Estrogen Receptor Negative	3.0 years	3.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000692	P-TABM-212	4000692_e1	total_RNA	P-TABM-214	4000692_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2382.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	3.0 years	St Gallen category:high clinical risk	3.3 years	Estrogen Receptor Negative	US22502555_251188612939_S01_2_1_04000692_1_MRP	US22502555_251188612939_S01_2_1_04000692_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2382.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	3.0 years	St Gallen category:high clinical risk	3.3 years	Estrogen Receptor Negative	US22502555_251188612939_S01_2_1_04000692_1_MRP	US22502555_251188612939_S01_2_1_04000692_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
302	44 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	13 mm diameter	2	CRH	89.4%	2.0 years	Estrogen Receptor Positive	17.2 years plus	17.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000642	P-TABM-212	4000642_e1	total_RNA	P-TABM-214	4000642_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1607.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_2_MRP_04000642_1	US22502555_251188612421_S01_1_2_MRP_04000642_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1607.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_1_2_MRP_04000642_1	US22502555_251188612421_S01_1_2_MRP_04000642_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219800	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	78.9%	15.5 years plus	Estrogen Receptor Negative	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000277	P-TABM-212	4000277_e1	total_RNA	P-TABM-214	4000277_e1_l2Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1147.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612320_S01_1_4_MRP_04000277_2	US22502555_251188612320_S01_1_4_MRP_04000277_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1147.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188612320_S01_1_4_MRP_04000277_2	US22502555_251188612320_S01_1_4_MRP_04000277_2.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247845	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	90.9%	13.4 years plus	Estrogen Receptor Positive	13.4 years plus	13.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000319	P-TABM-212	4000319_e1	total_RNA	P-TABM-214	4000319_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2186.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.4 years plus	13.4 years plus	St Gallen category:low clinical risk	13.4 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_2_2_MRP_04000319_1	US22502555_251188612774_S01_2_2_MRP_04000319_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2186.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.4 years plus	13.4 years plus	St Gallen category:low clinical risk	13.4 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_2_2_MRP_04000319_1	US22502555_251188612774_S01_2_2_MRP_04000319_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
245471	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	IGR	67.6%	0.7 years	Estrogen Receptor Negative	0.7 years	1.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000284	P-TABM-212	4000284_e1	total_RNA	P-TABM-214	4000284_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.47.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188611677_S01_2_2_MRP_04000284_1	US22502555_251188611677_S01_2_2_MRP_04000284_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.47.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.7 years	0.7 years	St Gallen category:high clinical risk	1.6 years	Estrogen Receptor Negative	US22502555_251188611677_S01_2_2_MRP_04000284_1	US22502555_251188611677_S01_2_2_MRP_04000284_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1721	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	77.1%	4.4 years	Estrogen Receptor Positive	4.4 years	5.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000621	P-TABM-212	4000621_e1	total_RNA	P-TABM-214	4000621_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1552.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	4.4 years	St Gallen category:high clinical risk	5.1 years	Estrogen Receptor Positive	US22502555_251188612393_S01_2_4_MRP_04000621_1	US22502555_251188612393_S01_2_4_MRP_04000621_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1552.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	4.4 years	St Gallen category:high clinical risk	5.1 years	Estrogen Receptor Positive	US22502555_251188612393_S01_2_4_MRP_04000621_1	US22502555_251188612393_S01_2_4_MRP_04000621_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3367	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	38 mm diameter	3	KAR	60.8%	0.8 years	Estrogen Receptor Negative	0.8 years	1.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000563	P-TABM-212	4000563_e1	total_RNA	P-TABM-214	4000563_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1662.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.8 years	0.8 years	St Gallen category:high clinical risk	1.8 years	Estrogen Receptor Negative	US22502555_251188612424_S01_1_3_04000563_1_MRP	US22502555_251188612424_S01_1_3_04000563_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1662.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.8 years	0.8 years	St Gallen category:high clinical risk	1.8 years	Estrogen Receptor Negative	US22502555_251188612424_S01_1_3_04000563_1_MRP	US22502555_251188612424_S01_1_3_04000563_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
287611	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	92.8%	1.4 years plus	Estrogen Receptor Positive	1.4 years plus	1.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000305	P-TABM-212	4000305_e1	total_RNA	P-TABM-214	4000305_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2163.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.4 years plus	1.4 years plus	St Gallen category:low clinical risk	1.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_4_MRP_04000305_1	US22502555_251188612773_S01_2_4_MRP_04000305_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2163.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.4 years plus	1.4 years plus	St Gallen category:low clinical risk	1.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_2_4_MRP_04000305_1	US22502555_251188612773_S01_2_4_MRP_04000305_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.417.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.5 years plus	13.5 years plus	St Gallen category:low clinical risk	13.5 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_4_MRP_04000317_1	US22502555_251188611802_S01_2_4_MRP_04000317_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247401	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	1	IGR	92.4%	13.5 years plus	Estrogen Receptor Positive	13.5 years plus	13.5 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000317	P-TABM-212	4000317_e1	total_RNA	P-TABM-214	4000317_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.417.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	13.5 years plus	13.5 years plus	St Gallen category:low clinical risk	13.5 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_4_MRP_04000317_1	US22502555_251188611802_S01_2_4_MRP_04000317_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2492.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612944_S01_1_2_MRP_04000698_1	US22502555_251188612944_S01_1_2_MRP_04000698_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
449	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	JRH	69%	12.5 years plus	Estrogen Receptor Positive	12.5 years plus	12.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000698	P-TABM-212	4000698_e1	total_RNA	P-TABM-214	4000698_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2492.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612944_S01_1_2_MRP_04000698_1	US22502555_251188612944_S01_1_2_MRP_04000698_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04045	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	45 mm diameter	3	GUY	62.7%	17.1 years plus	Estrogen Receptor Negative	17.1 years plus	17.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000539	P-TABM-212	4000539_e1	total_RNA	P-TABM-214	4000539_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1989.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612457_S01_1_2_MRP_04000539_1	US22502555_251188612457_S01_1_2_MRP_04000539_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1989.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612457_S01_1_2_MRP_04000539_1	US22502555_251188612457_S01_1_2_MRP_04000539_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
307327	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	85.5%	9.7 years plus	Estrogen Receptor Positive	9.7 years plus	9.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000297	P-TABM-212	4000297_e1	total_RNA	P-TABM-214	4000297_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.256.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.7 years plus	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_3_04000297_1_MRP	US22502555_251188611798_S01_1_3_04000297_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.256.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.7 years plus	9.7 years plus	St Gallen category:high clinical risk	9.7 years plus	Estrogen Receptor Positive	US22502555_251188611798_S01_1_3_04000297_1_MRP	US22502555_251188611798_S01_1_3_04000297_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.327.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.7 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_1_3_04000306_1_MRP	US22502555_251188611800_S01_1_3_04000306_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246919	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	87.6%	9.7 years	Estrogen Receptor Positive	14.9 years plus	14.9 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000306	P-TABM-212	4000306_e1	total_RNA	P-TABM-214	4000306_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.327.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.7 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_1_3_04000306_1_MRP	US22502555_251188611800_S01_1_3_04000306_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1433.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years plus	7.9 years plus	St Gallen category:high clinical risk	7.9 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_1_1_04000592_1_MRP	US22502555_251188612388_S01_1_1_04000592_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
4188	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	3	CRH	62.3%	7.9 years plus	Estrogen Receptor Negative	7.9 years plus	7.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000592	P-TABM-212	4000592_e1	total_RNA	P-TABM-214	4000592_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1433.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years plus	7.9 years plus	St Gallen category:high clinical risk	7.9 years plus	Estrogen Receptor Negative	US22502555_251188612388_S01_1_1_04000592_1_MRP	US22502555_251188612388_S01_1_1_04000592_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.857.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Negative	US22502555_251188612200_S01_2_1_04000601_1_MRP	US22502555_251188612200_S01_2_1_04000601_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2587	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	3	CRH	77.7%	7.0 years plus	Estrogen Receptor Negative	7.0 years plus	7.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000601	P-TABM-212	4000601_e1	total_RNA	P-TABM-214	4000601_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.857.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Negative	US22502555_251188612200_S01_2_1_04000601_1_MRP	US22502555_251188612200_S01_2_1_04000601_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171620	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	27 mm diameter	3	IGR	64.9%	15.5 years plus	Estrogen Receptor Negative	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000344	P-TABM-212	4000344_e1	total_RNA	P-TABM-214	4000344_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188611675_S01_1_1_04000344_1_MRP	US22502555_251188611675_S01_1_1_04000344_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Negative	US22502555_251188611675_S01_1_1_04000344_1_MRP	US22502555_251188611675_S01_1_1_04000344_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
218086	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	1	IGR	90.6%	5.3 years	Estrogen Receptor Negative	5.3 years	8.6 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000270	P-TABM-212	4000270_e1	total_RNA	P-TABM-214	4000270_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.685.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.3 years	5.3 years	St Gallen category:high clinical risk	8.6 years	Estrogen Receptor Negative	US22502555_251188611837_S01_1_2_MRP_04000270_1	US22502555_251188611837_S01_1_2_MRP_04000270_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.685.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	5.3 years	5.3 years	St Gallen category:high clinical risk	8.6 years	Estrogen Receptor Negative	US22502555_251188611837_S01_1_2_MRP_04000270_1	US22502555_251188611837_S01_1_2_MRP_04000270_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1974	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	CRH	74.8%	8.4 years plus	Estrogen Receptor Negative	8.4 years plus	8.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000613	P-TABM-212	4000613_e1	total_RNA	P-TABM-214	4000613_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1491.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.4 years plus	8.4 years plus	St Gallen category:high clinical risk	8.4 years plus	Estrogen Receptor Negative	US22502555_251188612389_S01_2_4_MRP_04000613_1	US22502555_251188612389_S01_2_4_MRP_04000613_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1491.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	8.4 years plus	8.4 years plus	St Gallen category:high clinical risk	8.4 years plus	Estrogen Receptor Negative	US22502555_251188612389_S01_2_4_MRP_04000613_1	US22502555_251188612389_S01_2_4_MRP_04000613_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
125B43	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	KAR	90.4%	16.9 years plus	Estrogen Receptor Positive	16.9 years plus	16.9 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000429	P-TABM-212	4000429_e1	total_RNA	P-TABM-214	4000429_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1397.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.9 years plus	16.9 years plus	St Gallen category:high clinical risk	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_3_04000429_1_MRP	US22502555_251188612377_S01_2_3_04000429_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1397.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.9 years plus	16.9 years plus	St Gallen category:high clinical risk	16.9 years plus	Estrogen Receptor Positive	US22502555_251188612377_S01_2_3_04000429_1_MRP	US22502555_251188612377_S01_2_3_04000429_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
218444	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	IGR	79.7%	1.9 years	Estrogen Receptor Negative	1.9 years	4.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000271	P-TABM-212	4000271_e1	total_RNA	P-TABM-214	4000271_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.530.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188611805_S01_2_4_MRP_04000271_1	US22502555_251188611805_S01_2_4_MRP_04000271_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.530.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.9 years	1.9 years	St Gallen category:high clinical risk	4.6 years	Estrogen Receptor Negative	US22502555_251188611805_S01_2_4_MRP_04000271_1	US22502555_251188611805_S01_2_4_MRP_04000271_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1708.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	14.3 years plus	St Gallen category:not applicable	14.3 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_4_MRP_04000569_1	US22502555_251188612425_S01_2_4_MRP_04000569_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2481	50 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	unknown	KAR	87.6%	6.7 years	Estrogen Receptor Positive	14.3 years plus	14.3 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000569	P-TABM-212	4000569_e1	total_RNA	P-TABM-214	4000569_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1708.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	14.3 years plus	St Gallen category:not applicable	14.3 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_4_MRP_04000569_1	US22502555_251188612425_S01_2_4_MRP_04000569_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1016.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_2_MRP_04000451_1	US22502555_251188612214_S01_1_2_MRP_04000451_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
220C70	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	KAR	89.8%	16.1 years plus	Estrogen Receptor Positive	16.1 years plus	16.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000451	P-TABM-212	4000451_e1	total_RNA	P-TABM-214	4000451_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1016.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612214_S01_1_2_MRP_04000451_1	US22502555_251188612214_S01_1_2_MRP_04000451_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
869	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	1	JRH	95.1%	8.7 years plus	Estrogen Receptor Positive	8.7 years plus	8.7 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000712	P-TABM-212	4000712_e1	total_RNA	P-TABM-214	4000712_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2434.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.7 years plus	8.7 years plus	St Gallen category:low clinical risk	8.7 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_4_MRP_04000712_1	US22502555_251188612941_S01_1_4_MRP_04000712_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2434.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.7 years plus	8.7 years plus	St Gallen category:low clinical risk	8.7 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_4_MRP_04000712_1	US22502555_251188612941_S01_1_4_MRP_04000712_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280328	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	2	IGR	79.6%	10.9 years	Estrogen Receptor Positive	10.9 years	12.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000316	P-TABM-212	4000316_e1	total_RNA	P-TABM-214	4000316_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.402.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.9 years	10.9 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_1_04000316_1_MRP	US22502555_251188611802_S01_2_1_04000316_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.402.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.9 years	10.9 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_2_1_04000316_1_MRP	US22502555_251188611802_S01_2_1_04000316_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246047	39 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	IGR	81.4%	4.4 years	Estrogen Receptor Positive	14.4 years plus	14.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000290	P-TABM-212	4000290_e1	total_RNA	P-TABM-214	4000290_e1_l4Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2145.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_1_4_MRP_04000290_4	US22502555_251188612773_S01_1_4_MRP_04000290_4.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2145.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	4.4 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188612773_S01_1_4_MRP_04000290_4	US22502555_251188612773_S01_1_4_MRP_04000290_4.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1119.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_2_1_04000628_1_MRP	US22502555_251188612218_S01_2_1_04000628_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1522	31 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	3	CRH	80.1%	14.2 years plus	Estrogen Receptor Positive	14.2 years plus	14.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000628	P-TABM-212	4000628_e1	total_RNA	P-TABM-214	4000628_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1119.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	14.2 years plus	14.2 years plus	St Gallen category:high clinical risk	14.2 years plus	Estrogen Receptor Positive	US22502555_251188612218_S01_2_1_04000628_1_MRP	US22502555_251188612218_S01_2_1_04000628_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1792.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.6 years plus	19.6 years plus	St Gallen category:not applicable	19.6 years plus	Estrogen Receptor Positive	US22502555_251188612446_S01_2_4_MRP_04000477_1	US22502555_251188612446_S01_2_4_MRP_04000477_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04006	51 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	unknown	GUY	87.2%	19.6 years plus	Estrogen Receptor Positive	19.6 years plus	19.6 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000477	P-TABM-212	4000477_e1	total_RNA	P-TABM-214	4000477_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1792.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.6 years plus	19.6 years plus	St Gallen category:not applicable	19.6 years plus	Estrogen Receptor Positive	US22502555_251188612446_S01_2_4_MRP_04000477_1	US22502555_251188612446_S01_2_4_MRP_04000477_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5226	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	2	CRH	89.2%	19.1 years	Estrogen Receptor Positive	19.2 years plus	19.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000589	P-TABM-212	4000589_e1	total_RNA	P-TABM-214	4000589_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1238.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	19.1 years	19.2 years plus	St Gallen category:high clinical risk	19.2 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_1_4_MRP_04000589_1	US22502555_251188612338_S01_1_4_MRP_04000589_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1238.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	19.1 years	19.2 years plus	St Gallen category:high clinical risk	19.2 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_1_4_MRP_04000589_1	US22502555_251188612338_S01_1_4_MRP_04000589_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1885.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_1_04000511_1_MRP	US22502555_251188612450_S01_2_1_04000511_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04076	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	6 mm diameter	2	GUY	92.8%	15.2 years plus	Estrogen Receptor Positive	15.2 years plus	15.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000511	P-TABM-212	4000511_e1	total_RNA	P-TABM-214	4000511_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1885.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612450_S01_2_1_04000511_1_MRP	US22502555_251188612450_S01_2_1_04000511_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04105	34 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	79.9%	1.0 years	Estrogen Receptor Positive	3.3 years	3.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000467	P-TABM-212	4000467_e1	total_RNA	P-TABM-214	4000467_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1762.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	3.3 years	St Gallen category:high clinical risk	3.5 years	Estrogen Receptor Positive	US22502555_251188612446_S01_1_1_04000467_1_MRP	US22502555_251188612446_S01_1_1_04000467_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1762.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	3.3 years	St Gallen category:high clinical risk	3.5 years	Estrogen Receptor Positive	US22502555_251188612446_S01_1_1_04000467_1_MRP	US22502555_251188612446_S01_1_1_04000467_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
216939	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	79%	13.1 years plus	Estrogen Receptor Positive	13.1 years plus	13.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000265	P-TABM-212	4000265_e1	total_RNA	P-TABM-214	4000265_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.480.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_2_1_04000265_1_MRP	US22502555_251188611804_S01_2_1_04000265_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.480.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	13.1 years plus	13.1 years plus	St Gallen category:high clinical risk	13.1 years plus	Estrogen Receptor Positive	US22502555_251188611804_S01_2_1_04000265_1_MRP	US22502555_251188611804_S01_2_1_04000265_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04003	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	2	GUY	73.4%	13.5 years	Estrogen Receptor Positive	20.1 years plus	20.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000473	P-TABM-212	4000473_e1	total_RNA	P-TABM-214	4000473_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2286.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years	20.1 years plus	St Gallen category:high clinical risk	20.1 years plus	Estrogen Receptor Positive	US22502555_251188612910_S01_1_3_04000473_1_MRP	US22502555_251188612910_S01_1_3_04000473_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2286.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.5 years	20.1 years plus	St Gallen category:high clinical risk	20.1 years plus	Estrogen Receptor Positive	US22502555_251188612910_S01_1_3_04000473_1_MRP	US22502555_251188612910_S01_1_3_04000473_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
145	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	JRH	68.8%	12.9 years plus	Estrogen Receptor Negative	12.9 years plus	12.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000681	P-TABM-212	4000681_e1	total_RNA	P-TABM-214	4000681_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2246.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188612907_S01_2_3_04000681_1_MRP	US22502555_251188612907_S01_2_3_04000681_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2246.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.9 years plus	12.9 years plus	St Gallen category:high clinical risk	12.9 years plus	Estrogen Receptor Negative	US22502555_251188612907_S01_2_3_04000681_1_MRP	US22502555_251188612907_S01_2_3_04000681_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E6	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	KAR	81.4%	17.3 years plus	Estrogen Receptor Negative	17.3 years plus	17.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000426	P-TABM-212	4000426_e1	total_RNA	P-TABM-214	4000426_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1380.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.3 years plus	17.3 years plus	St Gallen category:high clinical risk	17.3 years plus	Estrogen Receptor Negative	US22502555_251188612377_S01_1_2_MRP_04000426_1	US22502555_251188612377_S01_1_2_MRP_04000426_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1380.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.3 years plus	17.3 years plus	St Gallen category:high clinical risk	17.3 years plus	Estrogen Receptor Negative	US22502555_251188612377_S01_1_2_MRP_04000426_1	US22502555_251188612377_S01_1_2_MRP_04000426_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2118.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	3.4 years	St Gallen category:high clinical risk	4.1 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_3_04000542_1_MRP	US22502555_251188612772_S01_1_3_04000542_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04041	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	81.5%	1.2 years	Estrogen Receptor Positive	3.4 years	4.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000542	P-TABM-212	4000542_e1	total_RNA	P-TABM-214	4000542_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2118.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.2 years	3.4 years	St Gallen category:high clinical risk	4.1 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_3_04000542_1_MRP	US22502555_251188612772_S01_1_3_04000542_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1271.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_2_2_MRP_04000412_1	US22502555_251188612372_S01_2_2_MRP_04000412_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E2	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	3	KAR	85.2%	7.0 years plus	Estrogen Receptor Positive	7.0 years plus	7.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000412	P-TABM-212	4000412_e1	total_RNA	P-TABM-214	4000412_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1271.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.0 years plus	7.0 years plus	St Gallen category:high clinical risk	7.0 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_2_2_MRP_04000412_1	US22502555_251188612372_S01_2_2_MRP_04000412_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2061.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.9 years	15.9 years plus	St Gallen category:high clinical risk	15.9 years	Estrogen Receptor Positive	US22502555_251188612769_S01_1_1_04000545_1_MRP	US22502555_251188612769_S01_1_1_04000545_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04036	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	1	GUY	82.1%	15.9 years	Estrogen Receptor Positive	15.9 years plus	15.9 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000545	P-TABM-212	4000545_e1	total_RNA	P-TABM-214	4000545_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2061.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.9 years	15.9 years plus	St Gallen category:high clinical risk	15.9 years	Estrogen Receptor Positive	US22502555_251188612769_S01_1_1_04000545_1_MRP	US22502555_251188612769_S01_1_1_04000545_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1992.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.4 years plus	16.4 years plus	St Gallen category:low clinical risk	16.4 years plus	Estrogen Receptor Positive	US22502555_251188612457_S01_1_3_04000540_1_MRP	US22502555_251188612457_S01_1_3_04000540_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04044	50 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	8 mm diameter	1	GUY	94.3%	16.4 years plus	Estrogen Receptor Positive	16.4 years plus	16.4 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000540	P-TABM-212	4000540_e1	total_RNA	P-TABM-214	4000540_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1992.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.4 years plus	16.4 years plus	St Gallen category:low clinical risk	16.4 years plus	Estrogen Receptor Positive	US22502555_251188612457_S01_1_3_04000540_1_MRP	US22502555_251188612457_S01_1_3_04000540_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
382	60 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	JRH	73.4%	12.8 years plus	Estrogen Receptor Positive	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000693	P-TABM-212	4000693_e1	total_RNA	P-TABM-214	4000693_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2307.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_3_04000693_1_MRP	US22502555_251188612911_S01_2_3_04000693_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2307.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_3_04000693_1_MRP	US22502555_251188612911_S01_2_3_04000693_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16B4	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	KAR	67.3%	19.0 years plus	Estrogen Receptor Negative	19.0 years plus	19.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000419	P-TABM-212	4000419_e1	total_RNA	P-TABM-214	4000419_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1329.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.0 years plus	19.0 years plus	St Gallen category:high clinical risk	19.0 years plus	Estrogen Receptor Negative	US22502555_251188612375_S01_1_3_04000419_1_MRP	US22502555_251188612375_S01_1_3_04000419_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1329.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	19.0 years plus	19.0 years plus	St Gallen category:high clinical risk	19.0 years plus	Estrogen Receptor Negative	US22502555_251188612375_S01_1_3_04000419_1_MRP	US22502555_251188612375_S01_1_3_04000419_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04055	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	GUY	88%	16.1 years plus	Estrogen Receptor Positive	16.1 years plus	16.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000529	P-TABM-212	4000529_e1	total_RNA	P-TABM-214	4000529_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1964.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612455_S01_1_1_04000529_1_MRP	US22502555_251188612455_S01_1_1_04000529_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1964.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612455_S01_1_1_04000529_1_MRP	US22502555_251188612455_S01_1_1_04000529_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2355.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.5 years plus	3.5 years plus	St Gallen category:high clinical risk	3.5 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_1_2_MRP_04000720_1	US22502555_251188612938_S01_1_2_MRP_04000720_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1415	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	2	JRH	91.6%	3.5 years plus	Estrogen Receptor Negative	3.5 years plus	3.5 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000720	P-TABM-212	4000720_e1	total_RNA	P-TABM-214	4000720_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2355.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.5 years plus	3.5 years plus	St Gallen category:high clinical risk	3.5 years plus	Estrogen Receptor Negative	US22502555_251188612938_S01_1_2_MRP_04000720_1	US22502555_251188612938_S01_1_2_MRP_04000720_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.537.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_2_MRP_04000272_1	US22502555_251188611806_S01_1_2_MRP_04000272_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
219139	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	1	IGR	84.5%	10.4 years plus	Estrogen Receptor Positive	10.4 years plus	10.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000272	P-TABM-212	4000272_e1	total_RNA	P-TABM-214	4000272_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.537.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.4 years plus	10.4 years plus	St Gallen category:high clinical risk	10.4 years plus	Estrogen Receptor Positive	US22502555_251188611806_S01_1_2_MRP_04000272_1	US22502555_251188611806_S01_1_2_MRP_04000272_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1771	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	CRH	74.2%	12.5 years plus	Estrogen Receptor Positive	12.5 years plus	12.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000618	P-TABM-212	4000618_e1	total_RNA	P-TABM-214	4000618_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1520.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_1_1_04000618_1_MRP	US22502555_251188612393_S01_1_1_04000618_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1520.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.5 years plus	12.5 years plus	St Gallen category:high clinical risk	12.5 years plus	Estrogen Receptor Positive	US22502555_251188612393_S01_1_1_04000618_1_MRP	US22502555_251188612393_S01_1_1_04000618_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1777.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188612446_S01_2_1_04000475_1_MRP	US22502555_251188612446_S01_2_1_04000475_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04005	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	GUY	64.3%	1.4 years	Estrogen Receptor Positive	1.4 years	9.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000475	P-TABM-212	4000475_e1	total_RNA	P-TABM-214	4000475_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1777.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.4 years	1.4 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188612446_S01_2_1_04000475_1_MRP	US22502555_251188612446_S01_2_1_04000475_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
211132	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	1	IGR	82.1%	10.8 years plus	Estrogen Receptor Positive	10.8 years plus	10.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000260	P-TABM-212	4000260_e1	total_RNA	P-TABM-214	4000260_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.447.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.8 years plus	10.8 years plus	St Gallen category:high clinical risk	10.8 years plus	Estrogen Receptor Positive	US22502555_251188611803_S01_2_2_MRP_04000260_1	US22502555_251188611803_S01_2_2_MRP_04000260_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.447.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.8 years plus	10.8 years plus	St Gallen category:high clinical risk	10.8 years plus	Estrogen Receptor Positive	US22502555_251188611803_S01_2_2_MRP_04000260_1	US22502555_251188611803_S01_2_2_MRP_04000260_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1356.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	23.9 years plus	23.9 years plus	St Gallen category:high clinical risk	23.9 years plus	Estrogen Receptor Negative	US22502555_251188612376_S01_1_4_MRP_04000423_1	US22502555_251188612376_S01_1_4_MRP_04000423_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15H3	33 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	KAR	68.1%	23.9 years plus	Estrogen Receptor Negative	23.9 years plus	23.9 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000423	P-TABM-212	4000423_e1	total_RNA	P-TABM-214	4000423_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1356.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	23.9 years plus	23.9 years plus	St Gallen category:high clinical risk	23.9 years plus	Estrogen Receptor Negative	US22502555_251188612376_S01_1_4_MRP_04000423_1	US22502555_251188612376_S01_1_4_MRP_04000423_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
535j	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	JRH	82.3%	12.2 years plus	Estrogen Receptor Positive	12.2 years plus	12.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000706	P-TABM-212	4000706_e1	total_RNA	P-TABM-214	4000706_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2394.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_2_MRP_04000706_1	US22502555_251188612940_S01_1_2_MRP_04000706_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2394.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188612940_S01_1_2_MRP_04000706_1	US22502555_251188612940_S01_1_2_MRP_04000706_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1619.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.2 years plus	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_2_1_04000640_1_MRP	US22502555_251188612421_S01_2_1_04000640_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
329	60 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	73.4%	17.2 years plus	Estrogen Receptor Positive	17.2 years plus	17.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000640	P-TABM-212	4000640_e1	total_RNA	P-TABM-214	4000640_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1619.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	17.2 years plus	17.2 years plus	St Gallen category:high clinical risk	17.2 years plus	Estrogen Receptor Positive	US22502555_251188612421_S01_2_1_04000640_1_MRP	US22502555_251188612421_S01_2_1_04000640_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2520.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.25 years	1.89 years	St Gallen category:high clinical risk	2.68 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_3_04000530_1_MRP	US22502555_251188612910_S01_2_3_04000530_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04049	33 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	68.1%	1.25 years	Estrogen Receptor Negative	1.89 years	2.68 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000530	P-TABM-212	4000530_e1	total_RNA	P-TABM-214	4000530_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2520.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.25 years	1.89 years	St Gallen category:high clinical risk	2.68 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_3_04000530_1_MRP	US22502555_251188612910_S01_2_3_04000530_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
530	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	JRH	85.7%	2.7 years	Estrogen Receptor Positive	4.7 years	5.8 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000703	P-TABM-212	4000703_e1	total_RNA	P-TABM-214	4000703_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2274.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	4.7 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Positive	US22502555_251188612909_S01_1_3_04000703_1_MRP	US22502555_251188612909_S01_1_3_04000703_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2274.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.7 years	4.7 years	St Gallen category:high clinical risk	5.8 years	Estrogen Receptor Positive	US22502555_251188612909_S01_1_3_04000703_1_MRP	US22502555_251188612909_S01_1_3_04000703_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04058	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	89.8%	2.6 years	Estrogen Receptor Positive	8.1 years plus	8.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000526	P-TABM-212	4000526_e1	total_RNA	P-TABM-214	4000526_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2045.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612459_S01_2_1_04000526_1_MRP	US22502555_251188612459_S01_2_1_04000526_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2045.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.6 years	8.1 years plus	St Gallen category:high clinical risk	8.1 years	Estrogen Receptor Positive	US22502555_251188612459_S01_2_1_04000526_1_MRP	US22502555_251188612459_S01_2_1_04000526_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1536.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.4 years plus	13.4 years plus	St Gallen category:high clinical risk	13.4 years plus	Estrogen Receptor Negative	US22502555_251188612393_S01_1_4_MRP_04000619_1	US22502555_251188612393_S01_1_4_MRP_04000619_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1767	41 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	3	CRH	67.5%	13.4 years plus	Estrogen Receptor Negative	13.4 years plus	13.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000619	P-TABM-212	4000619_e1	total_RNA	P-TABM-214	4000619_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1536.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.4 years plus	13.4 years plus	St Gallen category:high clinical risk	13.4 years plus	Estrogen Receptor Negative	US22502555_251188612393_S01_1_4_MRP_04000619_1	US22502555_251188612393_S01_1_4_MRP_04000619_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.926.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.0 years plus	8.0 years plus	St Gallen category:high clinical risk	8.0 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_4_MRP_04000608_1	US22502555_251188612202_S01_1_4_MRP_04000608_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2322	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	24 mm diameter	2	CRH	79.6%	8.0 years plus	Estrogen Receptor Positive	8.0 years plus	8.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000608	P-TABM-212	4000608_e1	total_RNA	P-TABM-214	4000608_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.926.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.0 years plus	8.0 years plus	St Gallen category:high clinical risk	8.0 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_4_MRP_04000608_1	US22502555_251188612202_S01_1_4_MRP_04000608_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1248.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.0 years	19.6 years	St Gallen category:high clinical risk	19.4 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_2_MRP_04000590_1	US22502555_251188612338_S01_2_2_MRP_04000590_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5224	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	CRH	86.1%	11.0 years	Estrogen Receptor Positive	19.6 years	19.4 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000590	P-TABM-212	4000590_e1	total_RNA	P-TABM-214	4000590_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1248.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	11.0 years	19.6 years	St Gallen category:high clinical risk	19.4 years plus	Estrogen Receptor Positive	US22502555_251188612338_S01_2_2_MRP_04000590_1	US22502555_251188612338_S01_2_2_MRP_04000590_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1743.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_1_4_MRP_04000575_1	US22502555_251188612427_S01_1_4_MRP_04000575_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
386	51 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	14 mm diameter	2	KAR	87.2%	13.8 years plus	Estrogen Receptor Positive	13.8 years plus	13.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000575	P-TABM-212	4000575_e1	total_RNA	P-TABM-214	4000575_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1743.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.8 years plus	13.8 years plus	St Gallen category:high clinical risk	13.8 years plus	Estrogen Receptor Positive	US22502555_251188612427_S01_1_4_MRP_04000575_1	US22502555_251188612427_S01_1_4_MRP_04000575_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1158.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612322_S01_1_1_04000406_1_MRP	US22502555_251188612322_S01_1_1_04000406_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
101B88	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	KAR	81.3%	17.1 years plus	Estrogen Receptor Negative	17.1 years plus	17.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000406	P-TABM-212	4000406_e1	total_RNA	P-TABM-214	4000406_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1158.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.1 years plus	17.1 years plus	St Gallen category:high clinical risk	17.1 years plus	Estrogen Receptor Negative	US22502555_251188612322_S01_1_1_04000406_1_MRP	US22502555_251188612322_S01_1_1_04000406_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.872.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.6 years plus	9.6 years plus	St Gallen category:low clinical risk	9.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_1_04000603_1_MRP	US22502555_251188612201_S01_1_1_04000603_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2393	45 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	CRH	94%	9.6 years plus	Estrogen Receptor Positive	9.6 years plus	9.6 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000603	P-TABM-212	4000603_e1	total_RNA	P-TABM-214	4000603_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.872.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	9.6 years plus	9.6 years plus	St Gallen category:low clinical risk	9.6 years plus	Estrogen Receptor Positive	US22502555_251188612201_S01_1_1_04000603_1_MRP	US22502555_251188612201_S01_1_1_04000603_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1264.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:low clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_1_4_MRP_04000411_1	US22502555_251188612372_S01_1_4_MRP_04000411_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
27C4	47 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	1	KAR	93.4%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000411	P-TABM-212	4000411_e1	total_RNA	P-TABM-214	4000411_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1264.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:low clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612372_S01_1_4_MRP_04000411_1	US22502555_251188612372_S01_1_4_MRP_04000411_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
531	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	JRH	89.8%	12.0 years plus	Estrogen Receptor Positive	12.0 years plus	12.0 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000704	P-TABM-212	4000704_e1	total_RNA	P-TABM-214	4000704_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2511.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.0 years plus	12.0 years plus	St Gallen category:high clinical risk	12.0 years plus	Estrogen Receptor Positive	US22502555_251188612946_S01_1_4_MRP_04000704_1	US22502555_251188612946_S01_1_4_MRP_04000704_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2511.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.0 years plus	12.0 years plus	St Gallen category:high clinical risk	12.0 years plus	Estrogen Receptor Positive	US22502555_251188612946_S01_1_4_MRP_04000704_1	US22502555_251188612946_S01_1_4_MRP_04000704_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1720	24 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	1	CRH	79.5%	2.2 years	Estrogen Receptor Positive	2.2 years	3.6 years	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000622	P-TABM-212	4000622_e1	total_RNA	P-TABM-214	4000622_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1560.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	3.6 years	Estrogen Receptor Positive	US22502555_251188612394_S01_1_2_MRP_04000622_1	US22502555_251188612394_S01_1_2_MRP_04000622_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1560.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.2 years	2.2 years	St Gallen category:high clinical risk	3.6 years	Estrogen Receptor Positive	US22502555_251188612394_S01_1_2_MRP_04000622_1	US22502555_251188612394_S01_1_2_MRP_04000622_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1605	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	JRH	95.2%	6.3 years	Estrogen Receptor Positive	7.7 years plus	7.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000721	P-TABM-212	4000721_e1	total_RNA	P-TABM-214	4000721_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2358.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	6.3 years	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188612938_S01_1_3_04000721_1_MRP	US22502555_251188612938_S01_1_3_04000721_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2358.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	6.3 years	7.7 years plus	St Gallen category:high clinical risk	7.7 years plus	Estrogen Receptor Positive	US22502555_251188612938_S01_1_3_04000721_1_MRP	US22502555_251188612938_S01_1_3_04000721_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
16B5	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	KAR	81.5%	2.5 years	Estrogen Receptor Negative	3.6 years	4.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000418	P-TABM-212	4000418_e1	total_RNA	P-TABM-214	4000418_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1321.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.5 years	3.6 years	St Gallen category:high clinical risk	4.3 years	Estrogen Receptor Negative	US22502555_251188612375_S01_1_1_04000418_1_MRP	US22502555_251188612375_S01_1_1_04000418_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1321.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.5 years	3.6 years	St Gallen category:high clinical risk	4.3 years	Estrogen Receptor Negative	US22502555_251188612375_S01_1_1_04000418_1_MRP	US22502555_251188612375_S01_1_1_04000418_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1702.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	14.8 years plus	14.8 years plus	St Gallen category:low clinical risk	14.8 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_2_MRP_04000568_1	US22502555_251188612425_S01_2_2_MRP_04000568_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2656	54 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	1	KAR	92.2%	14.8 years plus	Estrogen Receptor Positive	14.8 years plus	14.8 years plus	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000568	P-TABM-212	4000568_e1	total_RNA	P-TABM-214	4000568_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1702.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	14.8 years plus	14.8 years plus	St Gallen category:low clinical risk	14.8 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_2_MRP_04000568_1	US22502555_251188612425_S01_2_2_MRP_04000568_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.649.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.7 years plus	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_2_1_04000329_1_MRP	US22502555_251188611809_S01_2_1_04000329_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254485	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	1	IGR	88.4%	12.7 years plus	Estrogen Receptor Positive	12.7 years plus	12.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000329	P-TABM-212	4000329_e1	total_RNA	P-TABM-214	4000329_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.649.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.7 years plus	12.7 years plus	St Gallen category:high clinical risk	12.7 years plus	Estrogen Receptor Positive	US22502555_251188611809_S01_2_1_04000329_1_MRP	US22502555_251188611809_S01_2_1_04000329_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
247141	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	IGR	88.9%	2.9 years plus	Estrogen Receptor Positive	2.9 years plus	2.9 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000310	P-TABM-212	4000310_e1	total_RNA	P-TABM-214	4000310_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2174.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.9 years plus	2.9 years plus	St Gallen category:high clinical risk	2.9 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_1_3_04000310_2_MRP	US22502555_251188612774_S01_1_3_04000310_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2174.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	2.9 years plus	2.9 years plus	St Gallen category:high clinical risk	2.9 years plus	Estrogen Receptor Positive	US22502555_251188612774_S01_1_3_04000310_2_MRP	US22502555_251188612774_S01_1_3_04000310_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.487.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Negative	US22502555_251188611804_S01_2_3_04000266_1_MRP	US22502555_251188611804_S01_2_3_04000266_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
217004	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	35 mm diameter	3	IGR	63.8%	12.3 years	Estrogen Receptor Negative	15.7 years plus	15.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000266	P-TABM-212	4000266_e1	total_RNA	P-TABM-214	4000266_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.487.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Negative	US22502555_251188611804_S01_2_3_04000266_1_MRP	US22502555_251188611804_S01_2_3_04000266_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
28C76	56 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	9 mm diameter	2	KAR	89%	15.8 years plus	Estrogen Receptor Positive	15.8 years plus	15.8 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000450	P-TABM-212	4000450_e1	total_RNA	P-TABM-214	4000450_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1007.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_2_2_MRP_04000450_1	US22502555_251188612213_S01_2_2_MRP_04000450_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1007.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	15.8 years plus	15.8 years plus	St Gallen category:high clinical risk	15.8 years plus	Estrogen Receptor Positive	US22502555_251188612213_S01_2_2_MRP_04000450_1	US22502555_251188612213_S01_2_2_MRP_04000450_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04077	53 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	10 mm diameter	2	GUY	90.9%	4.3 years	Estrogen Receptor Positive	7.0 years	9.1 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000510	P-TABM-212	4000510_e1	total_RNA	P-TABM-214	4000510_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1882.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.3 years	7.0 years	St Gallen category:high clinical risk	9.1 years	Estrogen Receptor Positive	US22502555_251188612450_S01_1_4_MRP_04000510_1	US22502555_251188612450_S01_1_4_MRP_04000510_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1882.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	4.3 years	7.0 years	St Gallen category:high clinical risk	9.1 years	Estrogen Receptor Positive	US22502555_251188612450_S01_1_4_MRP_04000510_1	US22502555_251188612450_S01_1_4_MRP_04000510_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
211132	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	1	IGR	82.1%	10.8 years plus	Estrogen Receptor Positive	10.8 years plus	10.8 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000260	P-TABM-212	4000260_e1	total_RNA	P-TABM-214	4000260_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.440.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.8 years plus	10.8 years plus	St Gallen category:high clinical risk	10.8 years plus	Estrogen Receptor Positive	US22502555_251188611803_S01_2_1_04000260_1_MRP	US22502555_251188611803_S01_2_1_04000260_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.440.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.8 years plus	10.8 years plus	St Gallen category:high clinical risk	10.8 years plus	Estrogen Receptor Positive	US22502555_251188611803_S01_2_1_04000260_1_MRP	US22502555_251188611803_S01_2_1_04000260_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04060	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	64.5%	5.0 years	Estrogen Receptor Negative	7.8 years	9.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000525	P-TABM-212	4000525_e1	total_RNA	P-TABM-214	4000525_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2298.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.0 years	7.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_2_MRP_04000525_1	US22502555_251188612910_S01_2_2_MRP_04000525_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2298.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.0 years	7.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_2_MRP_04000525_1	US22502555_251188612910_S01_2_2_MRP_04000525_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
310260	43 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	IGR	89.6%	1.2 years	Estrogen Receptor Positive	1.2 years	5.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000287	P-TABM-212	4000287_e1	total_RNA	P-TABM-214	4000287_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.70.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.2 years	1.2 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611678_S01_1_3_04000287_1_MRP	US22502555_251188611678_S01_1_3_04000287_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.70.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	1.2 years	1.2 years	St Gallen category:high clinical risk	5.9 years	Estrogen Receptor Positive	US22502555_251188611678_S01_1_3_04000287_1_MRP	US22502555_251188611678_S01_1_3_04000287_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04014	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	3	GUY	84.9%	6.0 years	Estrogen Receptor Positive	17.1 years plus	17.1 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000487	P-TABM-212	4000487_e1	total_RNA	P-TABM-214	4000487_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1827.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	17.1 years plus	St Gallen category:high clinical risk	17.1 years	Estrogen Receptor Positive	US22502555_251188612448_S01_1_1_04000487_1_MRP	US22502555_251188612448_S01_1_1_04000487_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1827.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.0 years	17.1 years plus	St Gallen category:high clinical risk	17.1 years	Estrogen Receptor Positive	US22502555_251188612448_S01_1_1_04000487_1_MRP	US22502555_251188612448_S01_1_1_04000487_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1469	35 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	KAR	81.8%	10.9 years	Estrogen Receptor Negative	15.3 years plus	15.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000574	P-TABM-212	4000574_e1	total_RNA	P-TABM-214	4000574_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1737.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Negative	US22502555_251188612427_S01_1_2_MRP_04000574_1	US22502555_251188612427_S01_1_2_MRP_04000574_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1737.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	10.9 years	15.3 years plus	St Gallen category:high clinical risk	15.3 years plus	Estrogen Receptor Negative	US22502555_251188612427_S01_1_2_MRP_04000574_1	US22502555_251188612427_S01_1_2_MRP_04000574_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
306818	39 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	90.3%	6.9 years	Estrogen Receptor Positive	10.7 years plus	10.7 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000301	P-TABM-212	4000301_e1	total_RNA	P-TABM-214	4000301_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.295.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.9 years	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_3_04000301_1_MRP	US22502555_251188611799_S01_1_3_04000301_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.295.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	6.9 years	10.7 years plus	St Gallen category:high clinical risk	10.7 years plus	Estrogen Receptor Positive	US22502555_251188611799_S01_1_3_04000301_1_MRP	US22502555_251188611799_S01_1_3_04000301_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2115.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.5 years	10.5 years	St Gallen category:high clinical risk	11.3 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_2_MRP_04000497_1	US22502555_251188612772_S01_1_2_MRP_04000497_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04022	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	GUY	80.2%	10.5 years	Estrogen Receptor Positive	10.5 years	11.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000497	P-TABM-212	4000497_e1	total_RNA	P-TABM-214	4000497_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2115.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	10.5 years	10.5 years	St Gallen category:high clinical risk	11.3 years	Estrogen Receptor Positive	US22502555_251188612772_S01_1_2_MRP_04000497_1	US22502555_251188612772_S01_1_2_MRP_04000497_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.236.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.3 years plus	9.3 years plus	St Gallen category:high clinical risk	9.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_3_04000343_1_MRP	US22502555_251188611797_S01_2_3_04000343_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256939	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	IGR	81.9%	9.3 years plus	Estrogen Receptor Positive	9.3 years plus	9.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000343	P-TABM-212	4000343_e1	total_RNA	P-TABM-214	4000343_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.236.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.3 years plus	9.3 years plus	St Gallen category:high clinical risk	9.3 years plus	Estrogen Receptor Positive	US22502555_251188611797_S01_2_3_04000343_1_MRP	US22502555_251188611797_S01_2_3_04000343_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2517.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	5.3 years plus	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Negative	US22502555_251188613295_S01_2_4_MRP1_8_04000702_1	US22502555_251188613295_S01_2_4_MRP1_8_04000702_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
513	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	38 mm diameter	2	JRH	64.5%	3.1 years	Estrogen Receptor Negative	5.3 years plus	5.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000702	P-TABM-212	4000702_e1	total_RNA	P-TABM-214	4000702_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2517.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	3.1 years	5.3 years plus	St Gallen category:high clinical risk	5.3 years	Estrogen Receptor Negative	US22502555_251188613295_S01_2_4_MRP1_8_04000702_1	US22502555_251188613295_S01_2_4_MRP1_8_04000702_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.50.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611677_S01_2_3_04000285_1_MRP	US22502555_251188611677_S01_2_3_04000285_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
314827	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	IGR	80%	9.0 years plus	Estrogen Receptor Negative	9.0 years plus	9.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000285	P-TABM-212	4000285_e1	total_RNA	P-TABM-214	4000285_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.50.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.0 years plus	9.0 years plus	St Gallen category:high clinical risk	9.0 years plus	Estrogen Receptor Negative	US22502555_251188611677_S01_2_3_04000285_1_MRP	US22502555_251188611677_S01_2_3_04000285_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1592.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	21.7 years plus	21.7 years plus	St Gallen category:high clinical risk	21.7 years plus	unknown	US22502555_251188612420_S01_2_3_04000643_1_MRP	US22502555_251188612420_S01_2_3_04000643_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256	54 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	3	CRH	79.9%	21.7 years plus	unknown	21.7 years plus	21.7 years plus	NPI:high clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000643	P-TABM-212	4000643_e1	total_RNA	P-TABM-214	4000643_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1592.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	21.7 years plus	21.7 years plus	St Gallen category:high clinical risk	21.7 years plus	unknown	US22502555_251188612420_S01_2_3_04000643_1_MRP	US22502555_251188612420_S01_2_3_04000643_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.724.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.2 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_2_3_04000327_2_MRP	US22502555_251188611855_S01_2_3_04000327_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
254162	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	23 mm diameter	3	IGR	74.2%	9.2 years	Estrogen Receptor Positive	14.4 years plus	14.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000327	P-TABM-212	4000327_e1	total_RNA	P-TABM-214	4000327_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.724.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.2 years	14.4 years plus	St Gallen category:high clinical risk	14.4 years plus	Estrogen Receptor Positive	US22502555_251188611855_S01_2_3_04000327_2_MRP	US22502555_251188611855_S01_2_3_04000327_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1769.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.6 years	Estrogen Receptor Negative	US22502555_251188612446_S01_1_3_04000471_1_MRP	US22502555_251188612446_S01_1_3_04000471_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04002	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	62.7%	2.0 years	Estrogen Receptor Negative	2.0 years	2.6 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000471	P-TABM-212	4000471_e1	total_RNA	P-TABM-214	4000471_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1769.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.6 years	Estrogen Receptor Negative	US22502555_251188612446_S01_1_3_04000471_1_MRP	US22502555_251188612446_S01_1_3_04000471_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
309C49	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	KAR	84.6%	15.2 years plus	Estrogen Receptor Positive	15.2 years plus	15.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000438	P-TABM-212	4000438_e1	total_RNA	P-TABM-214	4000438_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1430.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612379_S01_2_2_MRP_04000438_1	US22502555_251188612379_S01_2_2_MRP_04000438_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1430.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.2 years plus	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Positive	US22502555_251188612379_S01_2_2_MRP_04000438_1	US22502555_251188612379_S01_2_2_MRP_04000438_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.146.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_4_MRP_04000332_1	US22502555_251188611795_S01_1_4_MRP_04000332_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
271834	38 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	18 mm diameter	2	IGR	90.4%	12.2 years plus	Estrogen Receptor Positive	12.2 years plus	12.2 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000332	P-TABM-212	4000332_e1	total_RNA	P-TABM-214	4000332_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.146.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	12.2 years plus	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611795_S01_1_4_MRP_04000332_1	US22502555_251188611795_S01_1_4_MRP_04000332_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1191.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	3.4 years	Estrogen Receptor Negative	US22502555_251188612337_S01_1_1_04000584_1_MRP	US22502555_251188612337_S01_1_1_04000584_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5232	46 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	32 mm diameter	3	CRH	62.7%	1.1 years	Estrogen Receptor Negative	1.1 years	3.4 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000584	P-TABM-212	4000584_e1	total_RNA	P-TABM-214	4000584_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1191.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	1.1 years	St Gallen category:high clinical risk	3.4 years	Estrogen Receptor Negative	US22502555_251188612337_S01_1_1_04000584_1_MRP	US22502555_251188612337_S01_1_1_04000584_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04055	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	2	GUY	88%	16.1 years plus	Estrogen Receptor Positive	16.1 years plus	16.1 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000529	P-TABM-212	4000529_e1	total_RNA	P-TABM-214	4000529_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1967.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612455_S01_1_2_MRP_04000529_1	US22502555_251188612455_S01_1_2_MRP_04000529_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1967.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	16.1 years plus	16.1 years plus	St Gallen category:high clinical risk	16.1 years plus	Estrogen Receptor Positive	US22502555_251188612455_S01_1_2_MRP_04000529_1	US22502555_251188612455_S01_1_2_MRP_04000529_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
5230	53 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	CRH	71.1%	7.2 years plus	Estrogen Receptor Positive	7.2 years plus	7.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000585	P-TABM-212	4000585_e1	total_RNA	P-TABM-214	4000585_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1206.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.2 years plus	7.2 years plus	St Gallen category:high clinical risk	7.2 years plus	Estrogen Receptor Positive	US22502555_251188612337_S01_1_4_MRP_04000585_1	US22502555_251188612337_S01_1_4_MRP_04000585_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1206.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.2 years plus	7.2 years plus	St Gallen category:high clinical risk	7.2 years plus	Estrogen Receptor Positive	US22502555_251188612337_S01_1_4_MRP_04000585_1	US22502555_251188612337_S01_1_4_MRP_04000585_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.399.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.1 years	11.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_4_MRP_04000315_1	US22502555_251188611802_S01_1_4_MRP_04000315_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280352	57 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	75.5%	9.1 years	Estrogen Receptor Positive	11.1 years	12.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000315	P-TABM-212	4000315_e1	total_RNA	P-TABM-214	4000315_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.399.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	9.1 years	11.1 years	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611802_S01_1_4_MRP_04000315_1	US22502555_251188611802_S01_1_4_MRP_04000315_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1472	42 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	26 mm diameter	1	CRH	88.9%	11.9 years	Estrogen Receptor Positive	11.9 years	14.9 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000631	P-TABM-212	4000631_e1	total_RNA	P-TABM-214	4000631_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.777.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years	11.9 years	St Gallen category:high clinical risk	14.9 years	Estrogen Receptor Positive	US22502555_251188612196_S01_1_3_04000631_1_MRP	US22502555_251188612196_S01_1_3_04000631_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.777.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	11.9 years	11.9 years	St Gallen category:high clinical risk	14.9 years	Estrogen Receptor Positive	US22502555_251188612196_S01_1_3_04000631_1_MRP	US22502555_251188612196_S01_1_3_04000631_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.430.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	5.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188611803_S01_1_3_04000259_1_MRP	US22502555_251188611803_S01_1_3_04000259_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
211068	37 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	74.7%	1.0 years	Estrogen Receptor Positive	5.8 years	9.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000259	P-TABM-212	4000259_e1	total_RNA	P-TABM-214	4000259_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.430.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.0 years	5.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Positive	US22502555_251188611803_S01_1_3_04000259_1_MRP	US22502555_251188611803_S01_1_3_04000259_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04099	58 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	19 mm diameter	2	GUY	83.1%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000478	P-TABM-212	4000478_e1	total_RNA	P-TABM-214	4000478_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2008.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_1_3_04000478_1_MRP	US22502555_251188612458_S01_1_3_04000478_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2008.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188612458_S01_1_3_04000478_1_MRP	US22502555_251188612458_S01_1_3_04000478_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1767	41 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	3	CRH	67.5%	13.4 years plus	Estrogen Receptor Negative	13.4 years plus	13.4 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000619	P-TABM-212	4000619_e1	total_RNA	P-TABM-214	4000619_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1529.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.4 years plus	13.4 years plus	St Gallen category:high clinical risk	13.4 years plus	Estrogen Receptor Negative	US22502555_251188612393_S01_1_3_04000619_1_MRP	US22502555_251188612393_S01_1_3_04000619_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1529.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.4 years plus	13.4 years plus	St Gallen category:high clinical risk	13.4 years plus	Estrogen Receptor Negative	US22502555_251188612393_S01_1_3_04000619_1_MRP	US22502555_251188612393_S01_1_3_04000619_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1460.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.0 years	11.1 years plus	St Gallen category:high clinical risk	11.1 years plus	Estrogen Receptor Positive	US22502555_251188612389_S01_1_1_04000610_1_MRP	US22502555_251188612389_S01_1_1_04000610_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2248	49 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	CRH	79.3%	7.0 years	Estrogen Receptor Positive	11.1 years plus	11.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000610	P-TABM-212	4000610_e1	total_RNA	P-TABM-214	4000610_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1460.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	7.0 years	11.1 years plus	St Gallen category:high clinical risk	11.1 years plus	Estrogen Receptor Positive	US22502555_251188612389_S01_1_1_04000610_1_MRP	US22502555_251188612389_S01_1_1_04000610_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
246919	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	87.6%	9.7 years	Estrogen Receptor Positive	14.9 years plus	14.9 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000306	P-TABM-212	4000306_e1	total_RNA	P-TABM-214	4000306_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.334.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.7 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_1_4_MRP_04000306_1	US22502555_251188611800_S01_1_4_MRP_04000306_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.334.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	9.7 years	14.9 years plus	St Gallen category:high clinical risk	14.9 years plus	Estrogen Receptor Positive	US22502555_251188611800_S01_1_4_MRP_04000306_1	US22502555_251188611800_S01_1_4_MRP_04000306_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04049	33 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	GUY	68.1%	1.25 years	Estrogen Receptor Negative	1.89 years	2.68 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000530	P-TABM-212	4000530_e1	total_RNA	P-TABM-214	4000530_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2526.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.25 years	1.89 years	St Gallen category:high clinical risk	2.68 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_4_MRP_04000530_1	US22502555_251188612910_S01_2_4_MRP_04000530_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2526.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.25 years	1.89 years	St Gallen category:high clinical risk	2.68 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_4_MRP_04000530_1	US22502555_251188612910_S01_2_4_MRP_04000530_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04060	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	64.5%	5.0 years	Estrogen Receptor Negative	7.8 years	9.8 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000525	P-TABM-212	4000525_e1	total_RNA	P-TABM-214	4000525_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2294.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.0 years	7.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_1_04000525_1_MRP	US22502555_251188612910_S01_2_1_04000525_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2294.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.0 years	7.8 years	St Gallen category:high clinical risk	9.8 years	Estrogen Receptor Negative	US22502555_251188612910_S01_2_1_04000525_1_MRP	US22502555_251188612910_S01_2_1_04000525_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.450.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	2.2 years	St Gallen category:high clinical risk	3.9 years	Estrogen Receptor Negative	US22502555_251188611803_S01_2_3_04000261_1_MRP	US22502555_251188611803_S01_2_3_04000261_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
211980	42 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	16 mm diameter	3	IGR	81%	1.1 years	Estrogen Receptor Negative	2.2 years	3.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000261	P-TABM-212	4000261_e1	total_RNA	P-TABM-214	4000261_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.450.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	1.1 years	2.2 years	St Gallen category:high clinical risk	3.9 years	Estrogen Receptor Negative	US22502555_251188611803_S01_2_3_04000261_1_MRP	US22502555_251188611803_S01_2_3_04000261_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.966.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	0.6 years	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Negative	US22502555_251188612211_S01_2_2_MRP_04000442_1	US22502555_251188612211_S01_2_2_MRP_04000442_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
43C47	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	2	KAR	83.1%	0.6 years	Estrogen Receptor Negative	15.2 years plus	15.2 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000442	P-TABM-212	4000442_e1	total_RNA	P-TABM-214	4000442_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.966.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	0.6 years	15.2 years plus	St Gallen category:high clinical risk	15.2 years plus	Estrogen Receptor Negative	US22502555_251188612211_S01_2_2_MRP_04000442_1	US22502555_251188612211_S01_2_2_MRP_04000442_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
366	57 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	3	JRH	62.7%	2.8 years	Estrogen Receptor Negative	3.0 years	3.3 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000692	P-TABM-212	4000692_e1	total_RNA	P-TABM-214	4000692_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2387.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	3.0 years	St Gallen category:high clinical risk	3.3 years	Estrogen Receptor Negative	US22502555_251188612939_S01_2_2_MRP_04000692_1	US22502555_251188612939_S01_2_2_MRP_04000692_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2387.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.8 years	3.0 years	St Gallen category:high clinical risk	3.3 years	Estrogen Receptor Negative	US22502555_251188612939_S01_2_2_MRP_04000692_1	US22502555_251188612939_S01_2_2_MRP_04000692_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.324.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.8 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188611800_S01_1_2_MRP_04000304_1	US22502555_251188611800_S01_1_2_MRP_04000304_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
287897	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	1	IGR	94.3%	8.8 years	Estrogen Receptor Positive	9.9 years plus	9.9 years	St Gallen category:low clinical risk	NPI:low clinical risk	Adjuvant online:low clinical risk	mammary gland	EFO	EFO_0000854	  	4000304	P-TABM-212	4000304_e1	total_RNA	P-TABM-214	4000304_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.324.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	8.8 years	9.9 years plus	St Gallen category:low clinical risk	9.9 years	Estrogen Receptor Positive	US22502555_251188611800_S01_1_2_MRP_04000304_1	US22502555_251188611800_S01_1_2_MRP_04000304_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.820.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188612198_S01_2_2_MRP_04000636_1	US22502555_251188612198_S01_2_2_MRP_04000636_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1158	60 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	12 mm diameter	3	CRH	73.4%	16.0 years plus	Estrogen Receptor Negative	16.0 years plus	16.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000636	P-TABM-212	4000636_e1	total_RNA	P-TABM-214	4000636_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.820.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Negative	US22502555_251188612198_S01_2_2_MRP_04000636_1	US22502555_251188612198_S01_2_2_MRP_04000636_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
256253	52 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	IGR	86.7%	12.3 years plus	Estrogen Receptor Positive	12.3 years plus	12.3 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000348	P-TABM-212	4000348_e1	total_RNA	P-TABM-214	4000348_e1_l2Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.752.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_1_1_04000348_2_MRP	US22502555_251188611857_S01_1_1_04000348_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.752.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.3 years plus	12.3 years plus	St Gallen category:high clinical risk	12.3 years plus	Estrogen Receptor Positive	US22502555_251188611857_S01_1_1_04000348_2_MRP	US22502555_251188611857_S01_1_1_04000348_2_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
3642	40 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	42 mm diameter	3	CRH	66.6%	6.7 years	Estrogen Receptor Positive	6.7 years	14.5 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000599	P-TABM-212	4000599_e1	total_RNA	P-TABM-214	4000599_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.847.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	6.7 years	St Gallen category:high clinical risk	14.5 years	Estrogen Receptor Positive	US22502555_251188612200_S01_1_2_MRP_04000599_1	US22502555_251188612200_S01_1_2_MRP_04000599_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.847.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	6.7 years	St Gallen category:high clinical risk	14.5 years	Estrogen Receptor Positive	US22502555_251188612200_S01_1_2_MRP_04000599_1	US22502555_251188612200_S01_1_2_MRP_04000599_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.376.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_3_04000313_1_MRP	US22502555_251188611801_S01_2_3_04000313_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
280391	52 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	IGR	78.1%	2.0 years	Estrogen Receptor Positive	12.2 years plus	12.2 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000313	P-TABM-212	4000313_e1	total_RNA	P-TABM-214	4000313_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.376.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	2.0 years	12.2 years plus	St Gallen category:high clinical risk	12.2 years plus	Estrogen Receptor Positive	US22502555_251188611801_S01_2_3_04000313_1_MRP	US22502555_251188611801_S01_2_3_04000313_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2051.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.5 years plus	16.5 years plus	St Gallen category:high clinical risk	16.5 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_2_3_04000543_1_MRP	US22502555_251188612459_S01_2_3_04000543_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04040	47 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	73.2%	16.5 years plus	Estrogen Receptor Positive	16.5 years plus	16.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000543	P-TABM-212	4000543_e1	total_RNA	P-TABM-214	4000543_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2051.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.5 years plus	16.5 years plus	St Gallen category:high clinical risk	16.5 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_2_3_04000543_1_MRP	US22502555_251188612459_S01_2_3_04000543_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2481	50 years at diagnosis	St Gallen category:not applicable	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	unknown	KAR	87.6%	6.7 years	Estrogen Receptor Positive	14.3 years plus	14.3 years plus	MammaPrint result:high risk	Adjuvant online:high clinical risk	NPI:not applicable	mammary gland	EFO	EFO_0000854	  	4000569	P-TABM-212	4000569_e1	total_RNA	P-TABM-214	4000569_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1705.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	14.3 years plus	St Gallen category:not applicable	14.3 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_3_04000569_1_MRP	US22502555_251188612425_S01_2_3_04000569_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1705.Hybridization	A-MEXP-318	P-TABM-216	NPI:not applicable	Adjuvant online:high clinical risk	MammaPrint result:high risk	6.7 years	14.3 years plus	St Gallen category:not applicable	14.3 years plus	Estrogen Receptor Positive	US22502555_251188612425_S01_2_3_04000569_1_MRP	US22502555_251188612425_S01_2_3_04000569_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1848.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_3_04000502_1_MRP	US22502555_251188612449_S01_1_3_04000502_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04087	37 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	17 mm diameter	3	GUY	85.6%	14.7 years plus	Estrogen Receptor Positive	14.7 years plus	14.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000502	P-TABM-212	4000502_e1	total_RNA	P-TABM-214	4000502_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1848.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	14.7 years plus	14.7 years plus	St Gallen category:high clinical risk	14.7 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_3_04000502_1_MRP	US22502555_251188612449_S01_1_3_04000502_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2207.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.6 years plus	17.6 years plus	St Gallen category:high clinical risk	17.6 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_2_2_MRP_04000351_1	US22502555_251188612775_S01_2_2_MRP_04000351_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
171897	44 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	IGR	89.4%	17.6 years plus	Estrogen Receptor Positive	17.6 years plus	17.6 years plus	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000351	P-TABM-212	4000351_e1	total_RNA	P-TABM-214	4000351_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2207.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:low risk	17.6 years plus	17.6 years plus	St Gallen category:high clinical risk	17.6 years plus	Estrogen Receptor Positive	US22502555_251188612775_S01_2_2_MRP_04000351_1	US22502555_251188612775_S01_2_2_MRP_04000351_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
15E6	39 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	11 mm diameter	3	KAR	81.4%	17.3 years plus	Estrogen Receptor Negative	17.3 years plus	17.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000426	P-TABM-212	4000426_e1	total_RNA	P-TABM-214	4000426_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1374.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.3 years plus	17.3 years plus	St Gallen category:high clinical risk	17.3 years plus	Estrogen Receptor Negative	US22502555_251188612377_S01_1_1_04000426_1_MRP	US22502555_251188612377_S01_1_1_04000426_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1374.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	17.3 years plus	17.3 years plus	St Gallen category:high clinical risk	17.3 years plus	Estrogen Receptor Negative	US22502555_251188612377_S01_1_1_04000426_1_MRP	US22502555_251188612377_S01_1_1_04000426_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1953.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_2_2_MRP_04000523_1	US22502555_251188612453_S01_2_2_MRP_04000523_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04062	50 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	GUY	87.6%	16.0 years plus	Estrogen Receptor Positive	16.0 years plus	16.0 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000523	P-TABM-212	4000523_e1	total_RNA	P-TABM-214	4000523_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1953.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	16.0 years plus	16.0 years plus	St Gallen category:high clinical risk	16.0 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_2_2_MRP_04000523_1	US22502555_251188612453_S01_2_2_MRP_04000523_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
217743	56 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	28 mm diameter	3	IGR	63.2%	15.1 years plus	Estrogen Receptor Negative	15.1 years plus	15.1 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000269	P-TABM-212	4000269_e1	total_RNA	P-TABM-214	4000269_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.520.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188611805_S01_2_2_MRP_04000269_1	US22502555_251188611805_S01_2_2_MRP_04000269_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.520.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.1 years plus	15.1 years plus	St Gallen category:high clinical risk	15.1 years plus	Estrogen Receptor Negative	US22502555_251188611805_S01_2_2_MRP_04000269_1	US22502555_251188611805_S01_2_2_MRP_04000269_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2440.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_2_2_MRP_04000714_1	US22502555_251188612941_S01_2_2_MRP_04000714_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1006	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	JRH	84.8%	7.3 years plus	Estrogen Receptor Positive	7.3 years plus	7.3 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000714	P-TABM-212	4000714_e1	total_RNA	P-TABM-214	4000714_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2440.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.3 years plus	7.3 years plus	St Gallen category:high clinical risk	7.3 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_2_2_MRP_04000714_1	US22502555_251188612941_S01_2_2_MRP_04000714_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
662	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	3	JRH	74%	5.7 years	Estrogen Receptor Positive	11.5 years plus	11.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000711	P-TABM-212	4000711_e1	total_RNA	P-TABM-214	4000711_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2424.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.7 years	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_2_MRP_04000711_1	US22502555_251188612941_S01_1_2_MRP_04000711_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2424.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	5.7 years	11.5 years plus	St Gallen category:high clinical risk	11.5 years plus	Estrogen Receptor Positive	US22502555_251188612941_S01_1_2_MRP_04000711_1	US22502555_251188612941_S01_1_2_MRP_04000711_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1067.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_3_04000458_1_MRP	US22502555_251188612215_S01_2_3_04000458_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
268C87	32 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	15 mm diameter	2	KAR	87%	15.7 years plus	Estrogen Receptor Positive	15.7 years plus	15.7 years plus	Adjuvant online:high clinical risk	NPI:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000458	P-TABM-212	4000458_e1	total_RNA	P-TABM-214	4000458_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1067.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612215_S01_2_3_04000458_1_MRP	US22502555_251188612215_S01_2_3_04000458_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
382	60 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	2	JRH	73.4%	12.8 years plus	Estrogen Receptor Positive	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000693	P-TABM-212	4000693_e1	total_RNA	P-TABM-214	4000693_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2310.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_4_MRP_04000693_1	US22502555_251188612911_S01_2_4_MRP_04000693_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2310.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612911_S01_2_4_MRP_04000693_1	US22502555_251188612911_S01_2_4_MRP_04000693_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2446.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Positive	US22502555_251188612941_S01_2_4_MRP_04000715_1	US22502555_251188612941_S01_2_4_MRP_04000715_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1065	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	2	JRH	89.6%	2.0 years	Estrogen Receptor Positive	2.0 years	2.2 years	NPI:low clinical risk	Adjuvant online:low clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000715	P-TABM-212	4000715_e1	total_RNA	P-TABM-214	4000715_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2446.Hybridization	A-MEXP-318	P-TABM-216	NPI:low clinical risk	Adjuvant online:low clinical risk	MammaPrint result:high risk	2.0 years	2.0 years	St Gallen category:high clinical risk	2.2 years	Estrogen Receptor Positive	US22502555_251188612941_S01_2_4_MRP_04000715_1	US22502555_251188612941_S01_2_4_MRP_04000715_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2529.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.77 years	1.19 years	St Gallen category:high clinical risk	1.83 years	Estrogen Receptor Negative	US22502555_251188612911_S01_1_1_04000535_1_MRP	US22502555_251188612911_S01_1_1_04000535_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04054	38 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	GUY	81.5%	0.77 years	Estrogen Receptor Negative	1.19 years	1.83 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000535	P-TABM-212	4000535_e1	total_RNA	P-TABM-214	4000535_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2529.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	0.77 years	1.19 years	St Gallen category:high clinical risk	1.83 years	Estrogen Receptor Negative	US22502555_251188612911_S01_1_1_04000535_1_MRP	US22502555_251188612911_S01_1_1_04000535_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1570.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.0 years plus	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Negative	US22502555_251188612394_S01_2_1_04000624_1_MRP	US22502555_251188612394_S01_2_1_04000624_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1568	59 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	21 mm diameter	3	CRH	61.5%	13.0 years plus	Estrogen Receptor Negative	13.0 years plus	13.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000624	P-TABM-212	4000624_e1	total_RNA	P-TABM-214	4000624_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1570.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	13.0 years plus	13.0 years plus	St Gallen category:high clinical risk	13.0 years plus	Estrogen Receptor Negative	US22502555_251188612394_S01_2_1_04000624_1_MRP	US22502555_251188612394_S01_2_1_04000624_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
2322	48 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	24 mm diameter	2	CRH	79.6%	8.0 years plus	Estrogen Receptor Positive	8.0 years plus	8.0 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000608	P-TABM-212	4000608_e1	total_RNA	P-TABM-214	4000608_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.920.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.0 years plus	8.0 years plus	St Gallen category:high clinical risk	8.0 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_3_04000608_1_MRP	US22502555_251188612202_S01_1_3_04000608_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.920.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	8.0 years plus	8.0 years plus	St Gallen category:high clinical risk	8.0 years plus	Estrogen Receptor Positive	US22502555_251188612202_S01_1_3_04000608_1_MRP	US22502555_251188612202_S01_1_3_04000608_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04065	36 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	30 mm diameter	3	GUY	74.8%	15.5 years plus	Estrogen Receptor Positive	15.5 years plus	15.5 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000522	P-TABM-212	4000522_e1	total_RNA	P-TABM-214	4000522_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1947.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_4_MRP_04000522_1	US22502555_251188612453_S01_1_4_MRP_04000522_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1947.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	15.5 years plus	15.5 years plus	St Gallen category:high clinical risk	15.5 years plus	Estrogen Receptor Positive	US22502555_251188612453_S01_1_4_MRP_04000522_1	US22502555_251188612453_S01_1_4_MRP_04000522_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
1708	43 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	20 mm diameter	3	KAR	80.8%	7.9 years	Estrogen Receptor Negative	7.9 years plus	7.9 years	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000572	P-TABM-212	4000572_e1	total_RNA	P-TABM-214	4000572_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1717.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years	7.9 years plus	St Gallen category:high clinical risk	7.9 years	Estrogen Receptor Negative	US22502555_251188612426_S01_2_1_04000572_1_MRP	US22502555_251188612426_S01_2_1_04000572_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1717.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	7.9 years	7.9 years plus	St Gallen category:high clinical risk	7.9 years	Estrogen Receptor Negative	US22502555_251188612426_S01_2_1_04000572_1_MRP	US22502555_251188612426_S01_2_1_04000572_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2042.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_4_MRP_04000524_1	US22502555_251188612459_S01_1_4_MRP_04000524_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04061	46 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	25 mm diameter	2	GUY	80.2%	15.6 years plus	Estrogen Receptor Positive	15.6 years plus	15.6 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000524	P-TABM-212	4000524_e1	total_RNA	P-TABM-214	4000524_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.2042.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.6 years plus	15.6 years plus	St Gallen category:high clinical risk	15.6 years plus	Estrogen Receptor Positive	US22502555_251188612459_S01_1_4_MRP_04000524_1	US22502555_251188612459_S01_1_4_MRP_04000524_1.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
04088	48 years at diagnosis	MammaPrint result:high risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	40 mm diameter	3	GUY	65.2%	12.8 years plus	Estrogen Receptor Positive	12.8 years plus	12.8 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000501	P-TABM-212	4000501_e1	total_RNA	P-TABM-214	4000501_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1841.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_1_04000501_1_MRP	US22502555_251188612449_S01_1_1_04000501_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1841.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:high risk	12.8 years plus	12.8 years plus	St Gallen category:high clinical risk	12.8 years plus	Estrogen Receptor Positive	US22502555_251188612449_S01_1_1_04000501_1_MRP	US22502555_251188612449_S01_1_1_04000501_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
MRP	  	  	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	  	  	Agendia	  	  	  	  	  	  	  	  	mammary gland	EFO	EFO_0000854	P-TABM-213	MRP	P-TABM-212	MRP_e1	total_RNA	P-TABM-214	MRP_e1_l1Cy3	Cy3	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1081.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_3_04000460_1_MRP	US22502555_251188612217_S01_1_3_04000460_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
266C51	58 years at diagnosis	MammaPrint result:low risk	female	EFO	EFO_0001265	Malignant Neoplasm	Homo sapiens	EFO	http://purl.org/obo/owl/NCBITaxon#NCBITaxon_9606	22 mm diameter	2	KAR	74.8%	15.7 years plus	Estrogen Receptor Positive	15.7 years plus	15.7 years plus	Adjuvant online:high clinical risk	NPI:high clinical risk	St Gallen category:high clinical risk	mammary gland	EFO	EFO_0000854	  	4000460	P-TABM-212	4000460_e1	total_RNA	P-TABM-214	4000460_e1_l1Cy5	Cy5	synthetic_DNA	P-TABM-215	TABM:Tab2MAGE:E-TABM-77.1081.Hybridization	A-MEXP-318	P-TABM-216	NPI:high clinical risk	Adjuvant online:high clinical risk	MammaPrint result:low risk	15.7 years plus	15.7 years plus	St Gallen category:high clinical risk	15.7 years plus	Estrogen Receptor Positive	US22502555_251188612217_S01_1_3_04000460_1_MRP	US22502555_251188612217_S01_1_3_04000460_1_MRP.txt	ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/experiment/TABM/E-TABM-77/E-TABM-77.raw.1.zip
